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ABSTRACT OF THE DISSERTATION
Regional Reprogramming and the Small Intestine: Analysis and Modeling of Adaptive
Regeneration of the Epithelium
by
Sarah Elizabeth Waye
Doctor of Philosophy in Biology and Biomedical Sciences
Developmental, Regenerative & Stem Cell Biology
Washington University in St. Louis, 2021
Dr. Samantha A. Morris, Chair
The small intestine in homeostasis is capable of regular regeneration, but in cases of massive
injury like Short Bowel Syndrome, the innate human response often fails to fully compensate for
the loss of nutrient absorptive surface area that accompanies bowel resection. Murine models
display an active compensatory reaction deemed “adaptation” in which the surface area of the
bowel is increased to accommodate nutrient absorptive needs. This observation has highlighted
several gaps in knowledge regarding bowel adaptation. Firstly, what occurs on a molecular level
in murine models during adaptation? Secondly, how can the findings in mice be applied to
humans in an accurate modeling system?
Using a murine model of bowel resection, single cell RNA sequencing was employed to analyze
the molecular changes accompanying adaptation of the intestinal epithelium. We identify a
process we deem “regional reprogramming” through which distal enterocytes upregulate genes
associated with proximal intestinal nutrient transport during adaptation. In silico analysis
indicates the importance of region-specific diffusible signals, notably Vitamin A, in driving this
process through activation of transcription factors and signaling cascades. We further apply these
xi

findings to build an in vitro model of regional reprogramming utilizing chimerization of
proximal and distal intestinal organoids. The chimeric organoid model, when analyzed using
single cell RNA-seq, indicates proximalization of distal organoid tissue upon exposure to the
proximal organoid signaling environment—potentially related to changes in Guanylate CyclaseC signaling. Finally, we utilize direct reprogramming to investigate the ability potential upstream
transcription factor Gata4 to induce regional reprogramming in vitro in organoids. We find that
the use of Gata4 alone is not sufficient to induce regional reprogramming in vitro, necessitating
further study of the role of transcription factor signaling in regional reprogramming. This work
concludes that regional reprogramming occurs during adaptation in mice, introduces a novel
preliminary model of regional reprogramming due to diffusible signals—the chimera, and lays
the groundwork for use of direct reprogramming to study regional reprogramming related to
transcription factor activation in vitro.

xii

Chapter 1: Introduction
Much of translational biology today focuses on the repair and regeneration of tissues in
order to address ailments from a cellular level. However, studies directly on human or patient
tissue are difficult—not only are there restrictions on tissue procurement, but also an inability to
perform in vivo studies. Because of this, most translational research takes place in animals and
the findings are later applied to humans. Animal research allows for in vivo regeneration and
repair studies and provides critical data, but comes at a high monetary and time cost in addition
to obvious shortcomings regarding the differences in animal and human biology. Modeling
diseases and potential treatments in vitro provides higher throughput experimentation at a lower
cost, but many specialized cells fail to grow in generalized culture conditions in vitro. In
addition, the complex nature of heterogeneous tissues, such as the small intestine, makes in vitro
modeling and expanding such cells difficult.1 In recent years, advances in cell culture techniques
and cellular reprogramming have opened doors to in vitro modeling applications allowing
researchers to better understand disease physiology ex vivo for applications in healthcare fields.
This dissertation will focus on cellular reprogramming, disease and repair modeling, and
applications of single cell RNA-seq (scRNA-seq) in a small intestine-specific manner.
Specifically, we will use of scRNA-seq to uncover information in in vivo animal models and
apply these findings to develop in vitro models to aid in discovery and future human studies.

1.1 Review of the Literature
The following literature review, Subsections (1.1.1-1.1.4), will focus on the four topics
relevant to this dissertation: 1) Intestinal damage and regeneration, with a focus on Short Bowel
1

Syndrome, 2) Intestinal organoids, 3) Cellular reprogramming, and 4) scRNA-seq technology. In
these sections, a brief historical perspective of each topic and biological background relevant to
the work will be discussed. In addition, important models, methods, and technology relating to
each topic will be introduced.

1.1.1 Intestinal Damage and Regeneration: Short Bowel Syndrome, an
Example of Disease and Adaptation
The small intestine is the organ responsible for the majority of nutrient absorption in the
human body. The epithelium, or absorptive surface, of the small intestine is formed of a series of
peaks and valleys called villi and crypts respectively (Figure 1.1). These folds in the intestinal
epithelium help to increase the surface area available for nutrient absorption.2 The epithelium
consists of multiple, heterogeneous cell types with various functions. The stem cells (also known
as crypt base columnar cells or CBCs), originally observed in 1974, reside in the base of the
crypt. Transit amplifying cells (a progenitor-like cell located above the stem cell) differentiate
into enterocytes, goblet cells, enteroendocrine cells, tuft cells, and Paneth cells, among a few
other rarer types.3 As most cell types of the intestine differentiate, they migrate up out of the
crypt onto the villi. Enterocytes are the major absorptive cell of the intestine, forming the
majority (~80%) of the epithelium.4 Interspersed with enterocytes are the mucus secreting goblet
cells and hormone producing enteroendocrine cells. Most distinct among the small intestinal cell
types is the Paneth cell, a differentiated cell that migrates downward into crypt. These Paneth
cells provide antibacterial products to protect the stem cells but have additionally been shown to
help provide and maintain the stem cell niche by producing factors needed to maintain Wnt,
EGF, and Notch signaling (Figure 1.1).2,5–7
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Figure 1.1: Diagram of the small intestinal epithelium. The small intestinal epithelium is lined by multiple cell types.
The invaginated crypt area houses stem cells, Paneth cells, and transit amplifying cells, while the protruding villi
house enterocytes, goblet cells, and enteroendocrine cells. The grey line delineates the approximate cutoff between
villus and crypt.

The lifespan of most intestinal cells is relatively short. After differentiating from stem
cells (a constant process), cells move up the villi for 3-5 days until they reach the peak of the
villus and are sloughed off and replaced by younger cells.2,8 Because of this continual movement,
the intestinal epithelium is considered to regenerate every 5 days, making it one of the most
regenerative tissues in a mammal.9 The major exception to this rule, again, is the Paneth cell,
which has a much longer lifespan—near 1-2 months.2 Because of this short lifecycle of the
epithelium, the intestine is considered to be a highly regenerative organ and minor insults to the
epithelium often heal quickly. In addition, studies have shown that damage that eliminates or
mutates the Lgr5+ crypt-base stem cells can still be repaired by “reserve” stem cells, cellular
competition, and dedifferentiation.9,10 However, many intestinal diseases and major insults or
3

damage, such as necrotizing enterocolitis, Crohn’s disease, ischemia, volvulus, cancer treatment,
and colitis can cause much deeper issues—even complete death of the tissue—that are not
simply fixed by the turnover of the epithelium. Because of this, intestinal diseases and
regenerative treatments for such diseases comprise a large portion of GI research today.
Of significant interest to physicians and researchers alike is Short Bowel Syndrome
(SBS). SBS, while rare (24.5 children per 100,000 live births), has significant morbidity (5-year
mortality >30%) and is most common amongst neonatal and pediatric populations.11,12 SBS
occurs when an individual exhibits massive disease or injury to the bowel, due to issues like
necrotizing enterocolitis or gastroschisis, necessitating the removal of a large portion of bowel in
what is referred to as “small bowel resection” (SBR). The remaining bowel is anastomosed back
to a continuous tube. When a large portion of the bowel is removed, the patient suffers from
malabsorption, the extent of which is directly related to the amount of bowel removed.
Malabsorption occurs in these populations due to the loss of the surface area of the intestine.
Less intestinal length means less absorptive epithelium leading to fewer nutrients absorbed.
These patients often require total parenteral nutrition in order to survive. Unfortunately,
parenteral nutrition incurs a health and financial cost, causing liver damage, sepsis, stunted
growth, and costing up to $390,000/year.13,14 Because of these significant issues, alternative
treatments for SBS are highly sought after, but current treatments leave something to be desired.
Current treatments are not curative, relying on surgical lengthening of the intestine, or on full
intestinal transplantation, which can have dangerous complications such as leakage, bowel
dilation, transplant rejection, or donor scarcity, leading to a 3- year survival rate between 32%
and 60% 15–17.

4

Much current research into treatment of SBS focuses on tissue-engineered small intestine
(TESI) to fully replace the lost tissue length. TESI encompasses the use of intestinal cells seeded
on a scaffold (either decellularized biological matrices or synthetic) mimicking the intestinal
architecture.18–20 Much excitement surrounds the use of human intestinal organoids (HIOs)
(derived from human embryonic stem cells, induced pluripotent stem cells, or biopsies) to
recellularlize scaffolds for personalized regenerative therapies (organoids will be further
discussed in Subsection 1.1.2).21 While recellularized synthetic scaffolds have shown promise
when implanted in vivo, seemingly faithfully recapitulating the growth of necessary intestinal
cell types and architecture, the difficulties of inducing or providing neural components and
vascularization to the implanted TESI cripple the growth of these tissues.21–24 In addition, the
starting cell type for reseeding of the intestine is often pluripotent stem cells (PSCs), however the
use of PSCs for transplantation can be dangerous if there are populations of cells that have not
fully differentiated, and use of such cells can require immunosuppression.22 While the future of
TESI is promising, fully functional TESI grafts seem in the distant future. For this reason, in this
dissertation, we focus on potential methods for inducing and modeling endogenous regeneration
capacities of tissue.
Interestingly, in many animal models (mouse, rat, pig, and zebrafish), an in vivo response
to SBR called “adaptation” can produce enough absorptive epithelium to induce weight gain by
normal feeding after resection.25,26 In this adaptation process it is predominantly noted that the
villi get taller and the crypts deeper, a process called “structural adaptation”. It is also seen that
there is functionally increased nutrient absorption, creating more functional absorptive
epithelium to compensate for the lost intestinal sections, with the greatest adaptive response
occurring in the ileum.25,27 Unfortunately, however, this response is not as consistent or
5

significant in humans, highlighting the need for more knowledge about the molecular
underpinnings of adaptation in animals, such that it could potentially be induced or increased in
humans.25,26,28 Because studies in human populations are low-throughput in the SBS field due to
sample sizes, we utilize a murine model of resection and adaptation. The murine model is
considered to be effective for translational studies due to extensive characterization of intestinal
tissue and presence of genetic models.29 Specifically, this murine model used in our study
consists of control sham operations (bowel transection and reanastomosis) or SBR operations
(50% resection of proximal small bowel and anastomosis) to induce adaptive responses.30,31
Current literature on adaptation after SBR is growing as more studies look into the
pathways, hormones, and physiology associated with structural adaptation. Studies in zebrafish
have shown that fibroblast growth factor-1 signaling is critical for intestinal adaptation in SBS,
Igf1 signaling is important in progenitor cell replication, and EGFR signaling increases during
adaptation.26,32 In mammalian systems such as mouse and rat, many of these signals have also
been shown to play a role.14 IGF-1 treatment increased bowel length and crypt cell proliferation
in mice and increased body weight in rats with SBS.33,34 Rat models have showed that Vitamin A
signaling, or retinoic acid (RA), appears to have trophic effects on cell proliferation during
adaptation.35 Adapting mice show a doubling of EGFR expression in crypts, while administration
of exogenous EGF during adaptation in mice enhanced many aspects of adaptation.36,37
Physiologically speaking, recent studies of murine ileostomy have shown the importance of
luminal flow in the intestine in the stimulation of cell proliferation during the adaptation
period.29 Of critical importance to our study, it has been shown that HIOs produced from human
pluripotent stem cells (hPSCs) and engrafted under the kidney capsule undergo an adaptationlike process (increased villus height, cell proliferation, etc.) when the host animal undergoes
6

ileocecal resection. These engrafted organoids even retain absorptive functions. Presumably, the
engrafted organoids are responding to humoral circulating and diffusible factors in the host after
resection, promoting adaptation.1
As it stands, current research shows “hyperadaptation” as a promising avenue for
treatment of SBS through enhancing endogenous responses of the intestine. Currently, one
approved method, administration of glucagon-like-peptide-2 (GLP-2) assists in induction of
“hyperadaptation” in human adults, but the long term effects of treatment are unknown.38
Therefore, many questions regarding enhancement of adaptation remain to be answered.
Primarily, what is occurring in the animal models that is driving adaptation on a cell-population
level? On a high-throughput molecular level, what changes are occurring that drive the structural
and functional changes observed? To resolve these questions, we use scRNA-seq to profile the
adapting intestine to gain high-resolution insight into molecular changes occurring in single cells
to better understand what triggers effective adaptation in mice, the results of which are found in
Chapter 2.
However, animal models are not optimal for many studies due to their long development
times, potential inaccuracy in representing human data, and high cost of maintenance. Therefore,
we ask, can adaptation be modeled in a way that allows for higher throughput studies and greater
expandability at lower cost? Perhaps using in vitro organoids from adaptive model species from
which results could be applied to human tissue in the future? To address this, in Chapters 3 and
4, we test avenues of reprogramming of mouse intestinal organoids to simulate aspects of
adaptation in vitro, producing a preliminary model and results that lay the groundwork for future
applications in human tissue.

7

1.1.2 Modeling the Intestine: Organoids Shed 3-Dimensional Light on
Intestinal Development and Disease
After our findings in the in vivo SBR model (Chapter 2), we turned to organoids for use in
in vitro modeling of SBR induced adaptation.
In the past 50 years, “organoids” have quickly become a popular model for development
and disease. Organoids are defined as:
A 3-D structure derived from either pluripotent stem cells (ESCs or iPSCs),
neonatal or adult stem/progenitor cells, in which cells spontaneously self-organise
[sic] into properly differentiated functional cell types, and which recapitulates at
least some function of the organ…39
Organoids are being developed for a range of organs.40 These models can be used to look
at disease states and development with current applications ranging from brain development to
the effects of Zika virus to the actual functionality of neuronal networks organoids.39,41 Even
more promising to some is the use of disease organoids, such as those derived from cancerous
tissue or cystic fibrosis, in testing therapeutics on human tissue. The heterogeneous nature of the
organoids—many expressing multiple cell types representative of the tissue they model—
provides a more accurate representation of the in vivo environment than traditional 2dimensional culture of single cell types.40,42 Despite the development of organoids from a variety
of complex tissues, small intestinal organoids are one of the best developed and studied. They
generate a structure similar to that found in the small intestine and contain the major
differentiated cell types of the small intestine.7,43
The development of the intestinal organoid began in the 1980’s. Researchers were able to
culture rat duodenal tissue into self-enclosed structures with lumens. Research in this vein
continued, showing differentiation potential of these ex vivo tissues.6

In 2009, Sato and

colleagues created what they deemed “mini-gut organoids.”7 These “mini-guts” rely on the self8

organizational capabilities of intestinal stem cells as well as a multi-factored environment of
growth signals to mimic those found in the intestinal epithelium. The “mini-guts,” now referred
to as small intestinal organoids (SIOs), constituted the first culture system to establish and
maintain the budding crypt-villus structure of the intestinal epithelium (Figure 1.2). In order to
generate the budding 3-dimensional structure, the SIOs are embedded in Matrigel to support
epithelial growth because the high levels of laminin in Matrigel mimic the laminin found at the
crypt base. Specific factors are necessary for the growth of the SIOs and a nutrient dense
medium containing factors Wnt, R-spondin 1, EGF, and Noggin is used to promote the
proliferation of stem cells.5,44

Figure 1.2: Visualization of small intestinal organoids. (A-B) Small intestinal organoids are characterized by a layer
of epithelial cells surrounding a hollow lumen. Crypt-like protrusions (white arrowheads on B) contain stem and
Paneth cells while villus-like regions surrounding the lumen house other differentiated cell types. Scale bar = 100
µm. Image taken on Nikon Eclipse Ts2 with Nikon DS-Fi2 camera at with a 10× objective.
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SIO lines can be continually cultured with regular passaging for 8 months or more. They
are easily generated in two ways: the culture of full crypts from the native intestine or from
single Lgr5+ intestinal stem cells.7,45 In either case, as the intestinal stem cells (ISCs) proliferate,
the openings seal off, creating a self-enclosed lumen inside the monolayer of cells. Just as with
the in vivo epithelium, the cells are continually sloughed off into the lumen. Organoids can also
be derived from human pluripotent stem cells (hPSCs), and these additionally include a
mesenchymal layer, however this model is immature and resembles fetal tissue unlike the adult
tissue modeled by culture of ISCs.46
Many questions remain about just how close the organoid is to the tissue it mimics. Does
an intestinal organoid express all the signals of the in vivo tissue? Does organoid physiology
mimic intestinal physiology? In terms of physiology, evidence suggests that organoids reflect
aspects of intestinal physiology such as cellular differentiation, region-specific patterning and
gene expression, cellular transport abilities, and even interaction with pathogens.47,48 Evidence
from studies of growth of organoids from single stem cells without mesenchymal cells suggests
that organoids, with the addition of stromal-derived factors such as Noggin and R-spondin 1 in
the medium, recapitulate many aspects of the in vivo tissue, namely the stem cell niche.7,49
Importantly, microarray analysis indicates that the gene expression of organoids remains very
similar to that of endogenous crypts, indicating that the extraction from the intestinal epithelium
and subsequent ex vivo growth change very little about the transcriptome.7 Staining has shown
that the main cell types of the intestine are present in SIOs in comparable locations to the
endogenous intestine.4 Notably, Lgr5+ stem cells touch Paneth cells in the organoid crypt
domain, much as they are found endogenously. Paneth cells, therefore, can provide some of the
necessary factors for the organoid stem cell niche.45 The stem cell niche in vivo also involves
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many non-epithelial factors, such as mesenchymal tissue and myofibroblasts.50 The work of Sato
has shown that the intestinal organoids, with the help of the Matrigel matrix and supplemented
growth factors, appear to provide a physical stem cell niche without the necessity of
mesenchyme.7 This suggests that the niche can be created in vitro without the supporting stroma
but with the addition of necessary stromal factors in the medium. In fact, a single Lgr5+ stem
cell can differentiate to all the cell types of the organoid without true mesenchyme, only soluble
factors.50 Additionally, they can do it with a uniform solution of growth signals found in the
growth medium. Interestingly, modulation of the factors and growth signals in the medium can
quickly influence the cellular composition of the SIOs allowing for studies of rare cell types and
lineage specification.4 Ultimately, the 3-dimensional in vitro organoid culture system reportedly
recapitulates much more of the in vivo niche in vitro than other in vitro culture systems.46
Promoting intestinal epithelial regeneration to help improve nutrient absorption and treat
a number of intestinal issues through tissue engineering methods is an active area of research.51
Studies have shown that intestinal organoids (mouse and human) can repopulate crypt or cryptvillus structures in experimentally damaged mouse colon

51–53

. In addition, the use of organoids

to repopulate biological and synthetic intestinal scaffolds for transplantation has shown
promise16,54.
Many fascinating studies show the utility of organoids for modeling and studying disease.
These cultures have proven valuable in modeling intestinal development and regeneration.55–57
Because organoids can be derived from a patient, from diseased or healthy tissue, they are being
used to model onset of diseases such as cancer of various organs, diarrheal disease, host-microbe
interactions, and viral infections.56,58 Organoids additionally provide the ability to expand patient
cells for high-throughput screens for treatment purposes for cancer and other diseases like Cystic
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Fibrosis.46 As previously mentioned, in the frame of looking at adaptation after SBR, research
has shown that human intestinal organoids implanted under the kidney capsule in mice who have
undergone small bowel resection “adapt” with the structures of the organoid extending to
increase surface area in response to circulating humoral factors.1 This is great preliminary
evidence for the ability to model response to intestinal damage in organoids, but a major
roadblock exists: the in vivo environment must be exposing the organoids to unknown humoral
cues that we must recapitulate in order to model the response accurately.46 While organoids can
currently be used to study genetics of congenital SBS, methods of regenerating lost cells in SBS,
and can be used to elongate intestine using scaffolds, there is a gap of knowledge on how to use
organoids to model SBS adaptive responses fully in vitro.59
Even with all the current research and results from using organoids as disease and
development models, many questions still remain. Pertinent to this study, how can we use
genetic manipulations, perhaps such as cellular reprogramming (see Subsection 1.1.3), to
recapitulate adaptation, a response to damage, that can be studied in vitro? How can regional
organoids inform us more about the processes occurring during adaptation?

1.1.3 Cellular Reprogramming Presents Promise for in vitro Modeling
In Chapter 2, the results of our in vivo scRNA-seq experiments in mice indicate that the
distal intestine proximalizes or “regionally reprograms” during the adaptation period. These
results directed us to look at utilizing cellular reprogramming methods to model this effect in
vitro in organoids in Chapters 3 and 4.
Cellular differentiation is commonly imagined to follow what is called “Waddington’s
Landscape”—a trajectory through which each cell “rolls” downhill through the landscape during
development from a stem cell state to a mature fate, where it is “trapped” in a valley and fate is
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fully determined (Figure 1.3).60 Once a cell reaches its valley, it cannot roll back up the hill and
transition to a different valley (or fate) naturally, as its fate is fully determined. However, cellular
reprogramming has changed this “black and white” fate determination to a more flexible model
in which differentiated cells can be “rolled” back up the hill to less differentiated states or pushed
to move to new valleys to different differentiated fates (Figure 1.3).61

Figure 1.3: Waddington’s Landscape. In this model, cells begin at the top of the hill during development and
progress downward as they become more differentiated. Using reprogramming methods, cells can move from a fully
differentiated state to another identity through direct reprogramming or back toward a less differentiated state
through dedifferentiation (adapted from 60).

Historically, at the forefront of the field of regenerative biology is John Gurdon. In 1958,
he successfully cloned amphibians by taking the nucleus of one cell and implanting it into an
enucleated egg in a process called Somatic Cell Nuclear Transfer (SCNT). These experiments
revealed that a differentiated nucleus could be “reprogrammed” to a totipotent state through
exposure to endogenous developmental factors.62,63

In another historic landmark study,

researchers fused muscle and non-muscle cells together to create “heterokaryons.” They found
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that the non-muscle cells began to activate muscle gene expression, indicating that the expression
of genes in differentiated cells is plastic and that cells can be “reprogrammed” with diffusible
factors altering cell-cell communication.64,65 Diffusible factors were also shown to be capable of
reprogramming in the “organizer” experiments carried out by Spemann and Mangold where
dorsal signals induced ventral cells to take on different fates in an embryo.66
The

discoveries

surrounding

diffusible

factors,

cellular

communication,

and

reprogramming capabilities inspired the development of our novel model, the chimeric intestinal
organoid (chimera). Chimeras themselves are a commonly used developmental model defined as:
A composite organism in which the different cell populations are derived from
more than one fertilized egg, thereby combining tissues with distinct genetic
origins and identities. The distinct biological mechanisms underpinning chimera
formation
begin
with
the
persistence
of
donor
cells
after
transplantation…culminating in donor cell differentiation in a manner paralleling
the tissue in which they reside.67
Because of the ability of chimeras to combine distinct tissues and promote cellular
differentiation via diffusible factors and cellular communication, it is not a far leap to imagine
using organoids, which have self-organizational properties and capabilities to recapitulate the
niches in the tissue of origin, to create chimeras in an attempt to differentiate stem cells. This
idea has been carried out in kidney organoids successfully with mouse embryonic kidney cells
capable of forming organoids after aggregation. One such example used human amniotic fluid
stem cells combined with murine embryonic kidney cells. Using centrifugation, the human stem
cells were aggregated with mouse embryonic kidney cells to create chimeric organoids in which
podocytes differentiated from the amniotic fluid stem cells when engrafted in vivo.68,69 Using this
inspiration, we developed the chimeric intestinal organoid model by chimerizing proximal and
distal small intestinal organoid tissue. As previously mentioned, the ileum is more prone to
adaptation, so we investigated the hypothesis that we could model adaptation through distal
14

tissue exposure to and communication with proximal diffusible factors. We asked the question:
can we mimic the in vivo environment after resection in vitro with organoids to model regional
reprogramming in a dish to help us learn more about the process of regional reprogramming?
More recently, more controlled methods of reprogramming have been developed.
Notably, it was found that Oct4, Sox2, Klf4, and c-Myc are sufficient to move somatic cells from
differentiated cells to induced pluripotent stem cells (iPSCs).70 The popular process of directed
differentiation induces differentiation from pluripotent cells. In this method, iPSCs or embryonic
stem cells (ESCs) are directed to the desired cell type through addition of growth factors and
small molecules, such as ESCs to cardiomyocytes with addition of Activin-A and BMP4.71
Limitations of this process include length of time to reprogram and inefficient differentiation into
mature cell types. This results in heterogeneous populations of developmentally immature
cells.65,72
While directed differentiation shows that differentiated cells can be made pluripotent and
then directed to differentiate into another cell type, this raised the question of whether
differentiated cell types could be directly converted to other differentiated cell types, bypassing
the intermediate pluripotent state to produce more mature cell types. Some terminally
differentiated cells in vivo can change fate without going through a dedifferentiated state through
transdifferentiation.73 This “direct conversion” or “direct reprogramming” as we will refer to it,
is possible in vitro through the forced expression of ectopic transcription factors or application of
developmental signaling factors, which can direct lineage adoption.66,73,74
It is reported that use of transcription factors to convert fate is a more robust method and
will be utilized in our study.73 In a series of groundbreaking studies in the 1980’s, it was found
that ectopic expression of MYOD1 in fibroblasts produced myoblasts, a direct lineage and fate
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change without movement through an intermediate state.75 These types of direct reprogramming
are in use in many labs. A relevant example of the process is the production of iEPs (induced
Endoderm Progenitors) utilized in the Morris Lab. This process begins using mouse embryonic
fibroblasts (MEFs) and reprograms them through forced overexpression of the transcription
factors Hnf4α and Foxa1/2/3. The resulting cells move from a fibroblast identity to a more open,
endoderm progenitor identity—capable of functionally engrafting in the liver and colon.76–78
Current work on direct reprogramming from the Morris Lab aims to lineage trace
reprogramming cells in order to determine which cells will reprogram and also the states of the
cells as they move along the reprogramming trajectory.79 Building on the ability of iEPs to
engraft colon, direct reprogramming to intestinal organoids has also been achieved. Using a
cocktail of Hnf4α, Foxa3, Gata6, and Cdx2, it has been shown that mouse fibroblasts can be
reprogrammed to intestinal progenitors capable of forming organoids, broadening potential
applications of direct reprogramming approaches for use in modeling development and organs.80
In addition, there are direct reprogramming methods to produce pancreatic β-cells,
cardiomyocytes, neurons, and many more cell types.73
Neuronal reprogramming is a very active area due to the applications and the many types
of neurons that can be and need to be produced. While our study focuses on intestine, neuronal
reprogramming can inform on aspects of our goals—primarily, information regarding positional
identity. It has been shown that in reprogramming from fibroblast to neuron, the fibroblasts
maintain their positional identity markers and Hox gene expression but also that Hox gene
expression can be induced and influenced by signaling molecules, indicating that positional
identity is part of cellular memory but can be influenced by signals. 81,82 Both of these aspects are
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critical to our goals to reprogram distal tissue to be more proximal to model regional
reprogramming.
New avenues of research in direct reprogramming branch out from reprogramming cells
in a dish for use in studying reprogramming processes. Now, researchers are looking toward
using direct reprogramming of cells to model disease and developmental processes and even for
cellular replacement therapies such as in the injured brain.73,83 A current example is that of direct
conversion of somatic cells to neurons (using a variety of transcription factors but typically
including Ascl1, Brn2, and/or Myt1l) to be used to model patient specific diseases which animal
models failed to recapitulate.84 In one study, fibroblasts from patients with amyotrophic lateral
sclerosis (ALS) were directly reprogrammed to induced neurons. These neurons expressed
mislocalized FUS protein to the cytoplasm and recapitulated known mutant-FUS pathologies,
while in vivo rat models failed to recapitulate the pathology accurately.85 In another study,
induced neurons modeling pantothenate kinase-associated neurodegeneration (PKAN) were
reprogrammed from fibroblasts. Again, patient derived induced neurons showed mitochondrial
dysfunction and aberrant oxidation status representative of the disease, unlike animal models,
making a “suitable” reprogrammed model for therapeutic testing for the disease.86
As previously mentioned, directly reprogrammed cells maintain “memory” of identity,
and importantly, they can maintain genetic and epigenetic information from the patient donor.87
Therefore, we ask the question, can we utilize transcription factor direct reprogramming to
reprogram organoids to model regional reprogramming and dissect the roles and effects of
specific transcription factors during this process?
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1.1.4 scRNA-seq Technology Advances Provide Much Needed Resolution to
Transcriptomic Analysis of Modeling and Reprogramming
To analyze subtle molecular changes during adaptation in our in vivo model (Chapter 2)
and to classify cell types and identities in our reprogramming efforts (Chapters 3 and 4) we
turned to single cell RNA sequencing.
Advances in technology are the foundation of scientific advances, and advances in the
resolution of transcriptomics—driven by progress in the field of single cell RNA sequencing
(scRNA-seq)—are allowing researchers to truly understand what molecular changes occur on a
cellular level like never before.
Historically, the study of transcriptomics on a single cell level began with single-cell
qPCR and single-molecule fluorescence in situ hybridization (smFISH) in the 1990’s.88,89 Soon
after, microarrays were used for the first whole-transcriptome single cell analyses.90 In a final
push, bulk RNA-seq allowed the measurement of population level transcriptomes, pushing
forward the knowledge of expression patterns and identity in cells and tissues.91 However, RNAseq is performed on bulk populations in which the expression data for many cells in a
“homogeneous” population is averaged. These populations of cells can be truly heterogeneous at
the RNA expression level as well as in identity, microenvironment, and function. Because of this
intrinsic heterogeneity, it is easy to lose rare cell types in the large population, causing the truly
distinct transcriptomes of some cells to be blurred and lost.92 scRNA-seq follows directly on the
heels of RNA sequencing.93 scRNA-seq avoids the losses of RNA seq due to averaging of
heterogeneity. It allows us to see the expression pattern of each individual cell, instead of an
averaged, bulk reading. This allows for very rare cells to be detected in the population, helping to
further define the heterogeneity and identity of each cell within a population.92,94,95 Additional
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biology accessible through scRNA-seq includes high resolution tissue composition,
transcriptional dynamics, and even gene regulatory relationships.96,97
While there are multiple methods of scRNA-seq following a similar basic framework, we
now use the 10x Genomics Chromium 3’ platform (10x) for the analysis of thousands of single
cells. 10x is a method using aqueous droplets to capture the transcripts from many individual
cells for parallel sequencing and analysis. A microfluidic device is utilized to combine an
aqueous single-cell suspension, lysis buffer, microparticle beads, and oil together to encapsulate
a single cell with a single microparticle bead. When a droplet is formed that contains a cell and
bead, the lysis buffer lyses the cell, and the mRNAs attach to oligonucleotides on the bead due to
presence of poly-A tails. mRNAs are then reverse-transcribed, PCR amplified, and sequenced.
The resulting dataset allows for tracing of each transcript to a specific cell due to the presence of
a unique barcode on each bead and additionally gives gene expression levels for individual
transcripts in each cell due to presence of unique molecular identifiers (UMIs) (process overview
in Figure 1.4).94,97–99
The datasets generated through 10x can be analyzed in many ways, our work
predominantly uses the R package Seurat and additional in-house tools.41,100–102 Using Seurat,
data can be put through quality control, removing cells with aberrant barcodes and low-quality
reads and regressing out factors like mitochondrial genes. Gene expression is quantified and
normalized, and then analyzed by dimensional reduction and clustering analysis using
differential gene expression data.94 Such dimensional analysis, now visualized using UMAP,
allows users to visualize the transcriptional heterogeneity of populations in two dimensions
where cells of similar transcriptional expression cluster together quickly and with high
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Figure 1.4: Overview of scRNA-seq microfluidic pipeline. A microfluidic device is utilized to combine an aqueous
single-cell suspension (bottom, stars), lysis buffer, microparticle beads including poly(dT) primers, barcodes, and
UMIs (left), and oil (right) together to encapsulate a single cell with a single microparticle bead. The design of the
oligonucleotide on the beads is pictured above the microparticle bead (adapted from 98).

reproducibility.103 These clusters can then be used to identify cell types based on expression of
canonical or novel markers or comparison to reference atlases.96,97,100,104
As previously mentioned, scRNA-seq is superior to bulk sequencing in terms of the
resolution it allows for determining heterogeneity in populations—allowing the tracing of
lineages, reprogramming processes, development, and even identification of heterogeneity in
models like organoids and in vivo tissues. For example, our lab utilized lentiviral barcodes called
CellTags to map lineage and identity of iEPs during the direct reprogramming process. The
resolution provided by scRNA-seq allowed for the CellTags to be utilized to construct lineage
trees, leading to the discovery of two trajectories in iEP reprogramming: successful
reprogramming and the ‘dead-end’ state. Using the scRNA-seq analysis, Mettl7a1 was identified
as a novel factor promoting efficient successful reprogramming. This study successfully uses
scRNA-seq and novel technologies to look into direct reprogramming dynamics as never seen in
the iEP system and provides additional information on how to improve the efficiency of
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reprogramming.79 Additionally, scRNA-seq has been utilized to investigate the process of
gastrulation in mice, looking deep into developmental stages in which the molecular mechanisms
driving the process were once considered an unknown “black box”. The use of scRNA-seq on
1,205 cells from various stages of gastrulation allowed the researchers to resolve the
transcriptional programs driving gastrulation, finding new markers and regulators of gastrulation
such as Slc35d3, as well as a role of Tal1 in mesodermal blood formation.105 Heterogeneity of
the mouse small intestine was explored using scRNA-seq, even identifying new diversity in
enteroendocrine cells and previously unknown gene signatures.106 Even intestinal organoids have
been successfully studied using scRNA-seq. Organoids undergo a symmetry breaking event early
in development when a stochastic event produces a Paneth cell, creating the first budding stem
cell niche in the organoid. To study the gene variability causing this symmetry breaking event,
scRNA-seq in a time course was utilized to investigate variability in Yap1 expression in single
cells during symmetry breaking. They found that variability in expression of Yap1 induced
Paneth cell differentiation at high levels, inducing symmetry breaking critical to the formation of
traditional budding organoids.57
Based on these studies and others, we ask several questions. Can we use scRNA-seq to
learn more about the drivers of the regenerative adaptation state that occurs after SBR? How can
we combine scRNA-seq and novel analysis techniques built in our lab to predict reprogramming
factors capable of achieving organoid regional reprogramming? Can scRNA-seq help us to
accurately analyze the degree of reprogramming achieved by reprogramming factors in
organoids?100,101 Finally, can scRNA-seq data elucidate important changes in cell-cell
communication occurring during regional reprogramming?107
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1.2 Key Outstanding Questions in the Field and Hypotheses
This dissertation will address the following major questions: What are molecular changes
associated with adaptation after SBR on a single cell level? How can we apply scRNA-seq
technology to determine potential upstream drivers of adaptation? And finally, how can we
model and study adaptative responses using combinations of organoids, reprogramming, and
scRNA-seq analysis?
Based on these questions and expert knowledge of applicable technologies, we form the
following hypotheses:
1. scRNA-seq technology can provide high resolution data elucidating molecular
changes occurring during the adaptation process in mouse models of adaptation.
2. Applications of analysis of scRNA-seq data will identify potential upstream
regulators of adaptation.
3. Reprogramming of organoid models using potential regulators of adaptation will
build a collection of models of regional reprogramming that can be used to model and
test adaptation in human populations.
To answer these questions and study these hypotheses, a number of models and
technologies will be utilized. Major models will be the in vivo mouse model of SBR discussed in
Subsection 1.1.1 and mouse small intestinal organoids as discussed in Subsection 1.1.2. Major
methods and technologies will include: chimerization of proximal-distal organoids and
transcription factor-driven direct reprogramming of organoids as discussed in Subsection 1.1.3
and scRNA-seq of various experimental models as discussed in Subsection 1.1.4.
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1.3 Contributions of Dissertation to the Field
The contributions of this dissertation to the field are both on a translational and basic
science level. Firstly, the major dataset utilized in Chapter 2 is available to the public, allowing
other researchers to analyze and mine data regarding SBR and adaptation without necessitating
involvement of additional experiments. In addition, this dissertation provides SBS researchers
with data about a previously undescribed process during adaptation after SBR, regional
reprogramming, or the proximalization of enterocytes following resection during adaptation. It
suggests the high importance of exposure to region-specific diffusible signals, such as Vitamin
A, and changes in signaling cascades post-resection. This dissertation provides valuable
information regarding the use of organoids to model and study adaptation for applications to
personalized medicine in the future, specifically focusing on the role of proximal diffusible
factors in regional reprogramming through building of the chimeric organoid model. Finally, this
dissertation lays the groundwork to pursue further modeling of regional reprogramming through
direct reprogramming of organoids to dissect the effects of upstream transcription factor
signaling.

23

Chapter 2: In Vivo Regional Reprogramming
of the Mouse Intestine after Small Bowel
Resection
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2.1 Abstract
The small intestine (SI) displays known regionality in nutrient absorptive and
immunological functions. After loss of intestinal tissue, such as in SBS, the remaining SI
compensates, or “adapts” to the shortened intestine and resultant loss of surface area. However,
while the morphological results of adaptation are well described, the molecular capacity of SI
epithelium to reprogram its regional identity in response to resection has not been described.
Here, we apply single-cell resolution analyses to characterize molecular changes underpinning
adaptation to SBS. scRNA-seq was performed on epithelial cells isolated from distal SI of mice
following 50% proximal small bowel resection (SBR) surgery vs. sham surgery. Single-cell
profiles were clustered based on transcriptional similarity. An unsupervised computational
approach to score cell identity was used to quantify changes in regional (proximal vs. distal) SI
identity and findings were validated using molecular biology approaches. Cell identity scoring
demonstrated segregation of enterocytes by regional SI identity: a population of SBR enterocytes
assumed more mature proximal identities despite being sampled from the distal intestine. This
was associated with significant upregulation of lipid metabolism, which was validated via
orthogonal analyses. Observed upstream transcriptional changes suggest retinoid metabolism
through exposure to proximal levels of diffusible factors Vitamin A/Retinoic Acid and proximal
transcription factor Creb3l3 drive proximalization of cell identity in response to SBR.
Adaptation to proximal SBR involves regional reprogramming of ileal enterocytes toward a
proximal identity. Interventions bolstering the endogenous reprogramming capacity of SI
enterocytes—conceivably by engaging proximal diffusible factors and upstream transcription
factors—merit further investigation, as they may increase enteral feeding tolerance, and obviate
intestinal failure, in SBS.
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2.2 Introduction
The small intestine absorbs nutrients necessary to sustain life, and displays regional
specialization for absorption of specific nutrients from duodenum (proximal) to jejunum to ileum
(distal). The majority of nutrient absorption occurs in the duodenum and jejunum, while the
ileum is primarily responsible for absorbing bile, vitamin B12, and fat-soluble vitamins.
A variety of diseases require surgical resection of significant lengths of SI. These range
from congenital anomalies and necrotizing enterocolitis in children to trauma, embolism, and
malignancy in adults. The resulting loss of SI can cause short bowel syndrome—the inability of
the SI to completely support the metabolic demands of a patient. Due to loss of SI length, there is
a reduction in absorptive surface area for the patient, resulting in an inability to properly absorb
the nutrients necessary for survival. Management options for SBS are limited, including
parenteral nutrition (PN), intestinal lengthening procedures, and small bowel transplant, all
incurring significant morbidity and mortality.108,109
The murine model of SBS is based on small bowel resection (SBR), in which 50% of the
proximal SI is surgically removed.31 Sham surgery consists of transection and anastomosis,
without removal of any SI, and acts as a control for exposure to anesthesia, laparotomy, and
intestinal transection. This model elicits known adaptive responses such as villus lengthening in
the remnant ileum of SBR but not sham mice, increasing mucosal absorptive surface area to
compensate for lost tissue. Importantly, the degree of this “structural adaptation” response
correlates with “functional adaptation,” as evidenced by increased oral tolerance and weight gain
in mice. This model is relevant to clinical SBS, as structural adaptation correlates with oral
tolerance and weaning from PN observed in human patients.110 At the same time, structural
adaptation does not intrinsically predict functional adaptation.111 This leads us to conclude that
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additional factors beyond simple tissue hyperplasia are at play, likely underscored by molecular
changes detectable at the single-cell level.
While structural and, to a lesser extent, functional adaptation following SBR, has been
characterized, relatively little is understood about the molecular changes that accompany the
adaptation process. In this respect, messenger RNA (mRNA) expression analyses offer critical
insight, as clinically appreciable adaptation may require that cells assume molecular identities
mimicking those of the resected region as compensatory reactions. Studies of adaptation at the
structural and functional level lack the resolution to explore this possibility. Here, in the case of
proximal SBR, we hypothesize that remnant ileum (distal SI) upregulates gene expression
patterns characteristic of the jejunum (proximal SI) at the single-cell level, a process we term
“regional reprogramming.”
Clinical therapies to induce regional reprogramming could enhance an SBS patient’s
ability to tolerate oral intake and wean from PN by augmenting the innate regional functionality
of the lost epithelial cells. It is possible this approach may actually be more effective than the
previous “holy grail” of SBS research, which has primarily focused on inducing structural
adaptation. Enhanced structural adaptation through induction of tissue growth is intrinsically
more metabolically demanding and may or may not affect the key absorptive, metabolic, and
immunological pathways specifically deficient in an SBS patient.
To test our hypothesis and address gaps in our understanding of adaptation to SBS, we
employed high-throughput single-cell RNA sequencing to characterize gene expression changes
of distal SI epithelium during adaptation following massive proximal SBR. This allowed us to
dissect population heterogeneity within the epithelium and characterize the regionalization
pathways critical in the adaptive response. Here, we show that following SBR, the enterocytes of
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the distal SI epithelium regionally reprogram toward mature proximal enterocyte identity,
accompanied by increased proximal SI nutrient processing gene expression. These changes are
punctuated by the increased expression of the proximal SI transcription factor, Creb3l3, a novel
candidate for reprogramming distal SI gene regulatory networks to a more proximal identity.
Analysis of upstream pathways suggests a role for Retinoic Acid (RA) signaling or retinoid
metabolism in driving the adaptation response. Together, our single-cell analyses have enabled
high-resolution characterization of the molecular changes and regional reprogramming that
underlie adaptation and provide basis for the studies performed in Chapters 3 and 4.

2.3 Cellular Heterogeneity of the
Epithelium Is Captured by scRNA-seq

Small

Intestinal

Structural adaptation—or villus growth— reliably occurs by day 7 after SBR, making it a
commonly utilized experimental endpoint in SBR studies. Therefore, we utilized day 7 after
sham or SBR surgery as our experimental endpoint. We confirmed typical SBR structural
adaptation, with villi height increasing by 86.19 ± 19.14 μm (P < 0.01) relative to sham (Figure
2.1A). Epithelial cells from animals demonstrating structural adaptation or from sham surgery
animals were harvested from SI in an area distally equidistant from the anastomosis, dissociated
into single cells, and processed via high-throughput droplet-based scRNA-seq using the 10x
Genomics platform.99 In total, we sequenced 19,245 cells from 9 independent biological
replicates (sham: 8209 cells, n = 5 replicates; SBR: 11036 cells, n = 4 replicates). A mean of
1767 and 1763 genes per cell in sham and SBR, respectively, and 6754 and 6111 transcripts per
cell in sham and SBR, respectively, were detected (Figure 2.1B).
To reduce dimensionality of the data and visualize the clustering of cells, we used the R
package Seurat along with Uniform Manifold Approximation and Projection (UMAP)

28

visualization.102,103,112 UMAP analysis and plotting revealed 16 clusters of transcriptionally
distinct cell types/states (Figure 2.1C). Scoring and projection of cell cycle state onto the UMAP
plot revealed clustering of cells in S and G1 phases, corresponding to stem cells and transitamplifying (TA) cells (Figure 2.1D) as identified through classical marker expression (not
shown) and in Figure 2.2A. Gene expression between equivalent biological replicates was highly
correlated, demonstrating a high degree of consistency between the independent biological
replicates and reducing the possibility of batch effects between replicates driving results (Figure
2.1E). Furthermore, cells from every cluster were represented in each biological replicate,
demonstrating consistency of cell capture and thereby our collection methods (Figure 2.1F).
To assign cell identity to each cluster in an unsupervised manner, we used a
computational method based on quadratic programming (QP) to score individual cell identity
against an existing single-cell atlas of well-annotated SI cells.106,113 This reference atlas contains
stem cells, TA cells, early and late enterocyte progenitors, immature proximal and distal
enterocytes, mature proximal and distal enterocytes, goblet cells, Paneth cells, enteroendocrine
cells, and tuft cells, all annotated based on a list of previously identified and novel markers.114
We have previously demonstrated the efficacy of QP in placing cells into an identity continuum
during lineage reprogramming.79 The QP algorithm has since been enhanced and named
Capybara, it is used in Chapters 3 and 4.100
Cell identity scores generated by QP were projected onto the UMAP plot, enabling cell
cluster identity to be annotated (Figure 2.2A). Projection of all identity scores onto the UMAP
demonstrated this clustering and visualization method does indeed retain both local and global
information, capturing the differentiation trajectory from stem cells to mature enterocytes (Figure
2.2B). Further examination of these clusters revealed that expression of the proliferation
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Figure 2.1: Experimental design, quality control, and single-cell analysis. (A) A 50% proximal SBR and sham
operation were performed on mice. Seven days after surgery, the intestine distal to the anastomosis (ileum) was
harvested and equal amounts of tissue equidistant from the anastomosis were used to generate single-cell epithelial
suspensions. An area immediately adjacent to this was prepared for histological examination. Typical structural
adaptation of SBR mice (lengthened villi) was confirmed (P = 0.003), with a representative hematoxylin and eosin
image of SI tissue from a sham vs SBR mouse shown (20× image acquired using Nikon Eclipse 80i). Scale bar =
100 μm. Epithelium from mice demonstrating structural adaptation was prepared for scRNA-seq analysis. (B) A
mean of 1767 and 1763 genes per cell in sham and SBR, respectively, and 6754 and 6111 transcripts per cell in
sham and SBR, respectively, were detected. (C) UMAP of integrated biological replicates identified 16 unique cell
clusters. (D) Cell cycle states projected onto the UMAP. (E) Representative plot of SBR experimental replicates
demonstrated similar gene expression profiles. Correlation coefficients (R) of average gene expression are as shown
between these biological replicates. Total biological replicates were 5 sham and 4 SBR (n = 3 “sham1,” n = 1
“sham2,” n = 1 “sham3,” n = 3 “SBR1,” n = 1 “SBR2”). (F) The same 16 clusters were identified in both sham and
SBR, in all replicates, as described in panel E. Distribution of all cells across clusters 0–15 (from left to right), by
replicate, is shown.
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marker Mki67 is enriched in stem, TA, and progenitor cells, and is downregulated as cells begin
to differentiate. Conversely, expression of mature enterocyte marker alkaline phosphatase (Alpi)
increases with differentiation or maturation, with highest expression colocalizing in areas
identified by QP as mature enterocytes (Figure 2.2C), thereby supporting the QP analysis by
identification of cell populations with known marker genes.
In summary, our single-cell analyses identified all major SI epithelial cell populations,
demonstrating the strength of our unsupervised QP cell classification approach in concert with
single-cell analysis, showing the effectiveness of our collection and analytical methods. Our
analysis utilizing UMAP visualization to identify cells differentiating along a defined trajectory
reflects the normal cellular differentiation of the rapidly cycling intestinal epithelium and
identifies key cell types and transitional states. Together, this provides a comprehensive picture
of complex SI epithelial heterogeneity, under both sham and SBR conditions in our model.

2.4 Regional Reprogramming Toward Mature Proximal
Enterocyte Identity Occurs After SBR
Changes in cell type composition of the SI epithelium accompany adaptation. However,
which cell types expand during adaptation is highly debated in the literature. Some reports
describe expansion of enterocytes while others cite expansion of secretory cells.115–119 It is
possible that the differing reports exist due to use of different models, timepoints, and
experimental conditions as well as the historic use of limited resolution techniques for cellular
identification.
Here, we use our validated, unbiased single-cell resolution classification of cell identity
(QP) to precisely quantify changes in epithelial composition following SBR specific to our
model. We assessed the distribution of sham- vs SBR-derived cells by projecting the densities of
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Figure 2.2: Annotation of cell identities using QP. (A) QP-based identity scores of intestinal epithelial populations,
projected onto UMAP. Cell populations (from left to right) include stem, early TA, TA G1, TA G2, early enterocyte
progenitors, late enterocyte progenitors, immature proximal enterocytes, immature distal enterocytes, mature
proximal enterocytes, mature distal enterocytes, goblet cells, and Paneth cells. Low percentages of tuft and
enteroendocrine cells (0.3% and 0.003%, respectively) were identified and are not shown. (B) Aggregated QP scores
provide a summary of cell identities within the UMAP, demonstrating a maturation trajectory from stem cells to
mature enterocytes. (C) Projection of transcript enrichment for selected QP validation markers, from left:
proliferation marker antigen KI-67 (Mki67) is appropriately enriched in the stem, TA, and progenitor regions of
UMAP; alkaline phosphatase (Alpi) expression increases as enterocyte maturation occurs. Color scale bar indicates
relative intensity of cell identity scoring (A) or gene expression (C) across the UMAP.
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each population onto the UMAP (Figure 2.3A). Looking at the enterocyte population (comprised
of immature and mature enterocytes), we found a significant increase following SBR as a total of
all cells surveyed (68.9% ± 3.1% of sham events sampled, vs. 76.8% ± 0.1% of SBR (P < 0.05))
(Figure 2.3B).

Figure 2.3: Relative expansion of mature proximal enterocytes occurs in SBR mice. (A) Density of sampled cells
from sham and SBR epithelium, projected onto the UMAP, demonstrates a population shift toward mature proximal
enterocytes in SBR. Color scale bar indicates relative density. (B) Graphical representation of how epithelial
lineages (as identified by QP), contribute to the total composition of events sampled by scRNA-seq in sham vs SBR.

This finding supports reports in the literature of increases in enterocyte proliferation and
total number post resection.116,118,120 It has been reported that after resection, developing
enterocytes have accelerated differentiation and maturation in expressing nutrient transporters.121
Our use of a high-resolution, unbiased classification system based on gene expression may have
allowed us to detect and identify earlier stage and immature enterocytes based on their earlystage transcriptional profiles than traditional methods, allowing for the detection of the
expansion of full (mature and immature) enterocyte populations while previous studies could not
detect such expansion.
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Considering our hypothesis that cells adopt a different regional identity to aid adaptation,
we quantified the balance between proximal and distal enterocyte identities in sham vs. SBR
samples. Our hypothesis was initially supported by the density projections in Figure 2.3A, as the
highest density of SBR cells fell in a region identified to contain mature proximal enterocytes in
Figure 2.2A. As expected, considering the tissue was harvested from ileum, a large percentage of
cells (58.5% ± 7.5%) from sham samples received high mature distal enterocyte scores with very
few cells (1.4% ± 0.6%) scoring as mature proximal enterocytes (Figure 2.3B).
In contrast, in SBR samples we found a significant increase in the percentage of cells
receiving high mature proximal enterocyte scores (11.7% ± 4.1%, P < 0.05) when quantified
from QP scores (Figure 2.3B). This shift toward mature proximal enterocyte identity in SBR
suggests a transcriptional “proximalization,” we have termed “regional reprogramming”, of
ileum in response to proximal SI resection. The term “regional reprogramming” aims to describe
the complex array of changes on a molecular, single-cell level related to regional identity
detected in our study. While previous studies have looked at changes individual genes associated
with intestinal regions, by detecting arrays of genes associated with different regional identities
using QP instead of single genes, we gain higher resolution insight into the changing ileal
enterocyte identity than previous studies and gain more insight into the regulation of the known
transcriptional changes and subsequent regional reprogramming.

2.5 Regional Reprogramming After SBR Increases
Proximal SI Nutrient Processing Gene Expression
From our previous analyses, changes in SI epithelial composition following SBR focus
primarily on a shift toward mature proximal enterocyte identities, suggesting that these changes

34

are a key driver of the adaptive response. Thus, we next focused on characterizing the
transcriptional changes underlying the shift toward mature proximal enterocyte identity in SBR.
It has been reported that the ileum is the site of greatest adaptational changes in the small
intestine and previous studies have cited increases in major proximal absorptive genes such as
Fabp1 and Apoa4 in the ileum post-resection.27,120,122 Our scRNA-seq analysis supports these
previous findings, but additionally, use of scRNA-seq allows us to unbiasedly detect differential
gene expression after resection—finding potentially previously novel markers and molecular
regulators of proximalization through our expanded dataset.
To identify significant transcriptional changes after SBR, we performed differential gene
expression analysis, identifying 174 differentially expressed genes between all sham and SBR
cells. The 10 most significantly highly expressed genes in SBR, relative to sham, are shown
in Table 2.1. This list of SBR-associated transcripts is enriched for signature genes of proximal
SI nutrient processing function, including apolipoprotein A-IV (Apoa4), fatty acid binding
protein 1 (Fabp1), apolipoprotein C-III (Apoc3), lactase (Lct), and epoxide hydrolase 2 (Ephx2)
(Figure 2.4).114,123 In contrast, distal SI transcript fatty acid binding protein 6 (Fabp6) was
depleted in SBR (0.62 average log fold change depleted, P < 0.001).114
Table 2.1: Top 10 Genes Upregulated in SBR Relative to Sham Epithelium, With Average logFC and
Adjusted P Values (logFC: log fold change; SBR: small bowel resection)

Gene
Apoa4
Fabp1
Apoc3
Lct
Rbp2
Fapb2
Sepp1
Leap2
Ephx2
Apob

logFC
2.05
1.76
1.46
1.11
1.10
0.96
0.92
0.79
0.71
0.69
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P
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

Figure 2.4: Identification of signature proximal small intestine transcripts that increase after SBR. Violin plots (left)
show relative expression of transcripts in sham vs SBR populations and UMAP plots (right) show relative transcript
expression levels within cell populations. ****P < 0.0001.

Increased Apoa4 and Rbp2 expression following SBR has been previously described and
is closely related to the transport of Vitamin A—an essential nutrient typically absorbed in the
proximal bowel.35,124,125 Contrary to our findings, one of these studies reported no significant
changes in ileal Fabp1 mRNA expression. However, this study examined whole tissue
preparations, rather than epithelium at single-cell resolution which is likely to cause loss of
potentially subtle changes.124 Thus, to validate the transcriptional changes revealed by our
scRNA-seq analysis, we surveyed Fabp1 expression via RNA fluorescence in situ hybridization
(RNA-FISH) on histological sections of sham and SBR animals at 7 and 70 days post-surgery,
with the latter analysis designed to investigate whether the observed changes are stable over
time, a property rarely investigated in the context of SBR. At day 7, Fabp1 showed a 1.5 average
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log2-fold AU increased expression in SBR, relative to sham (P < 0.001), and this response was
maintained through day 70 post-surgery (1.4 average log2-fold AU increased expression, P
< 0.01) (Figure 2.5A). Such stability over time indicates that the changes in lipid transport via
Fabp1 are sustained long-term after resection and adaptation to contribute to the functionality of
the shortened intestine after adaptation.
To further validate our findings, we performed immunofluorescence and quantitative
polymerase chain reaction (qPCR) for selected proteins and transcripts, including FABP1,
FABP6, Rbp2, and Ephx2. These specific genes and proteins were chosen due to their
relationship to lipid and nutrient metabolism commonly associated with the proximal or distal
intestine in order to represent the “proximalization” of molecular expression we associate with
regional reprogramming of the distal intestine. Immunofluorescence demonstrated significant
increases in FABP1 (1.2 average log2-fold AU, P < 0.001) in SBR relative to sham (Figure
2.5B). In contrast, FABP6 was significantly decreased in SBR compared with sham (–1.2-fold
relative fluorescent intensity, P < 0.05) (Figure 2.5B). qPCR confirmed upregulation
of Rbp2 and Ephx2 (Figure 2.5C).
Together, these orthogonal validations confirm our scRNA-seq results, demonstrating
that gene expression programs to support proximal SI nutrient processing are engaged following
SBR. These mRNA-level changes underlie the regional reprogramming to mature proximal
identity we observe in SBR. Such experiments served dual purpose in validating our study with
benchmark studies in the literature reporting changes in gene expression and also introduces new
potential candidates representing proximalization after resection in genes such as Ephx2.
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Figure 2.5: Validation of proximal small intestine markers that increase after SBR. (A) RNA FISH for Fabp1 shows
significant upregulation of transcripts (fluorescein signal) per nucleated cell (DAPI) at days 7 and 70 after surgery.
Day 7: n = 15 sham images, n = 15 SBR images (3 biological replicates). Day 70: n = 12 sham images, n =15 SBR
images (3 biological replicates) (images acquired using Olympus FV1200 Confocal Microscope). (B)
Immunofluorescence staining images for FABP1 (n = 12 sham images, n = 15 SBR images, 3 biological replicates)
and FABP6 (n = 18 sham images (4 biological replicates), n =11 SBR images (3 biological replicates)) (images
acquired using Nikon Eclipse 80i with Ds-Ri2 camera). (C) Top to bottom: qPCR validation of upregulated SBR
genes Rbp2 and Ephx2 from SI tissue (n = 3 sham and n = 4 SBR mice). RNA-FISH images are at magnification
60×, scale bar = 30 μm. IF are at 40×, scale bar = 100 μm. All graphs are presented as mean ± SD. *P < 0.05, **P
< 0.01, ****P < 0.0001.
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2.6 Creb3l3 Shows Stable Upregulation in SBR Mice
We next aimed to identify candidate upstream transcription factors responsible for
driving the observed regional reprogramming and shift toward a mature proximal nutrient
transport and processing profile following SBR. While previous studies have seen changes in
upregulation of proximal-related transporters and metabolic factors, it is unknown how these
may be regulated. Of 44 transcription factors previously shown to be differentially expressed
between proximal vs. distal enterocytes in the literature, only two associated with proximal
identity, only two were upregulated in SBR. cAMP responsive element binding protein 3 like 3
(Creb3l3), was upregulated in SBR (0.46 average log-fold increase in SBR, P < 0.0001) (Figure
2.6B-C).106 Creb3l3 is a master regulator of lipid and cholesterol metabolism, a role fitting with
the increased lipid metabolism necessary in the ileum after SBR.126–128 Metabolically speaking,
Creb3l3 has been shown to bind to and directly regulate metabolic genes such as those in
gluconeogenesis and fatty acid synthesis and elongation; interestingly, it regulates Apoa4, a
significant player in our differential gene expression in SBR.126 Another proximally-related
transcription factor known to play a role in differentiation of enterocytes, Krüppel-like factor 4
(Klf4), was also upregulated after SBR (0.26 average log-fold increase in SBR, P < 0.001)
(Figure 2.6B-C) (note: classified as distal in Haber et al., 2017).129 It is worth noting the
possibility that a wider variety of proximal transcription factors were upregulated immediately
after surgery and stabilized to baseline by day 7, when structural adaptation was complete and
we collected our samples. Transcription factors can be difficult to detect using scRNA-seq due to
low levels and transient expression, so it is likely there are more, undetected transcription factors
at play. However, we focused our analysis on Creb3l3 as a novel putative driver of stable
regional reprogramming due to its more significant increase post-SBR, its interplay with lipid
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metabolism including Apoa4, and its ability to be regulated by other well-known intestinal
players such as Hnf4a and PPARa.126 Overall, the literature regarding Creb3l3 indicates great
ability of this factor to respond to signals like stress and nutrients, like those produced by SBR,
and to regulate genes involved in nutrition and metabolism—making it a novel upstream
candidate for response during adaptation. We further explore these factors in Chapter 4.
We sought to determine whether proximal SI transcription factor Creb3l3 expression was
transiently upregulated in SBR, or whether it was critical to maintaining a long-term adaptive
response. As Creb3l3 regulates lipid metabolism, and the increased demand for ileal lipid
absorption should persist indefinitely after SBR, we expected its expression to remain elevated.
Indeed, RNA-FISH for Creb3l3 at days 7 and 70 demonstrated its significant and long-term
upregulation following SBR (day 7: 1.3 average log2-fold AU increase in SBR, P < 0.001; day
70: 1.2 average log2-fold AU increase in SBR, P < 0.01) (Figure 2.6A-C). This long-term
upregulation indicates that Creb3l3 has long-term effects on lipid metabolism regulation,
indicating a regulatory effect of Creb3l3 upstream of the known molecular changes (i.e.: lipid
absorption and metabolism) accompanying adaptation.

2.7 Interactome
Analysis
Indicates
Regional
Reprogramming is Driven by Retinoid Metabolism and
Signaling
Although Creb3l3 was elevated at day 7 and sustained through day 70 after SBR—
suggesting

a

continued

role

in

maintaining

adaptation—no

significant

differences

in Creb3l3 expression were observed at day 3 post-surgery (Figure 2.6D). This suggested that
inductive upstream signaling at earlier stages of adaptation may be critical to driving
proximalization, which is subsequently mediated and sustained by Creb3l3. This indicated that
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an early/immediate upstream signal triggered downstream effects such as increased Creb3l3. As
Creb3l3 expression is known to be induced by a number of events including inflammatory
cytokines, stress, and nutrient level alterations, we sought to determine what events in the
intestine during adaptation may affect Creb3l3 activity.128
To investigate this, we generated an in silico interactome from single-cell gene
expression profiles of all analyzed sham and SBR cells to determine which differentially
expressed genes were most strongly co-expressed, thereby inferring gene-gene relationships and
pathways (Figure 2.6E). This approach identified a network of highly interacting genes induced
by SBR, including Apoa1, Fabp2, and Rbp2. We used a total of 59 genes from the SBR
interactome to perform gene list functional enrichment analysis (5 genes from the interactome
were excluded from analysis as they were absent from the database).130 This analysis generated a
list of pathways, some which were well-known and expected, including “lipid digestion,
mobilization, and transport” (P = 2.290 × 10-11) and “digestion of dietary carbohydrate”
(P = 2.857 × 10-8), and some that were more thought-provoking, such as “PPAR signaling
pathway” (P = 3.933 × 10-7) and “retinoid metabolism and transport” (P = 1.935 × 10-8).
In the context of this study, retinoid metabolism was of particular interest because it has
been shown to play a key role in structural adaptation.35,124,125,131,132 Retinoids are derived from
Vitamin A, which must be obtained from the diet, and are mostly absorbed in proximal SI. In
fact, a retinoid/Vitamin A gradient exists in the intestine from proximal to distal, meaning that
this gradient could be disrupted by resection and anastomosis.133–135 Retinoic Acid (RA) is the
intracellularly bioactive hydrolysis derivative of Vitamin A, the active product of retinoid
metabolism, and it interacts with retinoid X receptor (RXR) and RA receptor (RAR)
heterodimers, which bind to RA response elements (RAREs) within the nucleus, to drive effects,
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Figure 2.6: Dissecting genetic underpinnings of epithelial proximalization following SBR. (A) RNA-FISH
for Creb3l3 shows significant upregulation of transcripts (fluorescein signal) per nucleated cell (DAPI) at days 7 and
70 after surgery. Images are at 60×, scale bar = 30μm, acquired using Olympus FV1200 Confocal Microscope. Day
7: n = 15 sham images, n = 14 SBR images (3 biological replicates). Day 70: n = 9 sham images, n =10 SBR images
(2 biological replicates). (B) Projection of Creb3l3 and Klf4 transcript enrichment onto the UMAP plot shows
increased expression with enterocyte maturation. Color scale bar indicates relative intensity of gene expression. (C)
Violin plots showing differential expression of Creb3l3 and Klf4 between sham and SBR. (D)
Relative Creb3l3 expression in SI from day 3 postoperative sham and SBR mice (n = 3 sham and n = 5 SBR mice)
was measured using qPCR. (E) Interactome of genes upregulated in SBR epithelium. Genes in red are involved in
RA signaling. All graphs are presented as mean ± SD. ns, not significant. *P < 0.05, **P < 0.01, ***P < 0.001,
****P < 0.0001.
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hereby referred to as “RA signaling”.136 Notably, mice deficient in dietary Vitamin A do not
adapt after SBR, and it was observed that administration of RA drives adaptation in part via
regulation of enterocyte proliferation, migration, and apoptosis.131,132 However, relatively little
detail on the molecular changes induced by RA signaling has been revealed so far.
To investigate how retinoid metabolism leading to RA signaling induces the
transcriptional changes accompanying SBR, we mined our dataset for genes differentially
expressed between sham and SBR treatments which were either putative targets of RA signaling
based on the literature, or contain a predicted RARE as determined by FIMO Motif Search
(Table 2.2).137 As a result, we found 45 genes differentially expressed between sham and SBR
that are predicted to likely respond to RA signaling (Table 2.2). Several of these genes,
including Plb1 (phospholipase B1), Rbp2 (retinol binding protein 2), Apoa1 (apolipoprotein
A1), Apoa4 (apolipoprotein A4), Apob (apolipoprotein B), and Apoc3 (apolipoprotein C3)
(highlighted in red in Fig 2.6E), are known to be active in retinoid metabolism and transport, 4 of
which were are also found in our list of the top 10 most differentially expressed genes in SBR
(Table 2.1). Importantly, Rbp2 (1.1 log fold change enriched, P < 0.001) is preferentially
induced by RA in differentiated cells, such as the expanding enterocyte population we observe
after SBR.138 Furthermore, motif analysis indicated that Creb3l3, our novel proximal
transcription factor, contains a RARE and can be activated by RXRα based on ENCODE
transcription factor targets, making RA signaling a likely upstream regulator of the cascade of
events attributed to Creb3l3 activation (Table 2.3). Together, these findings confirm that RA
signaling and metabolism is induced in cells responding to SBR, placing these signals upstream
of the key transcriptional changes we observe, supporting a crucial role for RA signaling in
adaptation both on a structural level, inducing enterocyte proliferation as shown in the literature,
43

and a molecular level inducing downstream changes in lipid transport and other nutrient
metabolism, as shown by our high-resolution scRNA-seq.125
Table 2.2: Genes Increased in Small Bowel Resection vs Sham that are Putative Responders to RA Signaling (rows
in bold indicate prediction to contain retinoic acid response elements from Find Individual Motif Occurrences. 137
Rows in italics indicate putative direct and indirect retinoic acid signaling targets from literature.)
Apoa4

Apob

Gda

Mgam

Creb3l3

Slc43a2

Treh

Gpx4

Gk

Cdhr5

Fabp1139

Ace2140

Slc2a2141

Mme142

Pdzk1143

Nudt4144

Plb1145

Dio1141

App146

H2-Q2141

Klf4147

Lap3144

Ace146

Clca4b148

Slc5q1144

Mical1144

Fos149

Chka150

Rnf128151

Fbln1152

Prap1144

H2-K1141

Vnn1153

Gls154

Malat1155

Aqp1156

Clec2e157

Slc6a19144

Apol7a144

Rbp2158

Neat1159

Ogdh160

Egr1161

Apoa1162

Apoc3163

Table 2.3: Genes Identified in Small Bowel Resection vs Sham that are Target Genes of Retinoid X Receptor Alpha
from
ENCODE
Transcription
Factor
Targets
Dataset
(Human)
(Source:
http://amp.pharm.mssm.edu/Harmonizome/gene_set/RXRA-ENCODE+Transcription+Factor+Targets)

Fabp1
Pdzk1
Rfk
Gk

Apoc3
Creb3l3
Khk
Acox1

Sepp1
Slc43a2
Malat1
Cdhr5

Leap2 Ephx2 Apob Apoa1 Ace2
Slc2a2 Dnase1
Acsl5 Pls1
Chka Ano6 Rnf128 Fbln1 Prap1
Pepd Gsdmd Neat1 Ogdh Dhrs1 Gpx4 Egr1
Nudt4

2.8 Discussion
Here, we report epithelial single-cell analysis of ileum following proximal SBR, showing
expansion of cells identified as mature proximal enterocytes in SBR vs. sham mice. SBR
enterocytes differentiated significantly on the basis of solute and nutrient transporters typically
associated with proximal SI, especially with regard to lipid metabolism. Because the duodenum
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and jejunum, proximal portions of the small intestine, absorb the majority of nutrients under
normal conditions, we propose that this “regional reprogramming,” driven by transcriptional
proximalization, is a critical component of the adaptation response to SBR in the remnant ileum.
This is a novel principle, as the typically studied structural adaptation, which increases
absorptive surface area, does not necessarily facilitate functional adaptation.111 Rather than
simple tissue hyperplasia, as others have suggested, we demonstrate that enterocyte-level
alterations in transcriptional profiles of distal cells occurs after SBR, in order to mimic proximal
SI function.164 These changes mimic proximal SI function through the production of critical
nutrient and lipid transporters typically found on proximal enterocytes in the enterocytes of the
distal intestinal epithelium.
These findings highlight the significant contribution that single-cell analysis makes
toward our understanding of organ pathophysiology. While previous studies could identify a
small pool of “proximal” genes increasing in the ileum after resection, our scRNA-seq expands
the pool of “proximalization factors” and allows us to look at what cell types and identities are
changing during this process. Of note, we saw that the SBR epithelium also retained a mature
distal enterocyte population (Figure 2.2B and 2.3B), and differential gene expression results
suggest largely preserved ileal bile acid metabolism and cobalamin absorptive function. For
example, bile acid metabolism genes Slc10a2, Nr5a2, Slc51b, Abcc3, and Nr1h4, and also
cobalamin metabolism genes Lrp2 and Tcn2, showed no significant differential expression after
SBR. Enterocyte basolateral bile acid transporter Slc51a was depleted in SBR, (0.29 average log
fold change, P < 0.0001), while cobalamin receptor Cubn was enriched (0.54 average log fold
change, P < 0.0001). These results suggest a hybrid proximal-distal identity of ileal epithelium
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following SBR, gaining functions lost from resection but not losing important distal functions as
well, a true compensatory effect.
While investigating causative signaling mechanisms driving these proximalization
changes, we identified upregulation of a transcription factor associated in the literature with
proximal SI: Creb3l3. Upstream analysis reiterated the importance of retinoid metabolism to the
adaptation response, and the depth of our analysis allowed identification of previously
undescribed transcriptional changes likely mediated by RA signaling and Vitamin A gradients
after SBR, including changes in Creb3l3 expression levels. As Creb3l3 is known to respond to
nutrient availability among other things, the prediction of an RXR binding site (Table 2.3) for
Vitamin A signaling provides a viable hypothesis for Vitamin A-induced activation of Creb3l3.
We did not identify strong evidence for perturbed intestinal stem cell regional identity based on
previously identified markers, consistent with previous observations that RA exerts its effects on
differentiated cells. In addition, Creb3l3 is localized to villus enterocytes rather than crypt-based
cells (Figure 2.6A), again providing reasonable evidence that Creb3l3 likely responds to Vitamin
A and RA signaling through differentiated enterocytes and increased exposure of villus
enterocytes to gradients in the lumen compared to crypt cells.106,138 We therefore conclude that a
critical component of the adaptation response to massive proximal SBR is transcriptomic
“proximalization” of distal SI enterocytes, and that this is driven at least in part by an RA
signaling gradient, which is upstream of “proximalization” transcription factors such as Creb3l3
and signaling cascades. The appearance of Creb3l3 as a potential driver of regional
reprogramming directed our further interest in the potential of using known (from the literature)
and novel (from our scRNA-seq data) transcription factors for direct reprogramming to
investigate regional reprogramming in organoids in vitro (Chapter 4).
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As it is a product of Vitamin A to retinoid to active RA metabolism, RA is derived
entirely from the diet. Following proximal SBR, the ileum becomes exposed to nutrients and
molecules in the luminal content which would otherwise have been largely absorbed more
proximally, most notably lipids and other essential nutrients. Essential nutrient Vitamin A is
among the list of nutrients commonly absorbed in the proximal intestine that we propose
provides new stimulus to the ileum after resection as Vitamin A is found in a proximal-distal
gradient in the small intestine.134,165 When the ileum bypasses the previous jejunal and duodenal
length once responsible for Vitamin A absorption post-resection, this new exposure to
RA/Vitamin A provides a growth stimulus that is a likely driver of both structural and functional
adaptation through resultant increases in RA signaling in ileal enterocytes.121,133 Similar to the
diffusible reprogramming factors described in the early days of reprogramming research, this
alteration in the endogenous amount of Vitamin A available to the distal cells post resection
provides us with a new hypothesis: diffusion of factors endogenous to the proximal intestine
extends into the distal intestine post resection and we can harness these endogenous factors in
vitro to model regional reprogramming by exposing distal organoids to proximal organoids as
presented in Chapter 3.64,66
A series of studies utilizing an ileostomy model of SBS in mice and zebrafish have
shown the critical effects of mechanoluminal flow on the structural adaptation process after SBR,
including loss of structural adaptation and cellular proliferation in the distal bowel when isolated
from the flow of luminal contents.29,166 The importance of luminal nutrition or enteral feeding
has also been highlighted by other groups.167,168 As such, exposure to increased levels of dietary
Vitamin A is a likely mechanism driving structural adaptation, consistent with prior
reports.35,125,131,132 We hypothesize that additional proximal factors likely play a role in this
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mechanism as well. In addition to Vitamin A, the ileum also becomes exposed to higher levels of
dietary fatty acids after SBR, and this likely constitutes an additional driving force for adaptation
through “proximal” endogenous factor gradients.121
The PPAR signaling pathway was implicated by our interactome analysis. We
investigated this further since PPARs form heterodimers with RXRs to activate PPAR response
elements (PPREs) in the induction regions of many genes involved in lipid metabolism,
including Creb3l3, which is well known to interact with PPAR.128,169–171 Interestingly, treatment
of mice with a PPARα agonist induced villus growth by facilitating cell differentiation, similar to
the adaptation phenotype observed after SBR in which there are elongated villi with an
expansion

of

mature

enterocytes.172,173

Ultimately,

we

observed

neither

changes

in Pparα expression (1.5% decrease 3 days after SBR via qPCR, P = 0.96, not shown), nor
significant changes in Pparδ expression (55.2% decrease 3 days after SBR, P = 0.16, not
shown). Less is known about PPARδ, though it is thought to interact with corepressors and
function as an inhibitor of PPARα.147 Given these findings, we suspect that either (1) PPAR
signaling is important to SBR adaptation, but was not captured in our analysis temporally, or (2)
minimal to no transcriptional change in these specific genes is needed to drive a significant
biological effect. In support of option 1, as we found that Creb3l3 expression changes were not
detectable by 3 days but were by 7, and Creb3l3 and Ppara are interacting partners, it is possible
that changes in PPARs occur later, post 3 days after surgery, and were therefore not detected.
Further studies looking at the potential role of PPARs in early adaptation would be interesting.
In summary, our analysis has revealed a significant shift in metabolic machinery and
regional identity at the enterocyte level following SBR. Moving forward, additional studies are
warranted to better delineate causal factors driving changes between sham and SBR enterocytes,
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in conjunction with or independent of RA signaling. This is especially true considering prior
studies that demonstrated proliferative and morphometric effects of circulating factors on
structural “jejunalization” of ileum following SBR, which implicates additional, non-luminal
stimuli in driving structural adaptation.1,174 Similar studies exploring molecular changes in
response to circulating factors would provide further insight. Discerning the stimuli for
functional proximalization of ileum following SBR will prove critical, as it will provide insight
toward targeted therapeutic approaches, via the enteral or parenteral route, for patients suffering
from SBS. Targeted therapeutic approaches combining aspects of adaptation from both structural
and molecular avenues could induce heightened adaptive responses, yielding better patient
outcomes. For example, as RA signaling seems to play a role in both structural adaptation and
regional reprogramming, it is possible that therapeutic approaches involving increased Vitamin
A in enteral nutrition or administration of Retinoic Acid to the small bowel could improve
patient outcomes. Further studies regarding the exact role of RA and the pathways it activates,
perhaps through transcription factor activation, are warranted.
However, further studies on the influence of regional luminal factors such as Vitamin
A/RA (and others) and the effects of transcription factors are complicated in the multi-variate in
vivo environment—as many confounding variables are hard to control within the mouse.
Therefore, we propose that future studies should focus on moving from the mouse model of SBR
to an in vitro model, using organoids. Using organoids allows for a controlled environment and
ease of scaling up for experimentation. We will focus on the use of organoids to model regional
reprogramming via diffusible proximal signaling and transcription factor direct reprogramming
in Chapters 3 and 4. These studies aim to develop models of regional reprogramming that can be
used for future study of SBS and SBR responses in patients.
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2.9 Conclusions
Here, we have characterized the transcriptome of adapted intestinal epithelium at the
single-cell level following massive SBR, a laboratory model for SBS, using scRNA-seq. Our
analysis revealed the emergence of unique enterocyte gene expression patterns between sham
and SBR mice, which distinguished themselves on the basis of proximal vs. distal SI patterning
and cell identity, including critical absorptive features. Pathways driving these changes, such as
proximal signaling and transcription factor activation, deserve further investigation, as they
underlie the functional aspects of adaptation to SBS, which allow progressive tolerance of enteral
feeding and weaning from PN for patients.

2.10 Materials and Methods
2.10.1 Mice
A total of 50% proximal SBR was performed on male C57/B6 mice at 8–12 weeks of
age, according to standard protocol.31 Briefly, the SI was extruded via a midline laparotomy and
the ileocecal valve identified. The SI was transected 12 cm proximal to the ileocecal valve, and
∼2 cm distal to the ligament of Treitz. The intervening SI was removed, the mesentery ligated
with 3-0 silk suture, and the proximal and distal ends approximated with interrupted 9-0 nylon
stitches. Sham surgery, consisting of distal transection and anastomosis only, was performed as
control. Peritoneum and skin were approximated in separate layers, animals were resuscitated
with a subcutaneous bolus of normal saline (repeated on postoperative day 1) and co-housed in a
33°C incubator until the end of the 7 day experiment. For longer studies (70 days), mice were
moved to room temperature at day 7. Liquid diet (TestDiet PMI Micro-Stabilized Rodent Liquid
Diet LD 101) was initiated 24 hours before surgery, withheld the morning of surgery, and
subsequently provided on postoperative day 1 until the end of the experiment. Food and water
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were available ad libitum, and animals were housed under 12-hour light/dark cycles with corn
cob bedding and nestlet enrichment. All surgical and animal care procedures were approved by
the Washington University Institutional Animal Care and Use Committee, and meet Animal
Research: Reporting of In Vivo Experiments standards.

2.10.2 Tissue Isolation and Processing
At day 7 after surgery, epithelium was isolated from a 1-cm segment of SI 3 cm distal to
the anastomosis, similar to previously published protocols.175,176 Briefly, the SI was flushed with
ice cold sterile saline, filleted lengthwise, and placed in a conical tube containing ice cold 30 mM
EDTA in phosphate-buffered saline (PBS). After 15 minutes on ice without agitation, the SI
segment was transferred to a fresh conical tube containing 30-mM EDTA in PBS, briefly shaken,
and placed in a 37°C water bath for 15 minutes. Subsequently, the tube was shaken aggressively
by hand for 2 minutes. Subepithelial tissue floated to the top and was removed, and epithelium
was pelleted by centrifugation. Epithelium was then re-suspended in a 0.3-U/mL dispase solution
(StemCell Technologies #07923) and incubated at 37°C for 15 minutes, shaking every 2 minutes.
The solution was then quenched with media containing fetal bovine serum to a final
concentration of 5%, pipetted several times, and sequentially passed through 100-, 70-, and 40μm filters. Single-cell suspensions were confirmed by microscopy, pelleted by centrifugation,
and resuspended in 200-μL ice cold PBS. Then, 800-μL ice cold 100% methanol was added,
dropwise, with gentle mixing between drops. Samples were immediately stored in 80% methanol
in PBS at –80°C, according to Alles et al., 2017, for later processing.177 For Western blotting
analysis, whole epithelium was isolated using 30-mM EDTA, pelleted by centrifugation, and
lysed in sodium dodecyl sulfate sample buffer (50-mmol/L Tris-HCL, pH 6.8, 2% sodium
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dodecyl sulfate, 10% glycerol, and 5% 2-mercaptoethanol). Lysate was heated to 100°C and
stored at –20°C prior to processing. Protein concentration was measured using the RC DC
(reducing agent and detergent compatible) Protein Assay Kit II (Bio-Rad 5000122). For qPCR
experiments, RNA was isolated from homogenized whole SI using the standard Trizol method.
RNA concentration was measured using a NanoDrop Spectrophotometer (NanoDrop
Technologies ND-1000). A total of 1-μg RNA was converted to complementary DNA (cDNA)
using qScript cDNA Synthesis Kit (Quanta Bio 95047), according to the manufacturer’s
instructions, and stored at –20°C until use.

2.10.3 scRNA-seq Library Preparation
For single-cell library preparation on the 10x Genomics Chromium platform, we used the
Chromium Single 3′ Library & Gel Bead Kit v2 (PN-120237), Chromium Single Cell 3′ Chip kit
v2 (PN-120236), and Chromium i7 Multiplex Kit (PN-120262), according to the manufacturer’s
instructions in the Chromium Single Cell 3′ Reagents Kits V2 User Guide. Methanol-fixed cells
from sham (n = 3) and SBR (n = 3) animals were pooled for the first batch. Methanol-fixed cells
from sham (n = 2) vs SBR (n = 1) were processed individually in a separate experiment for a
final sample size of sham (n = 5) and SBR (n = 4). Just before cell capture, methanol-fixed cells
were placed on ice, then spun at 3000 rpm for 5 minutes at 4°C, followed by resuspension and
rehydration in PBS, as previously described.177 Resulting cDNA libraries were quantified on an
Agilent Tapestation and sequenced on an Illumina HiSeq 2500.

2.10.4 scRNA-seq Analysis
The Cell Ranger v2.1.0 pipeline was used to align reads to the mm10 genome build, and
generate a digital gene expression (DGE) matrix: (https://.support.10xgenomics.com/single-cellgene-expression/software/downloads/latest). For initial filtering of these DGE matrices, we first
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excluded cells with a low number (<200) of unique detected genes. We then excluded cells for
which the total number of unique molecules (UMIs) (after log10 transformation) was not within 3
standard deviations of the mean. This was followed by the exclusion of outlying cells with an
unusually high or low number of UMIs/genes given their number of reads by fitting a Loess
curve (span = 0.5, degree = 2) to the number of UMIs/genes with number of reads as predictor
(after log10 transformation), removing cells with a residual more than 3 standard deviations the
mean. Finally, we excluded cells in which the proportion of the UMI count attributable to
mitochondrial genes was >25%. Raw and processed data files are available via GEO: accession
number GSE130113. After filtering and normalization of the DGE, the R package
Seurat (Version 3) was used to cluster and analyze the single-cell transcriptomes.102 Independent
biological replicates from the sham and SBR surgeries were integrated by Canonical Correlation
Analysis, identifying common sources of variation to align the datasets, reducing batch
effects.112 Highly variable genes were identified and used as input for dimensionality reduction
via canonical correlation analysis. The resulting Canonical Correlation Vectors and the
correlated genes were examined to determine the number of components to include in
downstream analysis, followed by clustering and visualization via UMAP.103

2.10.5 Quadratic Programming Analysis to Assess Cell Identity and State
QP, previously described in Treutlein et al., 2016 and successfully modified and used by
our group in Biddy et al., 2018, was used to score cell identity. Here, we created a reference of SI
epithelial cell types, collected previously.79,106,113 The R Package QuadProg was used for QP to
generate cell identity scores.
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2.10.6 Immunohistochemistry
Ileal tissue adjacent to the region collected for single-cell preparation was fixed in 10%
neutral buffered formalin, paraffin embedded, and sectioned at a thickness of 5 μm.
Deparaffinization and immunolocalization were performed as previously.178 Briefly, slides were
deparaffinized in xylene, rehydrated in sequential ethanol baths, and prepared in 3% hydrogen
peroxide in methanol. Antigen retrieval was performed using 1× Diva Decloaking Solution
(Biocare Medical DV2004), and blocking was performed using the Avidin-Biotin kit (Biocare
Medical AB972L). Primary antibodies were diluted in Da Vinci green (Biocare Medical
PD900L) and incubated overnight at 4°C. Slides were rinsed in phosphate-buffered saline +
TWEEN 20 (PBST), incubated in biotin-labeled secondary IgG diluted in PBST, rinsed in PBST,
incubated in streptavidin-horseradish peroxidase diluted in PBST, developed in DAB (SigmaAldrich D9015), counterstained with hematoxylin and bluing agent, run in successive dilutions
of ethanol, and xylene, and cover-slipped using MM 24 mounting medium (Surgipath 100109).
Of note, samples used for confirmatory staining were from a different litter of mice than those
used for scRNA-seq analysis. This was done to validate consistency of results across cage and
littermates, which has been previously reported as a confounding variable in murine
gastrointestinal research.179 At least 3 sham and 3 SBR samples were analyzed after surgery;
20× images representative of the sample were obtained by a blinded investigator using a Nikon
Eclipse 80i with Ds-Ri2 camera and NIS Elements V4.3 software (Nikon Instruments, Inc).

2.10.7 Quantitative PCR
cDNA was amplified using TaqMan Gene Expression Master Mix (Applied Biosystems
4369016) and the specified primer probe on the Applied Biosystems 7500 Fast Real-Time PCR
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system.

Primer

probes

were

Creb3l3 (Mm00520279_m1), Ephx2 (Mm01313813_m1),

and Rbp2 (Mm00436300_m1), all from Applied Biosystems.

2.10.8 Immunofluorescence
Ileal tissue adjacent to the region collected for single cell-preparation was fixed overnight
in 4% paraformaldehyde and then overnight in 30% sucrose before being embedded in O.C.T.
Compound (Fischer Healthcare 23-730-571), sectioned at 5 μm, and stored at –80°C until use.
Slides were washed in PBS and blocked in 5% goat serum with 0.3% Triton X-100 (SigmaAldrich T8787) prior to incubation with primary antibody in antibody staining solution (1% goat
serum and 0.3% Triton X-100) at 4°C overnight. Slides were rinsed in PBS for 5 minutes 3
times, and secondary antibody was applied in antibody staining solution for 1 hour at room
temperature. A total of 300-nM DAPI (Invitrogen D1306) was applied for 1 minute, and slides
were rinsed in PBS for 5 minutes 3 times before a cover slip was applied using ProLong Gold
Antifade Mountant (Invitrogen P10144). The 40× images representative of the sample were
obtained by a blinded investigator using a Nikon Eclipse 80i with Ds-Ri2 camera and NIS
Elements V4.3 software (Nikon Instruments, Inc). Images were subsequently analyzed using the
FIJI Distribution of ImageJ for FABP6, or unbiased computational quantification (FABP1; see
“Quantitative analysis of RNA-FISH images”). Representative images were chosen.

2.10.9 ImageJ Quantitative Analysis
For FABP6, the full area of each villus was chosen as a region of interest. The mean
intensity of that region was calculated to represent the fluorescence of the diffuse FABP6
staining. For percent

villus occupancy, ImageJ was used to measure the areas

of Creb3l3 expression, and this was divided by the total villus length. For Creb3l3, there were 12
sham villi (3 biological replicates) and 11 SBR villi (3 biological replicates).180
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2.10.10 RNA Fluorescent in Situ Hybridization
Tissues were fixed and sectioned as previously described in methods for
immunohistochemistry and immunofluorescence. RNA-FISH was performed using the
RNAscope Multiplex Fluorescent v2 kit (Advanced Cell Diagnostics 323100), following the
protocol for Fixed Frozen Tissue. Briefly, tissue was pretreated with RNAscope Hydrogen
Peroxide (Advanced Cell Diagnostics 322335), target retrieval was performed for 5 minutes, and
tissue was treated with RNAscope Protease III (Advanced Cell Diagnostics 322337). Then,
specified probes were hybridized using the RNAscope HybEZ II Oven (Advanced Cell
Diagnostics 321710/321720). Probes were then amplified and the HRP signal was developed
using TSA Fluorescein Plus Evaluation Kit (Perkin Elmer NEL741E001KT). Finally, slides were
counterstained with DAPI (Advanced Cell Diagnostics 323108) and mounted with ProLong
Gold antifade reagent (Life Technologies Corporation P10144). Imaging was performed on an
Olympus FV1200 Confocal Microscope, in which multiple 60× images were taken per sample,
of which 2–3 samples were used for each timepoint (day 7 vs. day 70) in each treatment (sham
vs. SBR). Images were subsequently analyzed using unbiased computational quantification and
representative images were chosen.

2.10.11 Quantitative Analysis of RNA-FISH Images
RNA-FISH images were processed with a custom python script to quantify gene
expression level at single-cell resolution. Individual cell segmentation was achieved based on the
nuclear signal. First, DAPI images were transformed into binary images by thresholding the
fluorescent signal. The threshold values were determined by the Otsu method.181 Binarized
nuclei images were processed by the watershed segmentation method to completely separate
individual objects. The images were subjected to 2-step quality check: filtering of objects and
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filtering of images. First, inappropriately sized objects were filtered to remove noise and cell
multiplets. Then, images with a large number of inappropriate objects were removed. The
intensity of the fluorescent signal per individual cell area was then quantified. Fluorescent
signals per image were averaged to obtain mean signals per sample and treatment.

2.10.12 Gene Coexpression and Interactome Analysis
To further reveal relationships among differentially expressed genes following SBR, we
constructed gene coexpression networks using weighted gene correlation network analysis,
adapted for single-cell analysis as in https://hms-dbmi.github.io/scw/WGCNA.html. The analysis
was performed using the R package WGCNA. In brief, differentially expressed genes between
SBR and sham samples were identified via Seurat analysis, as previously (using the
function FindMarkers). Genes that were upregulated in SBR treatment were used for network
construction. Correlations of each gene pair among all significantly differentially expressed
genes were then calculated. A gene-gene correlation matrix was used to construct an adjacency
matrix by raising the correlations to a soft-threshold power, from which Topological Overlap
Matrix (TOM) was further computed to remove spurious correlations. With the TOM matrix, the
algorithm identifies modules/clusters of genes via clustering using Ward’s method and Dynamic
Branch Cut methods. Here, to identify the most significant connections, we select the top 5% of
the most differentially expressed genes for visualization. The network was visualized using
CytoScape based on the TOM matrix.

2.10.13 Statistical Analysis
Statistical comparison of the QP-generated identity scores between the 2 groups, sham
and SBR, was performed using an unpaired Student’s t test. For qPCR studies, statistical
analyses were performed using Prism 7.0 (GraphPad Software). Differences in protein
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expression and mRNA expression between sham and SBR were assessed using unpaired
Student’s t tests. Graphs with error bars represent mean ± SD. P < 0.05 was considered
significant. For immunofluorescence quantitative analysis using FIJI, FABP6 replicate values
were averaged between sham and SBR treatment identities. A Wilcoxon rank sum test was
performed to determine statistical significance. For quantitative analysis of RNA-FISH images,
and FABP1 immunofluorescence, statistics were calculated using the Wilcoxon rank sum test.
These processes were run with Python 3.6.7 and its libraries: scikit-image 0.13.1, numpy 1.14.3,
pandas 0.24.1, oiffile 2019.1.1, matplotlib 3.0.3, seaborn 0.8.1, and jupyter 1.0.0.
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Chapter 3: Novel Chimeric Intestinal
Organoids as a Preliminary Model of
Regional Reprogramming
3.1 Abstract
Moving studies from the in vivo environment to an in vitro environment is critical to the
future applicability of translational medicine to patient-specific purposes. Issues like SBS and the
accompanying process of regional reprogramming are difficult to model and study as they
currently require the utilization of an animal model, traditionally mouse, that does not exactly
recapitulate the human response. In addition, the in vivo models are low throughput and
expensive, leading researchers to look in vitro for the future of disease and treatment modeling.
In this chapter, we utilize findings from our in vivo study, specifically the presence of regionspecific diffusible factors influencing regional reprogramming, to approach in vitro modeling of
regional reprogramming utilizing intestinal organoids. We develop a novel, fully in vitro,
chimeric intestinal organoid model (“chimera”) to recapitulate murine regional reprogramming
in a dish and investigate novel signaling in the process. We find that our chimera model likely
increases proximal identity of distal organoid enterocytes based on scRNA-seq data and
computational analyses. Additionally, we note that exploration of cell-cell signaling pathways
through scRNA-seq data analysis in the chimera identifies Guanylate Cyclase-C signaling as
playing a role in the transcriptional changes seen within the chimeric model. We conclude that
our preliminary chimeric organoid model provides an in vitro environment capable of

60

recapitulating aspects of regional reprogramming, thereby producing a preliminary model for
continued development and study of murine regional reprogramming after SBR.

3.2 Introduction
The field of stem cell biology, especially the focus on reprogramming and regeneration,
is a relatively young but exponentially fast-growing field.63 One focus of the field is on
personalized medicine, or taking patient cells and reprogramming or differentiating them for
therapeutic or disease modeling purposes in vitro. The focus on in vitro medicine is important in
order for the field to move away from dependence on animal models that fail to completely
recapitulate the human system and to increase experimental throughput for drug and treatment
testing. The first step toward achieving this goal involves accurate in vitro models for disease
processes that can be applied to humans.
The development of small intestinal organoids from mice and humans provides a unique
opportunity to study intestinal disease and injury in vitro. Briefly, intestinal organoids are a 3dimensional in vitro culture system in which intestinal stem cells self-organize into an enclosed
structure containing the cell types and mimicking the functionality of the small intestinal
epithelium.7,43 Important to this study are two aspects of intestinal organoid biology. Firstly,
when taken from the in vivo system and cultured into organoids in vitro, the intestinal cells retain
their genetic memory of regional identity and even of disease states.47,48 Organoids are currently
being developed as a tool to model and test treatments for inflammatory bowel disease (IBD) and
Crohn’s Disease in vitro when derived from IBD or Crohn’s patients.182 Secondly, intestinal
organoids have been shown to react to bowel resection through undergoing structural adaptation
when engrafted in vivo.1 Together, this evidence supports the use of intestinal organoids to model
adaptation or regional reprogramming after SBR, as organoids maintain their in vivo genetic
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backgrounds in in vitro culture and can undergo “adaptation” if exposed to the correct factors
(for more detailed discussion of organoids, please refer to Subsection 1.1.2). The problem
remains, though, of how to expose organoids to the “correct” factors to mimic adaptation in
vitro.
Short Bowel Syndrome is a perfect system in which to utilize organoids as a model for
treatment response as adaptation in mice is detectable via altered expression of nutrient and lipid
transporters and other known genes, as discussed in Chapter 2. During our in vivo study in
Chapter 2, we utilized scRNA-seq to identify a process known as regional reprogramming which
occurs in the distal remnant intestine after resection. It is detectable based on the increased
expression of proximal-related tissue markers in the distal intestine post-adaptation. Notably, our
analysis identified Vitamin A metabolism (Retinoic Acid signaling) as an upstream trigger for
regional reprogramming in the mouse. We hypothesized that upon removing the proximal and
medial intestine, the distal intestine was exposed to much higher levels of Vitamin A signaling
due to an endogenous gradient of Vitamin A in the small intestine from proximal to distal.183
Based on this finding, we generated a more general hypothesis: region-specific diffusible
gradients of signals exist in the intestine and are interrupted by bowel resection such that changes
in signal exposure play a role in proximalization (regional reprogramming) of the distal intestine.
We further hypothesized that regional reprogramming could be modeled in vitro by reproducing
the exposure of distal intestinal tissue to the proximal signaling environment using a chimeric
organoid system and that we could further dissect the pathways at play using such an
environment.
Our development of a chimeric organoid system to model regional reprogramming has
great implications for the future study of SBS treatments for patients. Through building a model
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using mouse organoids, we enable the further study of regional reprogramming as it occurs
successfully in mice. In addition, we provide a framework for adaptation of this model to
humans. Chimerization of human patient organoids using this model in the clinic could provide
clinicians with valuable information regarding the extent of endogenous adaptation for individual
patients and will guide treatment options through providing a high-throughput system to
administer treatments in vitro and test effectiveness prior to treating the patient—lowering the
administration rate of ineffective treatments for SBS in humans.182
In our model, we were inspired by the developmental model of the chimeric organism
(see Subsection 1.1.3 for more details).67 Groups working in kidney organoids have previously
developed “chimeric” organoid systems in which they aggregate human stem cells with mouse
kidney cells and allow them to develop into organoids then engraft them in vivo to achieve
maturity of the cell types.68,69 While these studies provided us with support that chimerization
could influence cellular identity, the involvement of an in vivo maturation step needed
improvement. In moving to the intestinal organoid system instead of kidney, we found an
opportunity to utilize the unique attributes of the intestinal organoid—notably the presence of a
stem cell niche mimicking the in vivo environment capable of influencing cell identity outside of
an animal model.
We began by chimerizing iEP cells with mouse organoid cells to test the ability of the
mouse organoid to influence endoderm progenitors via diffusible signals. We found that the iEPs
chimerized with organoids took on more intestine-like identities. Based on this success, we
refined the chimera model using the chimerization of proximal intestinal organoids with distal
intestinal organoids. The resulting chimeras were analyzed using scRNA-seq for cellular identity
changes in the distal enterocyte populations. We found preliminarily that distal organoid cells,
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when exposed to the proximal organoid tissue in the chimera, acquire significantly higher
proximal enterocyte identity scores than controls and that the chimeric environment changes
Guanylate Cyclase-C signaling. However, these studies were underpowered and require further
replication to increase confidence in results. We conclude that the chimeric organoid model
recapitulates aspects of regional reprogramming in vitro and can be further developed to study
mouse and human adaptation after SBR.

3.3 Pilot of Chimeric Mouse Organoids Induce IntestineLike Transcriptomic Changes in iEPs
Taking a cue from chimeric kidney studies and the unique and valuable characteristics of
intestinal organoids, we began development of the chimeric intestinal organoid system.49,68,69
The Morris Lab works actively with the reprogrammed cell type known as induced endoderm
progenitors (iEPs) (detailed discussion found in Section 1.1.3).78,79 While these cells are directly
reprogrammed progenitors themselves, studies have shown that in vivo transplantation of these
cells in the mouse colon further reprograms them into functional intestinal cells.77,184 Because of
the known ability of these cells to reprogram in vivo, we chose them as our source cell type for
testing our new in vitro methods mimicking the in vivo environment using the intestinal organoid
stem cell niche.
In order to “hijack” the niche within the intestinal organoids, we developed our chimeric
intestinal organoid (“chimera” or “chimeric organoid”). In the small intestine, it has been
proposed that Paneth cells help to provide the niche for the Lgr5+ stem cells, encouraging the
maintenance and differentiation of the stem cells.49 It has been shown that dissociation of Lgr5+
stem cells and Paneth cells down to a single cell level, followed by centrifugation for
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reaggregation, results in the re-forming of small intestinal organoids, just as dissociation of the
kidney and reaggregation results in the formation of renal organoids.49,68
Based on this evidence, we generated the pilot chimera model through dissociation of
iEPs and mouse small intestinal organoids and then centrifugation to aggregate them to form
chimeras (Figure 3.1A). In brief, iEPs, identifiable by GFP expression, were cultured to maturity
and mouse organoids were cultured in 3-dimensions using Nicotinamide to enhance the stem cell
populations and enrich for the crypt-niche environment.49 The iEPs were then dissociated to a
single cell level while organoids were broken to small (2-5 cell) chunks to allow the presence of
Paneth cells next to stem cells to encourage organoid re-growth. The populations were combined
in a 1:2 (iEP to organoid) ratio in a low-bind U-bottom plate and centrifuged briefly to aggregate
cells to the bottom of the plate. The 1:2 combination ratio reflects the competitive growth of iEPs
vs. organoids to prevent competitive domination of a single cell type in culture. The aggregates
were suspended in Matrigel and allowed to grow in IntestiCult Medium. After a growth period in
vitro, we investigated the cells for chimerization via confocal microscopy (Figure 3.1B). We
observed an infiltration of the GFP positive iEPs into the organoid structure, a preliminary
indication of successful chimerization of the cell populations.
After the qualitative visual success of the chimerization process, we set out to determine
if the chimeric iEPs were being influenced toward intestinal fates by their exposure to the stem
cell niche of the in vitro organoids. We performed a pilot scRNA-seq study using Drop-seq in
order to compare control iEPs, control intestinal organoid cells, and chimeric iEPs grown in our
model (Figure 3.2).185
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Figure 3.1: iEP and Organoid Chimerization. (A) Schematic of chimerization process using dissociated iEPs and
mouse small intestinal organoids. The cells are aggregated via centrifugation and allowed to re-form into chimeric
organoids. (B) Confocal image of an iEP-organoid chimera. Nuclei are stained with DAPI (blue), allowing
visualization of the organoid budding structure. Integrated iEPs are visualized in GFP (green). White arrowhead
denotes integrated iEPs. Scale bar = 100 µm. Image taken on the ZEISS LSM 880 II Airyscan FAST Confocal
Microscope with a 20× objective.

Via Seurat-based tSNE analysis of the cell populations to dimensionally reduce the data,
we found that 3 clusters were formed from our cell types: an intestinal cluster identified by the
high proportion of control organoid cells (77.1% of cells in the cluster), a progenitor cluster
identified by a high proportion of control iEPs (68.8% of cells in the cluster), and a “transition”
cluster located between the two, built up of mixture of cells (15.1% organoid control, 42.5%
chimeric iEP, and 28.3% iEP controls) (Figure 3.2).102 Interestingly, we found that iEPs from the
chimeras were present in all three clusters, indicating that some are similar to normal iEPs
(25.7% of the progenitor cluster) while others are becoming more like organoid cell types
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Figure 3.2: scRNA-seq analysis results of iEP chimeras. (A) tSNE plot representing the transcriptomic analysis of
the iEP chimera dataset. Red dots represent iEPs derived from chimeras, blue dots represent mouse intestinal
organoid cells, green dots represent control iEPs. Blue circle outlines intestinal cluster, red circle outlines transition
cluster, green circle outlines progenitor cluster. (B) Breakdown of proportion of cell types in each cluster of (A). Key
of colors for A and B.

(31.9% of the intestinal cluster), and some are in a more intermediate, transitional state (42.5%
of the transitional cluster) (Figure 3.2). Within the chimera-derived iEPs found in the intestinal
organoid cluster, we found that some cells were expressing intestinal stem cell markers such as
Lgr5 and Prom1, indicating a potential transcriptomic change to a more intestinal stem cell-like
identity in chimerized iEPs (data not shown).
Overall, this analysis provided preliminary evidence that iEPs can be influenced by the
stem cell niche in intestinal organoids to take on more intestine-like identities. While the cells
remained predominantly intestinal stem cell-like in this analysis, we hypothesized that extended
culture time and alterations in culture conditions would lead to increased maturation. Even with
the immaturity of the data, we could see that the use of the organoid environment to influence
cells can induce reprogramming without the forced expression of exogenous factors, giving
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credence to our use of in vivo-like environments to induce cellular identity changes with
diffusible signals. Based on these results, we continued to refine and optimize the chimeric
model for use in modeling of regional reprogramming.

3.4 Proximal-Distal
Chimeric
Structurally Chimeric Organoids

Organoids

Produce

Due to the preliminary success of the pilot study, we refined the chimera model to suit
the needs of our proposed regional reprogramming model. This required the derivation of new
organoid lines from distinct regions of the intestine (proximal/duodenum and distal/ileum) that
could be differentiated from one another via scRNA-seq. To achieve this differentiation of
starting regional identities via scRNA-seq, we derived proximal organoids from the duodenum of
normal mice and distal organoids from the ileum of mT/mG mice, which express membranebound tdTomato in all cells, making the distal organoids fluoresce red and hopefully allowing
their differentiation from the proximal organoid cells when utilized for scRNA-seq.186,187
Proximal organoids were derived from the duodenum instead of the more medial jejunum to
ensure proximal identity of the cells, as regions of the intestine during dissection have little
delineation between jejunum and other regions.
The chimera aggregation process was adapted slightly from the pilot to encourage better
association of the cells. We began by breaking the proximal and distal organoids down to small
(2-5) cell clusters as before—to encourage the regrowth of organoids from stem cells.49 The
control (proximal or distal organoids broken down and individually reaggregated via
centrifugation to control for effects of aggregation on organoids, creating single-identity
controls) and experimental (proximal and distal organoid cells combined and chimerized through
aggregation) populations were then created totaling 2000 cells/well of a 96-well U-bottom low68

bind plate supplemented with custom growth media to promote maturation and differentiation of
the organoid cells. The movement from IntestiCult to a custom media blend allowed for
modulation of differentiation factors such as Noggin and R-spondin 1 as opposed to the
proprietary formulation of commercial IntestiCult Media (StemCell Technologies) which we
found maintains highly stem-like populations. The cells were allowed to settle with the plates on
ice for 10 minutes before centrifugation to aggregate. Finally, Matrigel was added to the wells
for extracellular matrix support and the chimeras and controls allowed to grow for 5 days in an
incubator prior to collection for downstream analysis (Figure 3.3).

Figure 3.3: Overview of proximal-distal chimera process. Schematic of chimerization process using normal
proximal mouse organoids and mT/mG distal mouse organoids. The cells are aggregated via centrifugation and
allowed to re-form into chimeric organoids.

Initial analysis began with visual inspection of the preliminary chimeras and controls
(organoids grown in IntestiCult). Brightfield imaging of the control and chimeric populations
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qualitatively revealed similar growth patterns among chimeras and controls. While some
variation existed between wells of each 96-well plate, all aggregates had re-formed visually
normal organoids of relatively equivalent size and exhibiting many distinct crypt structures
(Figure 3.4). This primary visual inspection indicated that both the aggregation and
chimerization processes had limited impact on organoid growth and cellular proliferation,
perhaps having no effect on structural adaptation characterized by expansion of cells (discussed
in Chapter 2).

Figure 3.4: Bright field imaging of controls and proximal-distal chimeras. (A) Ileal-Ileal (distal) control. (B)
Duodenal-Duodenal (proximal) control. (C) Chimeric (proximal-distal) experimental organoid. Images presented are
representative of IntestiCult growth conditions and taken on a Nikon Eclipse Ts2 with Nikon DS-Fi2 camera with a
10× objective. Scale bar = 100 µm.

To gain better understanding of the structure and compositional patterning of chimeric
organoids and to visualize the success of the chimerization process, confocal imaging was
utilized to view the combination of normal proximal and mT/mG distal cells in chimeras grown
in IntestiCult (Figure 3.5). The images display expected chimerization in which some regions
(crypts) have been grown from an mT/mG positive stem cell derived from the distal organoids
and are red and some regions (crypts) have been grown from an mT/mG negative stem cell
derived from the proximal organoids. This interspersed nature of the regions is expected based
on the growth patterns of organoids in which a single crypt is produced from an individual stem
cell as cells differentiate and migrate outward. It would not be expected to have alternating
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individual cells of differing colors due to this typical growth pattern. Instead, the regions of a
single color indicate normal growth and differentiation patterns of the intestinal epithelium.
These data indicate that chimerization results in regions of a single chimeric organoid being
derived from different regions of the intestine, a reflection of the anastomosis of remnant distal
and proximal intestine post resection. Imaging took place in IntestiCult prior to switch to custom
growth media but reflects growth patterns of chimeras vs. organoids in identical conditions.
Based on our qualitative imaging investigation, we conclude that chimeric organoids
composed of proximal and distal organoids display little change in growth or cellular
proliferation due to the chimerization process. Structural imaging also indicates success of the
chimerization process in combining regional organoids into a single structure, the chimeric
organoid. With promising images, we moved forward to quantitative analysis of the chimeras
using scRNA-seq.

Figure 3.5: Confocal imaging displays regions of chimerization in organoids. Confocal imaging of mT/mG (distal)
cells in red and nuclei in DAPI blue exhibits combined regions of red+ and red- cells in the chimeras, indicating
successful chimerization of proximal and distal organoids. White arrow heads distinguish distally-derived crypt
regions. Images presented are representative of IntestiCult growth conditions and taken on the ZEISS LSM 880 II
Airyscan FAST Confocal Microscope with a 20× objective. Scale bar = 100 µm.
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3.5 Distal Tissue in Chimeric Organoids
Significant Proximalization Scores via scRNA-seq

Displays

In two independent biological replicates, we used scRNA-seq to analyze the chimeric
organoids and the control organoids in our custom growth media. The data was aligned and run
through quality control measures before utilizing Seurat to perform dimensional reduction and
investigate differential gene expression between populations.102 Seurat analysis resulted in
UMAP visualizations of Replicate 1 (R1) and Replicate 2 (R2) in which R1 consisted of 12
clusters and R2 consisted of 10 clusters (data not shown). R1 contained 2416 duodenal control
cells, 1601 ileal control cells, and 343 chimeric experimental cells. R2 contained 3722 duodenal
control cells, 3485 ileal control cells, and 2114 chimeric experimental cells. Because of
difficulties in cell collection, demultiplexing, and subsetting, the following analysis was affected
by low cell numbers and results are considered preliminary—future replications are needed to
validate and increase confidence in conclusions.
Visualization of the UMAPs by original sample identity of the cells showed clear
delineation between the control duodenal and control ileal populations (Figure 3.6A). The
duodenal controls (green) are predominantly distinct from the ileal controls (blue), which
indicates clear transcriptional differences between control populations. These differences
validate the literature-reported maintenance of regional identity of organoids once derived.3,7 The
clear distinction also lends strength to the ability of this analysis to identify proximal vs. distal
regional identities transcriptionally. In both replicates, the chimeric organoids (red) are
distributed throughout the UMAP and fall into both control regions. This distribution is as
expected due to the derivation of 50% of the chimeric cells from the ileal organoids and 50% of
the chimeric cells from the duodenal organoids (Figure 3.6A). We expected the chimeras to fall
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in both populations as the chimeric cells derived from the ileum are not likely to completely lose
ileal identity but instead begin to take on markers of proximal or duodenal identity as well,
ultimately resulting in a “hybrid” identity as suggested in Chapter 2.183

Figure 3.6: Single cell RNA-seq analysis visualizations of chimera experiments. (A) UMAP visualizations of
Replicate 1 (left) and Replicate 2 (right) separated by original sample identity with key in center. (B) UMAP
visualizations of tdTomato expression (purple) as detected by scRNA-seq in the chimeric sample subset in Replicate
1 (left) and Replicate 2 (right) denoting original identity of chimeric cells as from distal organoids (mT/mG
positive).

To determine which chimeric cells came from which source (distal mT/mG cells or
proximal normal cells) we subsetted out the chimeric sample computationally and utilized gene
expression data to differentiate between the cells expressing tdTomato (distally derived) and
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others (Figure 3.6B). By doing so, we were able to directly compare distally derived chimeric
cells to the distal controls to look for differences in proximal enterocyte identity acquisition.
Using Haber et al., 2017, we compiled a list of markers of proximal enterocyte identity (Table
3.1).106 Seurat was utilized to generate a proximal identity score for each cell in the distal
chimeric and distal control populations based on their respective expression of the genes in the
list. Permutation testing was utilized to compare the mean proximal identity score of the control
distal and chimeric distal populations to determine if the difference between proximal enterocyte
identity scores was statistically significant. We found that in R1, distally derived chimeric cells
had significantly greater proximal enterocyte identity scores than distal controls (P = 0.01099).
Similarly, in R2, distally derived chimeric cells had significantly greater proximal enterocyte
identity scores than distal controls (P = 0.0091). The significance of these statistics indicates that
the chimera model induces acquisition of proximal enterocyte identity in distal organoid tissue
based on scRNA-seq analysis.
Table 3.1: Proximal Enterocyte Gene List for Identity Scores
Casp6
Gata4
Apoa4
Fabp1

Apoc3

Rbp2

Apoc2

Leap2

Cyp2b10

Cyp3a11

Lct

Gsta1

Gstm1

Gstm3

Ephx2

Ms4a10

Fam213a

Cbr1

Adh6a

Cyb5r3

Dhrs1

Ifi27l2b

Cyb5a

Cyp3a25

Ckb

Prap1

Cgref1

Dnase1

Aldh1a1

Khk

Lpgat1

Treh

Reg3g

Acsl5

Ace

Aldob

H2-Q2

Rdh7

Ckmt1

Cyp3a13

P4hb

Mdh1

Ppap2a

Slc2a2

Cox7a1

Sec14l2

Gsta4

Mme

Retsat

Mttp

Creb3l3

Slc5a1

Sult1b1

Hsd17b6

Scp2

Cyb5b

Cyp2c65

Gpx4

Xdh

Cyp2d26

Ugdh

Gstm6

Ndufa1

Gpd1

Cyp2c66

In seeking to validate our preliminary findings, we utilized Capybara, a quadratic
programming approach, to measure the identity classifications of individual cells in the distallyderived chimera dataset and the distal controls of R2 (the larger dataset) using the Haber et al.,
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2017 dataset as reference.100,106 Based on this analysis, we find that a higher percentage of cells
in the distally derived chimera dataset classify as proximal enterocytes (10.8%) compared to
distal controls (5.9%) (Figure 3.7). This result provides support to our finding that proximal
enterocyte identity scores increase in the chimeric organoid distal cells. Additionally, we noted
that immature and mature enterocyte populations (distal and proximal combined) were expanded
in the chimeric samples (27.1% vs. 13.3%). This finding reflects our finding of expanded
enterocyte identity within the in vivo model after resection presented in Figure 2.3B. Together
with the proximalization scores, these findings support the use of the chimeric organoid system
to reflect cell identity and population changes due to regional reprogramming.

Figure 3.7: Capybara analysis of chimera experiment. Capybara classifications of cells in each sample as percent
total cells. (No statistics available due to n = 1 and small sample sizes).

However, we must reiterate that these analyses were underpowered. While the distal
control dataset contained 3485 cells, the distal chimera data only contained 203 cells due to
issues with dropout resulting in distally-derived chimera cells going undetected (see Section 3.7).
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Ultimately, sampling of 203 cells for analysis leaves this data preliminary and underpowered.
However, we find that the increased proximalization scores and proximal enterocyte
classifications are a promising sign that proximal identity is being acquired.
We conclude, based on these analyses, that the chimeric organoid model as developed in
these studies provides a preliminary in vitro model of regional reprogramming using mouse
tissue. scRNA-seq analysis indicates that exposure of the distal organoid tissue to proximal
organoid tissue via chimerization significantly increases proximal enterocyte identity score
expression in distal cells when compared to distal controls. We hypothesize that the acquisition
of proximal identity is due to different exposure to diffusible factors or signals in the new
chimeric environment, mimicking the exposure to signaling gradients disrupted by resection as
discussed in Chapter 2.183 Replication of this experiment is necessary to increase confidence in
this analysis.

3.6 Computational Analysis Indicates Alterations
Guanylate Cyclase-C Signaling in Chimeras

in

To further dissect the mechanisms surrounding the potential regional reprogramming
occurring in our chimera model, we turned to in silico analysis of the Replicate 2 chimeric
scRNA-seq dataset. Replicate 2 was chosen for this purpose due to greater sample size for
increased analytical confidence (though still underpowered). We explored potential changes in
signaling pathways induced during chimerization compared to control organoids utilizing a
computational tool called CellPhoneDB.107 Briefly, CellPhoneDB generates “interaction scores”
between populations in scRNA-seq datasets based on permutation testing of expression of
ligands and receptors from a curated database. In the case of our dataset, we were able to
measure interactions between the chimeric cells (proximally derived → distally derived) and
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compare them to baseline interaction levels in control organoids. A heatmap of overall
interaction counts gave the first indication that signaling pathways had changed activity levels in
distally derived chimera cells as the population displayed high levels of interaction with the other
sample cell types (Figure 3.8A). When dissected, different combinations of sample cells showed
signaling pathway interactions, of most interest, due to high significance and expression levels in
chimeras, were the GUCY2C – GUCA2A and GUCY2C – GUCA2B interactions (Figure 3.8B).
GUCY2C is the receptor for the guanylate cyclase-C (GC-C) signaling pathway. GC-C
activation leads to a cyclic guanosine monophosphate (cGMP) cascade in the intestine and plays
roles in intestinal homeostasis, intestinal barrier integrity, and epithelial renewal among other
functions, making it a logical and fascinating potential player in regional reprogramming.188
GUCY2C is expressed along the length of the intestinal tract as a membrane bound receptor
facing the intestinal lumen.189 Of interest to regional reprogramming, Gucy2c is a downstream
target gene of transcription factor Cdx2, a major player in the development of regional identity
and patterning in the intestine.188,190
GUCY2C is known to have two endogenous peptide ligands: guanylin (Guca2a) and
uroguanylin (Guca2b). Importantly, GUCA2A is predominantly expressed in a distal→proximal
gradient in the intestine while GUCA2B is expressed in a proximal→distal gradient.188,189,191
These gradients reportedly are due to pH sensitivity of the ligands and the innate pH gradient of
the small intestine (acidic in proximal, neutral in distal).189,191 Both ligands are reported to be
released from the epithelium due to changes in luminal stimuli such as intestinal tonicity—a
variable that would be expected to change post-resection as transporters recalibrate and intestinal
volume changes.192 Based on the known role of GC-C signaling in the intestine and the

77

Figure 3.8: CellPhoneDB analysis identifies GUCY2C signaling changes in chimeras. (A) Heatmap of total
interaction counts by sample type. (B) Plot of significant interactions; x-axis denotes interacting samples with first
listed expressing the receptor and second expressing the ligand, y-axis denotes interacting pair receptor_ligand; P
values are denoted by dot size, colors indicate means of average expression values of interacting molecules.
Samples: chimera_1 = distally derived chimeric cells, chimera_0 = proximally derived chimeric cells, duodenum_0
= duodenal proximal controls, ileum_1 = ileal distal controls.
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distinct patterns of ligand expression by region, we further explored the interaction changes with
CellPhoneDB.107
First, looking at the interaction of GUCY2C and distal ligand GUCA2A, we noted that
the interactions of GUCY2C and GUCA2A were only considered significant in samples
containing ileal derived cells (chimera_1 and ileum_1) (Figure 3.9A). This was unsurprising as
Guca2a is known to be predominantly produced in the distal intestine and would likely come
from these cells. More interesting, perhaps, is that the mean interaction value between GUCY2C
and GUCA2A was increased in samples in which the distally derived chimera cells expressed the
ligand. We postulate that this increased value is due to an overall increase in Guca2a ligand
expression in distally derived chimera cells (Figure 3.9C).
Looking at the interaction of GUCY2C with proximal ligand GUCA2B, we were
surprised to see that GUCY2C and GUCA2B were only significantly interacting in comparisons
containing chimeric samples. Additionally, the interaction value was increased in samples in
which the distally derived chimera cells (chimera_1) expressed the ligand (Figure 3.9B). This
data indicates, again, that an overall increase in Guca2b ligand expression, a proximal ligand, in
the distally derived chimeras may be driving the significant interactions (Figure 3.9C). This is
especially interesting as it indicates that chimerization (regional reprogramming) increases
expression of a proximal ligand in distally derived cells. The increased expression of Guca2b in
the distal chimeric cells represents a response to chimerization resulting in increased production
of proximal signals.
Based on our findings in CellPhoneDB, we conclude that, via in silico analysis, guanylate
cyclase-C signaling is altered in and playing a role in the changes associated with the preliminary
in vitro chimeric model. Based on literature reports, GC-C signaling is present in and can be
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Figure 3.9: GC-C signaling and expression changes in chimeras. (A) Mean significant interactions of GUCY2C and
GUCA2A, means shown fit P < 0.05. (B) Mean significant interactions of GUCY2C and GUCA2B means shown fit
P < 0.05. x-axis in (A) and (B) denotes interacting samples with first listed expressing the receptor and second
expressing the ligand, samples: chimera_1 = distally derived chimeric cells, chimera_0 = proximally derived
chimeric cells, duodenum_0 = duodenal proximal controls, ileum_1 = ileal distal controls. (C) Mean expression of
each GUCY2C ligand gene by sample. (No statistics available for (C) due to n = 1 and small sample sizes).

stimulated in in vitro organoids, providing support to our in silico findings.193 In particular, we
note that the exposure of the distally derived chimeric cells to the proximally derived cells
upregulates expression of both the Guca2a (distal) and Guca2b (proximal) ligands in the
distally-derived populations (Figure 3.9C). These changes indicate definite changes in
regionally-regulated gene expression upon exposure to a proximal signaling environment in the
chimera. Our position that the novel exposure to a region-specific internal environment in this
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chimeric organoid (and the in vivo model) is driving regional reprogramming is supported by the
fact that these ligands are known to release based on exposure to luminal (internal)
environmental stimuli.192 It is reasonable to conclude that alterations in the internal environment
due to increased exposure to proximal signaling stimuli alters the expression of and release of
proximal and distal ligands in our model system and likely in the in vivo system as well.

3.7 Discussion
In this chapter, we report on the development of a preliminary in vitro model of regional
reprogramming we deem the “chimeric organoid” or “chimera” and the consequent downstream
analysis of identity changes in cells within the chimeric organoid using scRNA-seq. We show in
both a pilot and core experiment that aggregation of cells from two sources (organoids and/or
cultured 2-D cells) induces changes in cellular transcriptional identity detectable by scRNA-seq.
Because the distal cells in the chimeric organoid take on higher proximal enterocyte identity
scores and cell classifications indicative of regional reprogramming, we propose further use and
development of the chimeric organoid model to validate findings and for study of adaptation
signals after SBR in mice and treatment applications in humans. Due to further computational
analysis using CellPhoneDB highlighting changes in the GC-C signaling pathway in chimeric
organoids, we propose that diffusible signals in the internal environment of the chimeric
organoid play a role in regional reprogramming, a proposal supported by our findings regarding
Retinoic Acid/Vitamin A in Chapter 2.107,183
While others have explored chimerization of cell types to produce organoids to mature in
vitro, our model is novel due to the completely in vitro maturation cycle which relies on the
innate structure and function of intestinal organoids.68,69 Our model is stand-alone and offers
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independence from traditional animal models. These findings offer significant progress for the
future study of adaptation post bowel resection through isolation of an in vitro model which can
easily be adapted to patient samples simply through using patient-derived organoids. In addition,
this study gives insight into how findings from scRNA-seq studies can be used to provide insight
into disease response pathology. Similar to the findings in Chapter 2, we noted that the distallyderived cells in the chimeric populations did not shift completely to non-ileal regions of the
UMAP visualization, but still exhibited greater proximal identity scores (Figure 3.6A). These
results support our previous finding suggesting a “hybrid proximal-distal” identity of the ileum
after resection in which enterocytes gain proximal functions without fully losing their distal
functions.183
In our pilot study utilizing chimerization of mouse organoids and iEPs, we found that
exposure of iEPs to the signaling environment within the chimeric organoid system induced
transcriptional shifts in some cells moving them closer to intestinal identities (Figure 3.2).
Consistent with our previous reports regarding the adoption of intestinal identity in iEPs, we
found that some chimerized iEPs began expressing intestine-specific stem cell markers such as
Lgr5 and Prom1, indicating not only their ability to reprogram to intestinal cell types but also the
ability of the chimeric system to induce identity changes directing cells toward intestinal
fates.77,184 We conclude from this that intestinal organoids contain strong niche signaling to
promote intestinal identity and iEPs are a progenitor with multiple endodermal fate choices. The
continued investigation of iEPs as they differentiate down their varied fate pathways (liver and
intestine) can provide insight into multiple reprogramming and differentiation processes both by
engraftment in vivo and through chimerization models in vitro.
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The imaging, especially brightfield, brings an interesting qualitative observation to light.
We noted that the resulting organoids (control and experimental) were similar in size and shape
of crypt-like structures (Figure 3.4). This observation indicates that the well-known structural
adaptation (characterized by lengthening of villi and cellular proliferation) accompanying
regional reprogramming may not occur in the chimeric in vitro model.31 If structural adaptation
occurs in the chimeric model, we expect to see changes in the length of the crypt-like
outcroppings and overall size of the organoids due to increased cellular proliferation. While our
initial qualitative image analysis indicates, upon visual inspection of samples, that the overall
size of organoids and crypts appear no different in chimeric organoids, a more quantitative
analysis should be carried out to truly make a conclusion. To determine if the chimera undergoes
structural adaptation, in-depth image analysis in optimized media should be carried out to
measure crypts and perform statistics. In addition, proliferation and differentiation could be
investigated through labeling of the stem cells and tracking progeny differentiation and turnover.
Utilization of scRNA-seq to investigate gene expression differences between distal
controls and distally-derived chimera cells showed not only increased proximalization of the
chimera cells via proximal enterocyte identity scores, but also indicated changed proximal
identities based on differential gene expression between the samples in Replicate 2. Three highly
differentially expressed genes between sham and SBR populations in Chapter 2 were also
expressed at significantly higher levels in distally-derived chimera cells when compared to distal
controls.183 These genes, Fabp1 (avg_log2FC = 2.01), Fapb2 (avg_log2FC = 0.86), and Rbp2
(avg_log2FC = 0.81) are all associated with proximal intestinal nutrient or lipid transport and are
upregulated in the distally-derived chimera cells with P < 0.05. These results support the finding
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of increased proximal enterocyte identity scores by providing a more population-level significant
difference in proximal nutrient transporter expression levels.
Additionally, use of an alternative analytic tool, Capybara, to classify cells as distinct
identities, identified the chimeric-derived distal sample as having a higher incidence of mature
proximal enterocytes and an expansion of total enterocyte populations.100 These findings support
our previous work and provide evidence for the success of the chimeric model. Use of Capybara
also provided us with information regarding the maturity of our organoids due to media
formulation alterations. In initial 10x experiments (data not shown), cells cultured in IntestiCult
(a commercially available organoid growth media) showed a nearly ubiquitous stem cell identity
and failure to mature and differentiate, this finding was confirmed by a representative of
StemCell Technologies. Because of this, we changed from using IntestiCult to grow cells for the
10x experiments to using a custom media formulation with controlled amounts of Noggin, Rspondin 1, and EGF—factors known to promote maturity. We chose a formulation that indicated,
via qPCR, that organoid maturity was increasing (Alpi expression) and stemness was decreasing
(Lgr5 expression) but cells still proliferated well (consistent growth) (data not shown). While we
note that there is the presence of differentiated cells in the chimeric and control data, stem cells
make up 32.5% of the distally derived chimeric cells and 53.9% of the distal controls. This
abundance of stem cells may indicate that future media formulation tweaks are required to more
fully mature the organoids.194 Cellular composition can be further validated through staining.
Our use of scRNA-seq allowed us to identify GC-C signaling as being active during
regional reprogramming. GC-C signaling provides an interesting avenue for future study as
intestinal GC-C is not only implicated in homeostasis, but also in inflammatory intestinal
diseases like IBD and colitis. Interestingly, both ligands (GUCA2A and GUCA2B) and receptor
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(GUCY2C) have been shown to be down-regulated in IBD and it is proposed that this downregulation is to promote tissue regeneration through proliferation.188 As it seems that the
production of ligands is increased in chimeras, we hypothesize that in order to prevent mere
tissue hyperplasia and to promote expansion of only certain differentiated cell types, in our case,
enterocytes, ligand production increases to discourage proliferation.183,189 GC-C signaling is also
downstream of Retinoic Acid signaling, as increased RA signaling increases CDX2 protein
expression in some systems.195 Cdx2 is known to regulate Gucy2c expression in the intestine, so
it is possible that an increase in RA signaling due to resection (as discussed in Chapter 2)
increases Cdx2 expression and thereby alters GC-C signaling after resection.183,189 Future studies
should investigate changes in GC-C signaling in vivo after resection to validate these hypotheses.
A shortcoming of this scRNA-seq study of the chimeras relates to the small sample sizes
achieved in the datasets, especially in distally-derived chimeric cells, as mentioned when
discussing the underpowered nature of the analysis. This shortcoming comes from unexpected
difficulties in detecting tdTomato mRNA in the datasets, likely due to the structure of the
tdTomato mRNA. This resulted in decreased isolation of distally-derived chimeric cells from the
greater chimeric population due to drop-out of tdTomato reads. Methodologies to increase the
power of this study and avoid this shortcoming in the future will be discussed in Chapter 5.
Overall, the chimeric model provides support to the proposition of Chapter 2, that
diffusible signals whose gradients are altered by resection, such as RA, play a role in triggering
regional reprogramming. Our chimeric organoid model is a preliminary in vitro system in which
proximal signaling from proximally-derived organoid tissue influences distally-derived organoid
tissue. Further study utilizing this model on mouse tissue will provide additional insights into
signaling associated with regional reprogramming and should look into the possibility of
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structural adaptation in the model as well. Based on our analysis, GC-C signaling is changing in
the chimeric model. As GC-C signaling plays large roles in intestinal response to diseases and
homeostasis, this pathway deserves further investigation relating to SBR and adaptation. In vivo
studies looking for GC-C alterations in mice will validate these findings of a new pathway
involved in the adaptive response. By further developing and investigating the mouse chimeric
model, we can gain further insight into successful adaptation triggers and signaling for
applications in humans. The mouse chimeric model should be applied to human organoids in
subsequent studies. By comparing the chimeric model and regional reprogramming occurring in
mouse chimeras vs. human chimeras, we can glean more information regarding differences in the
successful adaptation process between the species.

3.8 Conclusions
Here, we have developed a novel model of mouse regional reprogramming using in vitro
organoids and analyzed cellular identity changes and signaling pathway alterations using
scRNA-seq. Our analysis of the chimeric organoid model reveals that distally-derived organoid
cells are capable of taking on more proximal enterocyte-like identities, indicative of regional
reprogramming, when exposed to a proximally-derived organoid environment. Pathways like
GC-C signaling are implicated in the chimeric setting, and reveal the importance of changed
availability of diffusible signals in the intestinal environment during regional reprogramming.
This model should be further developed for applications to human organoid systems and further
studied in mice in order to dissect the signaling pathways activated in regional reprogramming to
better understand the adaptive response after SBR.
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3.9 Materials and Methods
3.9.1 Mice
Mice utilized for organoid derivation were of C57BL/6J background (The Jackson
Laboratory #000664). Mice utilized for mT/mG organoid derivation were of C57BL/6J
background with homozygous mutations for mT/mG (The Jackson Laboratory #007676).186 All
animal care procedures were approved by the Washington University Institutional Animal Care
and Use Committee.

3.9.2 Organoid Derivation
Organoids from mouse small intestine were isolated and derived as intestinal crypts as
described in the StemCell Technologies Technical Bulletin.187 Modifications for regional
isolation were as follows: tissue for derivation of proximal organoids (duodenal) was isolated as
the ~5 cm of duodenum just distal to the pyloric sphincter; tissue for derivation of distal
organoids (ileal) was isolated as the ~5 cm of ileum just proximal to the ileocecal valve. Briefly:
tissue was collected and placed in cold PBS, tissue was flushed and minced. Minced tissue was
agitated and rinsed 20 times and supernatant filtered through a 70 µM filter to isolate intestinal
crypts for culture.

3.9.3 Cell Culture
iEPs were generated as previously described.78,79 Briefly, MEFs (from E13.5 C57BL/6J
mouse embryos, The Jackson Laboratory #000664) were cultured on gelatin and serially
transduced every 12h with Hnf4a-t2a-Foxa1 retrovirus 5 times over 3 days. The reprogrammed
cells were then cultured on collagen in HepBase Media consisting of: DMEM:F-12 (Gibco)
supplemented with 10% FBS, 1% penicillin/streptomycin, 55 µM 2-mercaptoethanol, 10 mM
Nicotinamide (Sigma-Aldrich), 100 nM dexamethasone (Sigma-Aldrich), 1 µg/mL insulin
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(Sigma-Aldrich), and 20 ng/mL epidermal growth factor (Sigma-Aldrich). Cells were maintained
at 37oC, 5% CO2 in an incubator.
Mouse organoids were maintained as previously described in the StemCell Technologies
Technical Bulletin with modifications.187 Briefly, organoids were plated in 48-well cell culture
plates (VWR 10062-898) in 20 µL droplets consisting of 50% Mouse IntestiCult Organoid
Growth Media (StemCell Technologies #06005) and 50% Growth-Factor Reduced Matrigel
(Corning 354230). Droplets were polymerized for 10 minutes at 37oC, 5% CO2 in an incubator
before 250 µL of Mouse IntestiCult Organoid Growth Media was added to each well. Organoids
were maintained at 37oC, 5% CO2 in an incubator. Organoids were passaged as described in the
StemCell Technologies Technical Bulletin.187 Briefly, Matrigel domes were broken down using
Gentle Cell Dissociation Reagent (StemCell Technologies #07174) and gentle rocking at room
temperature for 10 minutes. Cells were washed and centrifuged 2x before replating in 20 µL
droplets consisting of 50% Mouse IntestiCult Organoid Growth Media (StemCell Technologies
#06005) and 50% Growth-Factor Reduced Matrigel (Corning 354230) in 250 µL of Mouse
IntestiCult Organoid Growth Media.

3.9.4 Chimerization
Chimeras were formed using an adapted protocol based on aspects of Xinaris et al., 2012,
Xinaris et al., 2016, and Sato et al., 2011.49,68,69 Normal proximal and mT/mG distal organoids
were each collected and split to small clusters of cells using Gentle Cell Dissociation Reagent
(StemCell Technologies #07174) for 10 minutes on a rocker at room temperature. Cells were
counted and placed in 100 µL of growth media in 96-well low-bind U-bottom plates (Greiner
Bio-One 650970). Samples consisted of controls—2000 cells of a single type in a well;
experimental—1000 cells of each type in a well. Wells were gently pipetted 10x to mix and
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plates placed on ice for 10 minutes to allow organoids to settle. Plates were carefully centrifuged
for 5 minutes at 300xg, 4oC. Finally, 10 µL of Matrigel (Corning 354230) was added to each
well before the plates were allowed to grow for 5 days at 37oC, 5% CO2 in an incubator. Growth
media consists of 21.75 µL basal media, 0.5 mL B27 (Gibco 17504044), 250 µL N-2 (Gibco
17502048), 65 µL 500 mM N-acetylcysteine (Sigma-Aldrich A9165), 12.5 µL 100 µg/mL EGF,
25 µL 100 µg/mL stock mouse Noggin (PeproTech 250-38), 25 µL 100 µg/mL stock R-spondin
1 (R&D Systems 7150-RS0010/CF). Basal media consists of 48.5 mL Advanced DMEM:F12
(Gibco 12634010), 0.5 mL GlutaMax 100x (Gibco 35050061), 0.5 mL HEPES 1M (Gibco
15630106), 0.5 mL penicillin/streptomycin.

3.9.5 scRNA-seq Cell Collection
Controls and chimeras for scRNA-seq were collected and prepared as follows. Each
control or experimental sample was pipetted and combined in a 15 mL tube. Samples were
centrifuged at 500xg for 3 minutes. Media was carefully aspirated and 3 mL TrypLE Express
(Gibco 12605036) was added. Organoids were agitated through pipetting up and down 20-30x
with a p200 pipette and placed in a 37oC bath. Every 5 minutes, cells were agitated via pipetting
20-30x and checked for breakdown to single cells. When cells achieved single-cell state, 5 mL of
DMEM:F12 (Gibco) was added, and the cells were filtered through a 40 µm FlowMi strainer
(Bel-Art H136800040). Cells were counted and viability checked using Trypan Blue exclusion
(viability > 90% required). Final samples were centrifuged at 500xg for 3 minutes at 4oC.
Replicate 1 cells were used fresh while Replicate 2 cells were subsequently methanol fixed as
described in Alles et al., 2017 by resuspending cells in 200 µL PBS and adding 800 µL ice cold
100% methanol dropwise, then stored at -80oC until use.177
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3.9.6 scRNA-seq Library Preparation
For scRNA-seq on iEP chimeras using Drop-seq, Drop-seq was performed as previously
described (http://mccarrolllab.com/dropseq/).185 In brief, cells and beads were diluted to an
estimated

co-occupancy

rate

of

5%

upon

co-encapsulation:

1 × 105 cells/ml

and

1.2 × 105 beads/mL. Emulsions were collected and broken using 1 mL of Perfluorooctanol
(Sigma) for 15 ml of emulsion, followed by washing in 6× saline-sodium citrate (SSC) buffer to
recover beads. Reverse transcription was then performed using the Maxima H Minus Reverse
Transcriptase kit (Life Tech EP0752). After treatment with 2,000 U/mL of ExonucleaseI (New
England Biolabs), aliquots of beads were amplified by PCR using Kapa HiFi Hotstart Readymix
(Kapa Biosystems). The PCR product resulting from this reaction was purified by addition of
0.6× AMPure XP beads (Beckman Coulter). Purified cDNA product was tagmented using
Nextera XT according to the manufacturer’s protocol (Illumina). The resulting cDNA library
was again purified using 0.6× AMPure XP beads, followed by 1× AMPure XP beads. cDNA
concentrations were assessed by Agilent Tapestation. Libraries were sequenced on an Illumina
HiSeq 2500.
For single-cell library preparation of Replicate 1 on the 10x Genomics Chromium
platform, we used the 3’CellPlex Kit Set A (PN-1000261), Chromium Next GEM Single Cell 3’
Kit v3.1 (PN-1000268), 3’ Feature Barcode Kit (PN-1000262), Chromium Next GEM Chip G
Single Cell Kit (PN-1000120), and Dual Index Kit NN, Set A (PN-1000243), according to the
manufacturer’s instructions in the Chromium Next GEM Single Cell 3’ v3.1 Cell Surface Protein
User Guide (Rev. B). Replicate 2 was prepared as follows: methanol-fixed cells were placed on
ice, then spun at 3000 rpm for 5 minutes at 4°C, followed by resuspension and rehydration in
PBS, as previously described.177 Then, on the 10x Genomics Chromium platform, we used the
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Chromium Next GEM Single Cell 3’ Kit v3.1 (PN-1000268), Chromium Next GEM Chip G
Single Cell Kit (PN-1000120), and Dual Index Kit TT, Set A (PN-1000215), according to the
manufacturer’s instructions in the Chromium Next GEM Single Cell 3’ v3.1 Gene Expression
Dual Index User Guide (Rev. B). All resulting cDNA libraries were quantified on an Agilent
Tapestation and sequenced on an Illumina NextSeq500.

3.9.7 scRNA-seq Analysis
The Cell Ranger 6.0 pipeline was used to align 10x reads to a custom mm10 genome
build containing tdTomato, demultiplex at a confidence level of 0.75 for multiplexed R1, and
generate a digital gene expression (DGE) matrix: (https://support.10xgenomics.com/single-cellgene-expression/software/downloads/latest). For initial filtering of all DGE matrices, we first
excluded cells with a low number (<200) of unique detected genes. We then excluded cells for
which the total number of unique molecules (UMIs) (after log10 transformation) was not within 3
standard deviations of the mean. This was followed by the exclusion of outlying cells with an
unusually high or low number of UMIs/genes given their number of reads by fitting a Loess
curve (span = 0.5, degree = 2) to the number of UMIs/genes with number of reads as predictor
(after log10 transformation), removing cells with a residual more than 3 standard deviations the
mean. Finally, we excluded cells in which the proportion of the UMI count attributable to
mitochondrial genes was >20%. After filtering and normalization of the DGE, the R package
Seurat (Version 4) was used to cluster and analyze the single-cell transcriptomes.102 Highly
variable genes were identified and used as input for dimensionality followed by clustering and
visualization via UMAP.103 Module scores for proximal identity detection were calculated using
Seurat function AddModuleScore.102 R package Capybara was used to classify cells.100
CellPhoneDB was used on raw data as described in Efremova et al., 2020.107
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3.9.8 Imaging
Bright field images were taken on a Nikon Eclipse Ts2 with Nikon DS-Fi2 camera. For
confocal imaging, chimeric organoids were collected for imaging by gentle pipetting. Organoids
were fixed for 20 minutes in 4% paraformaldehyde and stained for 30 seconds in 300 nM DAPI
in PBS. Organoids were subsequently embedded in 0.75% agarose in a 96-well glass bottom
plate for imaging. Confocal imaging took place on a ZEISS LSM 880 II Airyscan FAST
Confocal Microscope using ZEISS Zen Software (ZEISS Group).

3.9.9 Statistical Analysis via Permutation Testing
To determine whether distally-derived chimeric cells had higher proximal enterocyte
identities than distal controls, we used permutation testing (also called randomized testing) to
evaluate whether the mean proximal enterocyte identity score of the experimental population was
greater than that of the control relative to a randomly selected null distribution of the data. Here,
the proximal enterocyte identity score is as defined by Seurat using the AddModuleScore
function.102 The methodology is adapted from Biddy et al., 2018.79 Let N represent the number of
cells in the experimental population and M represent the number of cells in the distal control
population. We pool the two groups of cells (size = N + M) and resample N random cells, without
replacement, from the pooled cells 100000 times such that many possible separations with
ending groups of size N can be sampled and captured. During this process, the mean is calculated
based on the N randomly sampled cells. With the mean calculated, P values can be evaluated
based on the proportion of randomly sampled cells with a mean greater than or equal to the null
percentage. Using the P value of <0.05, we evaluated proximal identity acquisition differences.
The calculations were performed using a custom R-based script.
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Chapter 4: Effects of Direct Reprogramming
on Modeling Intestinal Regional
Reprogramming in Organoids
4.1 Abstract
Utilization of an in vitro model of disease alleviates many issues surrounding the use of
animal models from high cost of maintenance and experimentation to limitations in animal
number. In the case of modeling SBS and the resulting regional reprogramming, while the mouse
model has provided valuable information regarding changes in the intestinal epithelium post
resection (see Chapter 2), and our novel chimeric organoid system provides insight into
endogenous signaling and new opportunities to discover signals playing a role in the process
(Chapter 3), we desire a model in which we can test specific signals for their effects on regional
reprogramming. In this chapter, we explore the use of upstream transcription factors in inducing
regional reprogramming via direct reprogramming of organoids in order to study the effects of
specific, known signals of interest on the activation of regional reprogramming. We identify
three candidate transcription factors, Creb3l3, Klf4, and Gata4, for inducing regional
reprogramming via direct reprogramming. We generate three overexpression organoid lines to
study the effects of these transcription factors on induction of regional reprogramming. Focusing
our efforts on the effects of Gata4, we find that overexpression of Gata4 alone is not sufficient to
induce regional reprogramming in distal organoids based on scRNA-seq data and computational
analysis. However, we do find that overexpression of Gata4 in distal organoids induces changes
in the balance of cell types expressed in the organoids toward more stem-like identities. We
conclude that overexpression of Gata4 alone is insufficient to induce regional reprogramming in
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vitro but based on noted changes in the epithelial composition after Gata4 overexpression,
hypothesize that inclusion of Gata4 in a cocktail of reprogramming factors will likely produce
the desired regional reprogramming in vitro response.

4.2 Introduction
As discussed in Chapter 3, the growing importance of personalized medicine necessitates
a shift in focus and experimental modeling in stem cell biology and regenerative medicine.
Animal models have provided the field with invaluable opportunities to study disease and
responses in vivo, however the drive to scale up and focus on human biology requires new, in
vitro, models to be built. In shifting our focus to in vitro modeling, we must apply what we know
about disease from our animal-based systems in a dish to recapitulate an in vivo process for
further study and new applications.
In the study of intestinal disease, an in vitro model of the small intestinal epithelium
exists as the intestinal organoid (for further discussion of organoids, see Subsection 1.1.2).
Intestinal organoids provide a valuable system for study as they can be easily derived from
animals or humans from a simple intestinal biopsy, making personalized patient organoids easily
attainable.196 Additionally, intestinal organoids maintain much of the biology of the in vivo
intestine in their genetics, cellular composition, and even functional signaling and responses to
signaling.1,7,43,47,48 A large body of literature provides evidence supporting the use of intestinal
organoids as models and drives us to utilize intestinal organoid systems to model regional
reprogramming after SBR. However, a large issue in the use of organoids to model regional
reprogramming in vitro is identifying upstream components responsible for the process and
activating those signals in the organoids.
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In Chapter 3, we built the preliminary chimeric organoid system which allowed us to
utilize endogenous signaling within the organoid environment to induce regional reprogramming
effects in distal organoids. This methodology didn’t require previous knowledge of the specific
signals at play and allowed us to utilize the resulting data to later identify GC-C signaling as
being involved. While this model is useful for the study of regional reprogramming and
discovery of new pathways, it does not allow for the specific testing of factors of interest for
their involvement in regional reprogramming.
During our study in Chapter 2, we utilized scRNA-seq to identify regional
reprogramming in the distal remnant intestine after resection. We can identify regional
reprogramming through increased expression of proximal-related tissue markers in the distal
intestine post-adaptation. In addition to Vitamin A metabolism and diffusible signals upstream of
regional reprogramming (Chapter 3), our study identified an increase in proximal transcription
factors Creb3l3 and Klf4 during and after adaptation.183 We hypothesized that Creb3l3 (a
putative downstream target of RA) was an upstream transcription factor driving and maintaining
the regional reprogramming response after resection. Unfortunately, in the in vivo system, it is
difficult to study the effects of a single transcription factor on a tissue as the complex biological
interactions of the in vivo system cannot be controlled as well as the environment in a dish.
Based on our findings, we generated a general hypothesis: regional reprogramming is
controlled by activation of transcription factor signaling in the bowel. We further hypothesized
that using direct reprogramming to test the effects of transcription factors on regional
reprogramming would provide us not only with information regarding which transcription
factors play a role in the process, but also allow us to dissect their downstream effects without
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the confounding interactions that can occur in vivo. We aim for this study to ultimately culminate
in a direct reprogramming model of regional reprogramming after the factors are delineated.
Our development of a direct reprogramming system for regional reprogramming provides
tighter molecular control over the regional reprogramming process. The addition of this model to
our collection of models provides a system in which putative regulators of regional
reprogramming can be studied for their effects on inducing adaptation in patient tissue. The
combination of this model with the chimeric system provides a model for signal discovery (the
chimera) and for pathway effect elucidation (the direct reprogramming model), the data from
which can improve our understanding of regional reprogramming after SBR in mice and the
effects of applying our findings to human organoids in vitro.
We initiated our transition from our traditional direct reprogramming of iEPs (a 2dimensional system) to direct reprogramming of organoids (a 3-dimensional system) through
first utilizing a direct reprogramming system from 2-D human umbilical vein endothelial cells
(HUVEC cells) to 3-D human intestinal organoids as published by Miura & Suzuki in 2017.80
This system proved difficult to scale up and mature the resulting spheroids for study, so we
refocused on direct reprogramming of existing intestinal organoids for use in modeling regional
reprogramming. Through gene regulatory network (GRN) reconstruction, we identified two
potential upstream regulators of regional reprogramming (Klf4 and Creb3l3) and searching the
literature provided us with an additional target (Gata4). Using these transcription factors, we
generated an organoid direct reprogramming system to study the effects of overexpression of
each factor on inducing regional reprogramming. We identified Gata4 as holding the most
promise in ability to proximalize distal organoids, but found that overexpression of Gata4 alone
was insufficient to recapitulate regional reprogramming for in vitro modeling. Interestingly,
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Gata4 does appear to induce differentiation changes in the epithelial composition of organoids.
We conclude that use of direct reprogramming on organoids allows for investigation of the
effects of gene overexpression on cellular identity. Additionally, we conclude that while Gata4
alone does not induce regional reprogramming, it is a likely candidate for this process if used in
combination with other transcription factors in future studies.

4.3 Direct Reprogramming to Human Induced Intestinal
Progenitors Pilot Indicates Inefficiency of Reprogramming
We began our work in organoid reprogramming through using an adaptation of the iEP
direct reprogramming process to produce human intestinal organoids from other cells. We
hypothesized that the production of mature human intestinal organoids from non-intestinal cells
could assist in the derivation of patient-derived organoids for use in disease and treatment
modeling purposes if the process proved efficient at generating mature organoids.
As discussed in Subsection 1.1.3, direct reprogramming was utilized to make induced
hepatocytes (iHeps) from mouse embryonic fibroblasts (MEFs) through overexpression of Hnf4a
and Foxa1/2/3.78 However, when iHep cells were further analyzed using a GRN analysis tool
called CellNet, it was discovered that these cells were not fully hepatocytes in identity but had
additional colonic identity potential. This was validated through in vivo transplantation of iHeps
into damaged mouse colon, where they were able to functionally engraft.77 This study showed a
wider endodermal potential for these cells, which we now refer to as induced Endoderm
Progenitors (iEPs).
After the discovery of colonic identity in iEPs, the Suzuki group generated
reprogrammed mouse organoids from MEFs capable of regenerating intestinal epithelium and
colonic epithelium. Overexpression of four factors, Hnf4a, Foxa3 (the two iEP factors), as well
as Gata6 and Cdx2, resulted in formation of budding organoids from induced intestinal stem
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cells (iISCs). However, while expression of these four factors in human umbilical vein
endothelial cells (HUVECs) produced expression of intestinal markers, it formed only immature
intestinal spheroids, failing to reach an intestinal stem cell state capable of mature
differentiation.80 These human cells are what we refer to as human induced intestinal progenitors
(HIIPs) but fail to fully mature and differentiate like their mouse counterparts (Figure 4.1). We
set out to enhance this model system through improving the maturity of the final organoids for
use in modeling patient specific intestinal disease and treatments.

Figure 4.1: Schematic of HIIP reprogramming. HUVEC cells are transduced with retroviral constructs for FOXA3,
CDX2, GATA6, and HNF4A (blue) every 12 hours for 8 times. Transduced cells are plated in 3-dimensions in
Matrigel and allowed to reprogram for 20-21 days, resulting in immature intestinal spheroid structures.

While this model was reported to be tractable in the literature, our attempts to recapitulate
the cell type in order to develop methods to further mature the end state suffered from one of the
main issues surrounding in vitro reprogramming, low reprogramming efficiency.197,198 Using
constructs cloned in our laboratory as well as the original constructs obtained from the Suzuki
Lab, we performed numerous rounds of reprogramming but struggled to achieve reported results
(Figure 4.1).80
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Initially, with our cloned constructs, we produced small spheroid-like clusters which we
analyzed for markers of the developing and mature intestine via qPCR (Figure 4.2). We
compared the 3-D cultured reprogrammed HIIPs to the parent cell type, HUVECs, grown in the
same 3-D conditions to control for the effects of culture on the cell identity. In doing so, we
aimed to determine if the resulting cells were taking on any sort of reprogrammed identities. We
found that the analyzed HIIPs showed increased expression of general stem cell markers (e.g.:
SOX9 and KLF5) and even intestinal stem cell (ISC) markers, notably LGR5, when compared to
HUVEC controls.199–201 However, markers of mature intestine, such as VIL1, a marker of mature
enterocytes, failed to be detected in either sample via qPCR. Based on these findings, we
concluded that the reprogramming process was working on some level. It was producing a more
progenitor-like state in the HIIPs than in the control HUVECs that, similar to Miura & Suzuki’s
results, failed to mature to a full, differentiated intestinal state.
The organoids produced in our experimentation using the constructs obtained from the
Suzuki Lab closely resembled immature intestinal organoids, sometimes referred to as fetal
spheroids or enteroids (Figure 4.3). These cultures consisted of round, epithelialized layers
surrounding a hollow lumen, similar to those expected based on the results in Miura & Suzuki,
2017.80 However, these resulting spheroids failed to represent a tractable system to achieve our
goals of an efficient, mature in vitro model. Primarily, the formation rate of spheroids was less
efficient than the expected 0.1%, with only 3 spheroids forming from a population of 100,000
initial cells. This initial inefficiency of reprogramming may have been able to be overlooked had
the cells been able to be passaged and expanded after the reprogramming for use in further
maturational studies. However, the cells failed to expand—making the ultimate goal of
increasing the maturity of the final cell types unlikely in this context.
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Figure 4.2: qPCR results indicate increased progenitor-like state in HIIPs. qPCR analysis shows upregulation of
SOX9 (stem cell marker), KLF5 (stem cell marker), and LGR5 (intestinal stem cell marker) when compared to
HUVEC controls. qPCR failed to detect VIL1 (mature enterocyte marker) in either sample. Fold change is calculated
vs. control sample (value = 1) using GAPDH as a normalization control. Graph presented as fold change ± SD. *P
< 0.05, **P < 0.01. Statistics shown represent mean delta CT of technical duplicates.

Figure 4.3: HIIP spheroids in vitro. Left: Control HUVECs cultured in 3-dimensions for 21 days; Right:
Reprogrammed HIIPs cultured in 3-dimensions for 21 days. White arrowhead denotes epithelialized spheroids.
Images taken on Nikon Eclipse Ts2 with Nikon DS-Fi2 camera with unknown objective.

Overall, this study highlighted the distinct challenges surrounding achieving efficient
direct reprogramming and maturation of reprogrammed cells for modeling purposes. While we
were able to generate cell types that were becoming more stem-like compared to controls, we
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couldn’t generate these cells at a high enough efficiency to merit continued use. Because of our
difficulties in expanding the cultures, we were ultimately unable to promote maturation.
However, having learned from the difficulties surrounding this reprogramming process, we
altered our approach moving forward to improve both the potential maturity of the final cells and
the expandability of the cultures after reprogramming. To improve on these fronts, we decided to
utilize existing organoids as the starting cell for reprogramming. By doing so, we were able to
ensure the genetic and regional origin of the starting organoid and promote the starting cell
maturity.

4.4 Determination of Potential Transcription
Regulators of Regional Reprogramming

Factor

In Chapter 2 we discussed the discovery that Creb3l3 and Klf4, transcription factors,
were upregulated post-resection. We noted the likelihood that other transcription factors could be
highly involved but undetectable by scRNA-seq due to transient temporal expression.183
Therefore, in order to predict transcription factors likely to be playing a role in regional
reprogramming that we could test in vitro, we again turned to in silico means, using a tool called
CellOracle, to identify (or validate) our targets.
CellOracle is a GRN reconstruction algorithm that additionally allows for simulation of
the effects of gene overexpression or knockout on scRNA-seq data. In brief, CellOracle uses the
differential gene expression data found in a scRNA-seq dataset to infer which transcription
factors are active to create the unique gene signatures in the dataset. Then it provides
visualization and prediction of what transitions the cells in the scRNA-seq dataset are likely to
undergo if the expression of different transcription factors is altered.101
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To identify transcription factors likely involved in regional reprogramming, we analyzed
the SBR datasets from Chapter 2. Initial analysis of the datasets provided a number of potentially
interesting factors involved in proximal enterocyte identity including: Fos, Fosb, Egr1, Klf4,
Jun, Creb3l3, and Atf3. To determine which had the most potential in our system to induce the
intended alterations, we used the perturbation simulation function of CellOracle on each factor.
Some factors, such as Egr1 and Atf3, did not show large induction of proximal enterocyte
identity when overexpressed and were dismissed (data not shown). Fos and Jun showed promise
when overexpressed (Figure 4.4A-B) as large portions of the enterocyte population shifted
toward proximal enterocyte identities. Creb3l3 and Klf4 also had large shifts toward proximal
enterocyte identities when overexpression was simulated (Figure 4.4C-D).
Fos and Jun are members of the Activator Protein1 (AP-1) complex which is known to
play roles in nearly every cellular process from developmental proliferation and differentiation to
tumorigenesis.202 We chose not to pursue Fos and Jun in our initial study due to their widespread
involvement across tissue and processes making their specific involvement in regional
reprogramming unlikely.
In lieu of Fos and Jun, we chose to target Creb3l3 and Klf4 based on their known actions
and the results of CellOracle. Interestingly, both Creb3l3 and Klf4 were detected as being
upregulated post-resection in Chapter 2, making them stand out as potential targets.183 Creb3l3 is
known to be proximally intestinally expressed and to control lipid metabolism and the response
to inflammatory infection. The Creb3 family of proteins are additionally known to be regulated
by nutrient and stress signals. The changes in nutrient absorption, inflammation, and innate stress
response following SBR will likely alter Creb3l3 expression levels, making it a very promising
target for regulation of regional reprogramming.126 Klf4, similar to Creb3l3, is reported to have
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highest expression levels in the proximal intestine. Functions of Klf4 in the intestine include
homeostatic regulation of growth, cellular maturation, and differentiation as well as tumor
suppression.129 We deemed Klf4 a promising target for regional reprogramming because of its
regional expression pattern and roles in homeostasis and cellular differentiation—processes that
are disrupted by SBR.
While researching potential regional regulators, we noted that an additional factor, Gata4,
had a very interesting relationship with the development and maintenance of regional identity in
the small intestine. Gata4 is a particular type of transcription factor known as a pioneer factor, or
a transcription factor capable of binding to nucleosomal sites and increasing their accessibility to
other transcription factors.203 According to the intestinal literature, GATA4 is expressed in
duodenal and jejunal (proximal) enterocytes and is not expressed in ileal (distal) enterocytes.
While it plays roles in development, most notable are the identity maintenance roles attributed to
Gata4. Gata4 is both necessary to maintain jejunal gene expression (loss of Gata4 induces ileal
gene expression profiles) and sufficient to drive jejunal (proximal) identity in ileal tissue.204–206
In addition, Gata4 is a transcriptional repressor of Fgf15, a marker of distal enterocyte identity in
the intestine.204 Because of its specific role in delineating distal vs. proximal enterocyte identity
in the small intestine, we chose to study Gata4 as well, as its functions are closely related to the
process of regional reprogramming. Unfortunately, CellOracle was unable to utilize Gata4 for
perturbation simulations as its detected expression in the dataset was too low, which is
unsurprising as transcription factors are often transiently or lowly expressed and difficult to
detect by scRNA-seq (data not shown).
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Figure 4.4: CellOracle perturbation simulations for regional reprogramming transcription factors. Top image of each
panel depicts a trajectory graph showing predicted transitions in cell identity. Bottom image in each panel depicts a
Sankey diagram of predicted transitions in cell identity (starting identity on left, ending on right). (A) Fos
perturbation analysis. (B) Jun perturbation analysis. (C) Creb3l3 perturbation analysis. (D) Klf4 perturbation
analysis. Visualization examples from dataset “SBR2” .
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In summation, using both in silico predictive tools and literature searching, we identified
Creb3l3, Klf4, and Gata4 as likely candidates for induction of regional reprogramming after
SBR. We moved forward to test the effects of these transcription factors on induction of regional
reprogramming using direct reprogramming methods on intestinal organoids.

4.5 Gata4 Overexpression Induces Molecular Changes in
Ileal Organoids Mimicking More Proximal Identities
To generate an organoid system in which to overexpress our factors of interest (Creb3l3,
Klf4, and Gata4), we inserted our genes of interest into an established retroviral vector system
for intestinal organoid transduction, pMSCV-loxp-dsRed-loxp-(GENE)eGFP-Puro-WPRE.43 The
use of this vector, when inserted into Cre-expressing organoids, allows for the inducible
recombination of the backbone such that dsRed and a stop codon are cut out, resulting in the
transcription of the gene of interest and eGFP. This makes for a simple, visual system to monitor
transduction efficiency (dsRed expression) and expression of the gene(s) of interest (eGFP
expression). We expressed each gene of interest containing vector, and an empty control vector,
in Villin-CreERT2 distal (ileal) intestinal organoids. The use of the Villin-CreERT2 organoids
allows for targeting of the Cre-recombinase to Villin expressing intestinal epithelial cells, a
marker of mature epithelium, and additionally allows for the activation of Cre-recombinase using
Tamoxifen.
While set up the same as in Koo et al., 2012, our system experienced leaking of the Crerecombinase, resulting in baseline levels of target gene expression (and eGFP) before Tamoxifen
was added to cultures (Figure 4.5). Gene expression of transgenes was significantly increased
compared to controls, but unpredictable in terms of expression by vehicle or Tamoxifen (Figure
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4.5B). In attempts to eliminate this leakage, we moved the organoids to Phenol Red-free
Matrigel, as phenol red can act as a weak estrogen and activate CreERT2 (estrogen responsive)
systems and maintained the cells in IntestiCult.207 However, this change did not lower the
baseline level of target gene expression. Further research revealed that CreERT2 systems can
experience spontaneous recombination if the cells express high endogenous levels of
CreERT2.208 We postulate that the leakiness in our system is due to naturally high CreERT2
expression in the mouse line the cells were derived from. As our system was initially set up
merely to test the effects of overexpression of transcription factors on regional reprogramming
and not necessarily to test temporal expression, we chose to continue using the lines we
generated for further experiments. In the case that administration of Tamoxifen induced
additional expression above baseline, we included Tamoxifen treatment in our experiments. This
decision was made with the understanding that future experiments in which a temporal aspect
was of interest would require use of a less leaky Cre-recombinase organoid line.

Figure 4.5: Organoids exhibit leaky CreERT2 expression. (A) Representative image of empty control VillinCreERT2 organoid expressing eGFP after vehicle administration (white arrowhead). Scale bar = 100 µm. (B) qPCR
analysis shows increased expression of all genes of interest when compared to empty controls. Samples indicate that
genes are expressed without the administration of tamoxifen (+T) and with only vehicle added to the wells (+V).
Fold change is calculated vs. control sample (value = 1) using Hprt as a normalization control. Images taken on
Nikon Eclipse Ts2 with Nikon DS-Fi2 camera with a 10× objective. Graph presented as fold change ± SD. *P
< 0.05, **P < 0.01, NS < not significant. Statistics shown represent mean delta CT of technical triplicates.
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After establishing 4 stable distal organoid lines expressing the 3 genes of interest and the
control empty vector, we decided to narrow our focus to the most promising factor to start so that
future studies could be more easily optimized. We induced gene expression in our cells using
Tamoxifen then used brightfield imaging to investigate for phenotypic differences between the
gene overexpression organoids and the empty vector containing distal control (hereby called
“empty control”). We anecdotally noted slight visual differences including appearance of
extended (long) crypt structures in Klf4, Gata4, and Creb3l3 and the appearance of more
immature/stem-like spheroids in Klf4, Creb3l3, and Gata4 in organoids grown in IntestiCult
(Figure 4.6A). Based on these observations, we posit that all three genes result in increased stem
cell proliferation, leading to the occurrence of deeper crypts and non-differentiated spheroids, but
we could not make any conclusions regarding differentiated regional identity.209
To obtain a more quantitative result, we then compared the samples (including a proximal
organoid control derived from Villin-CreERT2 duodenum treated with vehicle) via qPCR to look
for several markers (Fabp1, Fabp6, Apoa1, Apoc3, and Rbp2) defining regional
reprogramming/proximal enterocyte identity as determined in Chapter 2 in organoids grown in
our custom growth media to promote differentiation (Figure 4.6B).183 Our proximal control
displayed the expected gene expression pattern of increased Fabp1, Apoa1, Apoc3, and Rbp2 and
decreased Fabp6 when compared to the empty distal control. Only Gata4 recapitulated the
expected gene expression pattern for proximal tissue with increased Fabp1, Apoa1, Apoc3, and
Rbp2 and decreased Fabp6 when compared to the empty distal control, though all values were
still statistically significant in differences between the pairs (Figure 4.6B).
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Figure 4.6: Gata4 expressing organoids show most likely proximal identity acquisition. (A) Representative images
of phenotypic changes in gene expressing organoids and empty controls grown in IntestiCult. White arrowheads
indicate extended crypts and yellow arrowheads indicate stem-like spheroids. (B ) qPCR analysis for Fabp1, Apoa1,
Apoc3, Rbp2, and Fabp6 when compared to the empty distal control. Fold change is calculated vs. empty control
sample (value = 1) using Hprt as a normalization control. Images taken on Nikon Eclipse Ts2 with Nikon DS-Fi2
camera with a 10× objective. Graph presented as fold change ± SD. *P < 0.05, **P < 0.01. Statistics shown
represent mean delta CT of technical triplicates of only Gata4 sample and proximal control due to space constraints.

Therefore, we chose to move forward and focus on Gata4 in our scRNA-seq studies, as it
gave the greatest evidence of taking on more proximal identities. The failure of Creb3l3 and Klf4
to recapitulate the expected patterns of gene expression do not reflect a lack of potential
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involvement in regional reprogramming, there is still logical reasoning for their involvement.
Instead, we postulate that these transcription factors may not be responsible alone for regional
reprogramming but instead act in concert with other signals and a more combined approach is
necessary to investigate their effects in the future.

4.6 scRNA-seq Reveals Gata4 is Insufficient to Induce
Proximal Enterocyte Identity in Organoids
We used scRNA-seq to analyze the Gata4 overexpressing organoids alongside the empty
distal controls and proximal controls grown in custom growth media. The data was aligned and
run through quality control measures before utilizing Seurat to perform dimensional reduction
and investigate differential gene expression between populations.102 Seurat analysis resulted in a
UMAP visualization consisting of 12 clusters (Figure 4.7A). The analyzed data consisted of 1926
empty control cells, 3646 proximal control cells, and 1914 Gata4 expressing cells.
Visualization of the UMAP by original sample identity of the cells showed clear
delineation between the control proximal and control distal populations, similar to those
discussed in Chapter 3 (Figure 4.7B). The proximal controls (blue) are predominantly distinct
from the distal controls (red), which indicates clear transcriptional differences between control
populations, as previously described.3,7 The Gata4 expressing organoids (green) overlap with the
empty control populations and additionally extend out above the empty control populations into
a region populated only by Gata4 derived cells. This distribution does not support our hypothesis
that overexpression of Gata4 in distal organoid cells will induce a transition toward proximal
enterocyte cell identities representative of regional reprogramming. While we wouldn’t
necessarily expect the Gata4 cells to move to the proximal control area on the UMAP due to a
potential “hybrid” identity (discussed in Chapters 2 and 3), we did not expect to see Gata4 cells
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outside the controls on the UMAP. The appearance of these cells in their own region may
indicate expression profile transitions toward unknown cellular identities.

Figure 4.7: Single cell RNA-seq analysis visualizations of Gata4 experiment. (A) UMAP visualization of the 12
clusters. (B) UMAP visualizations original sample identities.

To verify that these results did not support our hypothesis, we compared the Gata4
expressing cells to the empty distal control populations to look for differences in proximal
enterocyte identity acquisition. As in Chapter 3, using Haber et al., 2017, we compiled a list of
markers of proximal enterocyte identity (Table 3.1).106 Seurat was utilized to generate a proximal
enterocyte identity score for each cell in the Gata4 and empty control populations based on their
respective expression of the genes in the list. Permutation testing was utilized to compare the
mean proximal identity score of the populations to determine if the difference between proximal
enterocyte identity scores was statistically significant. We found that Gata4 cells had
significantly lesser proximal enterocyte identity scores than empty distal controls (P = 0.01006).
This result was surprising, as the detection of proximal enterocytes in the empty distal control is
expected to be very low. Interested in this finding, we used Haber et al., 2017 to compile a list of
distal enterocyte markers to test if there was a difference in distal identity between the two
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samples (Table 4.1).106 We found that Gata4 cells had significantly lesser distal enterocyte
identity scores than empty distal controls as well (P = 0).
Table 4.1: Distal Enterocyte Gene List for Identity Scores
Reg3g
Gsdmc4
Prss32
Krt8

Tmigd1

Fabp6

Slc51b

Slc51a

Mep1a

Fam151a

Naaladl1

Slc34a2

Plb1

Nudt4

Dpep1

Pmp22

Xpnpep2

Muc3

Neu1

Clec2h

Phgr1

2200002D01Rik

Prss30

Cubn

Plec

Fgf15

Crip1

Krt20

Dhcr24

Myo15b

Amn

Enpep

Anpep

Slc7a9

Ocm

Anxa2

Aoc1

Ceacam20

Arf6

Xpnpep1

Abcb1a

Vnn1

Cndp2

Nostrin

Slc13a1

Aspa

Maf

Myh14

We were initially confused by this seemingly confounding result. First, we hypothesized
that the lesser detection of proximal identity could have to do with duodenal vs. jejunal proximal
identities. The proximal markers from the Haber et al., 2017 publication are not defined as
“duodenal” or “jejunal”.106 Most work on Gata4 indicates that it is specifically responsible for
jejunal identity, so we theorized that the markers used for our identity classification may not
align with specific markers of jejunal identity, skewing our detection of proximal identity. We
cross-referenced our list (Table 3.1) with the jejunal-enriched transcripts in Thompson et al.,
2017 and found that several factors overlapped (DnaseI, Fabp1, Hsd17b6, and Lct), indicating
that our marker identity list was likely not completely off the mark.204 This indicated that Gata4
overexpression did not increase proximal enterocyte identity in our system, but we wondered,
based on the outlying population in the UMAP, if the Gata4 population was seeing changes in
cellular composition outside of enterocyte identities. We hypothesized that our seemingly
confounding enterocyte identity scores may represent a loss of enterocytes in the Gata4 samples
compared to the empty distal controls, resulting in the control organoids having higher proximal
and distal enterocyte identities due to cell composition changes.
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We conclude, based on this analysis, that the Gata4 overexpression model as developed
in this study fails to recapitulate regional reprogramming as detected by scRNA-seq analysis. It
seems that in an in vitro system, Gata4 is not sufficient to induce proximal enterocyte identity in
organoids. It is apparent, however, that the overexpression of Gata4 in organoids produces
identity changes of an unknown type, so we set out to determine what compositional identity
changes were occurring due to Gata4 overexpression.

4.7 Gata4 Reprogrammed Organoids Take on More StemLike Identities
To dissect the cellular composition of our preliminary datasets to look for transitions due
to Gata4 overexpression, we again employed the quadratic programming approach Capybara.100
This computational method uses quadratic programming to compare the gene expression of
query datasets against annotated reference datasets, in our case, the Haber et al., 2017 intestinal
atlas.106 Uniquely, Capybara allows for classification of each cell in the dataset based on the
reference and additionally allows for the identification of cells in transition states expressing
intermediate identities (“multi-ID” cells).
We first utilized Capybara to generate specific cell classifications for the Gata4, empty
distal control, and proximal control populations (Figure 4.8). The majority population of each
sample consisted of stem cells (≥57.7%). While the presence of stem cells is normal and
indicates continued turnover of the organoids just like the endogenous epithelium, this large
population is a relative overabundance of what would be expected, similar to the results in
Chapter 3. Again, it is likely due to the composition of the growth medium and the abundance of
factors such as Noggin and R-spondin 1 as it has been reported that titrating small molecules in
the growth media of organoids can direct production of certain lineages.194 Future experiments
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using this system should optimize the media composition to promote differentiation, however,
we consider these results valid as all organoids for 10x were grown in the same medium
composition, therefore any cellular composition changes compared to one another are due to the
organoids themselves.
There were clear shifts in compositional identities between populations (Figure 4.8).
There was an increase in the tuft cell population in the Gata4 (0.8%) and empty distal controls
(1.2%) compared to proximal controls (0.2%). This finding supports literature reports of higher
incidence of tuft cells in the distal small intestine.210 Additional observations included a decrease
in goblet cells in Gata4 cultures compared to empty controls (6.9% vs. 9.4%). This finding
supports literature reports of the effects of Gata4 expression on goblet cell populations,
supporting our overexpression of Gata4 as having results in the in vitro system comparable to
reports in in vivo systems.123,205 Notably, Gata4 cultures showed higher stem cell populations
than the empty controls (68.1% vs. 57.7%).
Pertinent to our amended hypothesis, Gata4 cultures did show an overall decrease in
enterocyte identities (immature and mature, proximal and distal) when compared to distal and
proximal controls (combined 8.5% vs. 18.7% and 16.2% respectively). This finding supports our
hypothesis that Gata4 overexpression resulted in a loss of enterocyte identity in the in vitro
system and a shift toward more undifferentiated (stem cell) identities. As Gata4 is reported
sufficient to repress ileal enterocyte identity, we hypothesize that the loss in enterocyte number
may reflect an initial loss of distal enterocytes from the population (perhaps via dedifferentiation
to stem cells), a reported function of Gata4.204 We would expect that an increase in proximal
enterocytes would accompany this loss, but our dataset does not indicate this. We hypothesize
two possible explanations: 1) the accompanying upregulation of proximal enterocytes is a later
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temporal process and given more development time in vitro, we would see an increase in
proximal enterocyte in Gata4 organoids or 2) Gata4 depends on other in vivo signals and
variables to promote proximal identity after dedifferentiation which are not active in our in vitro
system. While not as underpowered as the experimentation in Chapter 3, to verify these
preliminary results and generate statistics regarding population composition changes, the Gata4
scRNA-seq should be replicated and additional staining experiments used as validation.
As we would expect our reprogramming via Gata4 would induce a transitional state in
which some cells have hybrid identities, we investigated the multi-ID cell populations as well. A
goblet-stem cell intermediate occurred at a frequency of 39.2% of multi-ID cells in Gata4
populations while only appearing at a frequency of 20% in empty controls. We hypothesize that
this intermediate may represent dedifferentiation of goblet cells toward stem cells in Gata4
populations, accounting for the overall loss of goblet cells in that treatment. Additionally, we
noted an increase in enterocyte progenitor early-stem cell intermediates in Gata4 populations
compared to empty distal controls (35.3% vs. 15% of multi-ID cells). We hypothesize that this
population accounts for some of the low levels of enterocyte populations we report in Gata4
overexpression. Based on our findings, we hypothesize that Gata4 overexpression is resulting in
a dedifferentiation of enterocyte progenitors to stem cells, resulting in the differentiation of fewer
enterocytes overall.211 This is supported by our qualitative deduction that Gata4 expressing
organoids had increased stem cell activity (Figure 4.6A). It is also possible that this population
represents stem cells differentiating toward enterocyte progenitors. In summation, we conclude
via Capybara analysis that Gata4 overexpression altered cellular composition of the organoids
such that there is a loss of enterocyte identities and an increase in stem-like states indicating roles
for Gata4 in cellular differentiation in the in vitro organoid system.
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Figure 4.8: Capybara analysis of Gata4 experiment. Capybara classifications of cells in each sample as percent total
cells. (No statistics available due to n = 1 and small sample sizes).

4.8 Discussion
In this chapter, we report on our generation of directly reprogrammed intestinal organoids
for the study of transcription factor effects on regional reprogramming in vitro and the
downstream analysis of cellular identity using scRNA-seq. We learn, in a pilot experiment, that
maturation of organoids is difficult to achieve and maintain in vitro and therefore utilize adult
intestinal organoids with custom growth media to promote maturity in additional experiments.
Our direct reprogramming model using Gata4 showed cellular identity changes detectable by
scRNA-seq and thus we propose the continued use and optimization of this model to look at
effects of various transcription factors on the intestinal epithelium. Because our analysis of
Gata4 overexpression indicates that Gata4 alone is insufficient to induce regional
116

reprogramming in vitro but is sufficient to alter cellular differentiation and composition, we
propose that combinations of transcription factors will be required in vitro to mimic regional
reprogramming. Our findings in this chapter fail to support our hypothesis that Gata4 induces
regional reprogramming in vitro but provide valuable information on utilization of direct
reprogramming and in vitro organoids models for the future.
The effects of Gata4 on in vivo intestinal systems have been well studied, but our model
allows us to zoom in on how Gata4 functions in the intestine without the complication of other
systems and signals in vivo. Our demonstration of the use of direct reprogramming to monitor the
effects of transcription factors on organoids provides the field with the groundwork for
investigating the potential roles of different transcription factors during regional reprogramming.
It is a valuable system to accompany our preliminary model from Chapter 3, the chimera, in that
while the chimera provides opportunity to discover new signals at play in regional
reprogramming, the direct reprogramming model provides the opportunity to test known signals
in vitro. Together, the combined use of these systems can help clearly delineate the upstream
elements triggering regional reprogramming in mice and their downstream effects. Improved
delineation of these triggers will better inform future studies of induction of regional
reprogramming in human populations.
In a pilot study attempting to address the immaturity of directly reprogrammed human
intestinal organoids, we found that generating organoids through direct reprogramming was so
inefficient that it prevented us from achieving our goal of increasing organoid maturity in vitro.
Both low efficiency of reprogramming (reported 0.1%-20% efficiency) and immature gene
expression patterns are issues that plague reprogramming experiments.72,77,197,198 However, since
improving efficiency was not a target of these experiments, we used the failure of the HIIP pilot
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study to inform our future experiments in intestinal direct reprogramming. Based on the low
efficiency in reprogramming HUVECs into intestinal organoids, we chose to start with intestinal
organoids as our starting cell type moving forward. We additionally hoped that use of adult
intestinal organoids would eliminate issues of cell maturity.
The use of CellOracle allowed us to easily identify transcription factors of interest
without the extended time needed to search the literature for potential factors. While the analysis
pointed toward Creb3l3 and Klf4 as interesting targets we chose to pursue, CellOracle alerted us
to the potential involvement of Fos and Jun as well. As previously mentioned, Fos and Jun are
part of the AP-1 Complex and are widely activated and expressed across systems. AP-1 is
activated by a number of stimuli including growth factors and stress, making it a likely responder
post intestinal resection.202 In fact, it has been found that the AP-1 complex is an “immediate
early” response post intestinal ischemia, meaning expression is immediately increased.212,213
Because of this immediate early response and the general roles attributed to AP-1, we chose to
forgo Fos and Jun as initial targets for direct reprogramming as we were interested in looking for
proximal-related transcription factors with sustained expression to maintain cellular identity
changes after resection. However, it is possible that the immediate early response of AP-1 to the
altered growth factor and stress signals after resection is critical to the full regional
reprogramming response, and we may need to target these in combination with other
transcription factors in the future to achieve regional reprogramming in vitro.
We initially chose to only pursue Gata4 based on the similarities between proximal and
distal gene expression patterns in Gata4 overexpressing organoids and proximal controls via
qPCR (Figure 4.6B). However, both Creb3l3 and Klf4 are still promising targets that merit
investigation. In the qPCR results from Figure 4.6B, Creb3l3 and Klf4 both indicate potential
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loss of some distal enterocyte identity based on Fabp6 expression decreasing, but it is worth
noting that fold change of genes detected in both populations is relatively small. We don’t
believe these results indicate that Creb3l3 and Klf4 are not players in regional reprogramming. It
is possible that these factors do not directly affect the downstream targets we measured or that
they require the assistance of other factors to induce the expected downstream effects. Ultimately
we conclude that Creb3l3 and Klf4 merit exploration based on the CellOracle results and their
reported functions from the literature. It is likely, however, that they do not act alone in induction
of regional reprogramming, just as Gata4 is unlikely to act alone. Testing of direct
reprogramming with combinations of transcription factors will be an important future direction
(discussed in Section 5.2).
Our use of scRNA-seq analysis indicated that Gata4 overexpression is insufficient to
induce proximal enterocyte identity in distal organoids but is sufficient to induce cellular
composition changes affecting differentiation. We saw an overall increase in stem cells and
decrease in enterocytes in the Gata4 samples. This was surprising, as while it is predicted that
Gata4 acts in intestinal stem cells to promote differentiation of enterocytes, it is not reported that
it promotes stem cell identities.205 However, we noted that Olfm4, a marker of intestinal stem
cells (as well as tumorigenesis), was significantly upregulated in the Gata4 samples compared to
the empty controls via scRNA-seq (avg_log2FC = 0.67, P = 1.11E-33).214–216 This increase in
Olfm4 expression in the Gata4 populations supports our preliminary findings of expansion of
stem cells after Gata4 overexpression. In an interesting connection between the effects of Gata4
and the chimera in Chapter 3, we noted that expression of both Guca2a (avg_log2FC = -2.06, P
= 2.14 × 10-49) and Guca2b (avg_log2FC = -1.17, P = 4.04 × 10-18) was downregulated when
comparing Gata4 to empty controls—a known hallmark of tumorigenesis in the colon.217 Many
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of the other highly upregulated genes in Gata4 populations compared to empty controls were
associated with increased risk of intestinal and gastric cancers (e.g.: Pgk1, Mif1, Ldha, Fabp5,
and Aldoa), indicating that Gata4 overexpression has a large effect on cellular metabolism,
differentiation, and proliferation in this system and may need to be carefully controlled during
reprogramming to avoid cancerous cell transformations.218–222
We were additionally surprised that there was no detectable acquisition of proximal
identity in the Gata4 organoids based on the reported function of Gata4 in maintenance of
jejunal identity.204 We postulate that there are several factors that could be playing into this
contrast to the literature. Most of the studies in the literature focus on deletion or knock-in of
Gata4, not overexpression. It is possible that our use of overexpression elevated the expression
of Gata4 far beyond normal levels, inducing unexpected changes in the system. In this vein, we
must bring up the identity of Gata4 as a pioneer factor as a consideration. Pioneer factors are a
unique class of transcription factor capable of binding to inaccessible DNA sequences and
opening them up to make them accessible to other transcription factors and further recruiting
such factors.72,223 It is additionally proposed that pioneer factors, when activated, activate gene
networks associated with early developmental patterning, a conclusion that makes sense based
on Gata4’s known role in regional patterning of the intestine. Overexpression of pioneer factors
is proposed to allow “promiscuous” binding of transcription factors to chromatin, which could
additionally account for our unexpected results due to off target effects and the host cell being
unable to control the pioneer factors accurately.72 We hypothesize that in maintenance of jejunal
identity, Gata4 acts as a pioneer factor, binding to the chromatin in the in vivo system and
allowing the activity of other transcription factors to express proximal enterocyte identities,
potentially through encouraging cells to pass back through a less mature state and then recommit.
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By overexpressing Gata4 in our in vitro system, we may have caused large perturbations to highlevel circuits regulating fate and maturity, explaining the immaturity of our cell population. It is
possible that Gata4 must be expressed in a much more controlled manner to achieve the intended
perturbations and to achieve the intended transcription factor binding. As it is likely that Gata4
requires the synchronized expression of other transcription factors to exert its effects, it is likely
that Gata4 may need to be combined with other factors and carefully controlled during direct
reprogramming to elicit regional reprogramming.
As in Chapter 3, Capybara analysis revealed unusually high stem cell abundance in all
three samples. We again attribute this lack of maturity to the abundance of small molecules in
the growth media. Downstream use of the proposed organoid models will require additional
optimization of the media formulation to promote a balance of maturity and proliferative
capabilities when continuing experiments.
We also noted in the Capybara analysis that there was an unexpectedly high number of
cells identified as mature proximal enterocytes in the empty distal controls (Figure 4.8A) as well
as the distal controls from the chimera experiment (Figure 3.7). As these organoids (two separate
lines) were derived from terminal ileum, this finding was unusual, especially based on the fact
that in the qPCR analyses in Chapter 4, the proximal controls showed increased levels of markers
of proximal enterocyte identity compared to the empty distal controls via fold change calculation
(Figure 4.6B). This result may indicate that further curation of the reference dataset for
identification of proximal enterocytes is necessary as some of the markers may be less specific
than expected. When investigating this possibility, we noted that the mature proximal enterocyte
score generated by Capybara for the ileum in the reference dataset was somewhat high, which
could account for the higher than expected detection in our samples as they are compared to the
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reference. Conversely, this result may indicate that distal organoids grown in vitro for extended
periods undergo a more proximal-like enterocyte conversion due to in vitro conditions. While the
literature reports maintenance of regional identity in vitro, we know culture conditions (media)
can affect cell identity, and perhaps this is playing a role in the aberrant appearance of mature
proximal enterocytes in distal controls. Future experiments should look for the presence of cells
identified as mature proximal enterocytes from freshly isolated intestinal crypts and utilize
additional reference datasets for Capybara to explore these possibilities.100
Technical difficulties in achieving quality cell multiplexing and demultiplexing resulted
in low levels of cells attributed to each sample. Due to this, the analysis is somewhat
underpowered and preliminary. Findings reported should be further supported and analyzed by
additional replicates of the study to increase cell number and power and confidence of the
analysis.
Overall, our direct reprogramming organoid model of regional reprogramming provides
valuable information on the effects of transcription factor overexpression on cells of the
intestinal epithelium in vitro. Investigation of Gata4 using this system provided evidence that
Gata4 alone is not responsible for regional reprogramming in the mouse epithelium. Based on
our preliminary analysis, overexpression of pioneer factor Gata4 induced a more stem-like
identity in cells. Further study utilizing the Gata4 model should investigate titration of Gata4
levels to attempt to better induce on-target effects. Based on our findings, future efforts should
optimize the culture conditions for our in vitro model such that cellular composition is
distributed in more normal ratios and to promote further differentiation. Finally, future work
should focus on the combined effects of transcription factors in inducing regional
reprogramming, as combinatorial effects are more likely to drive this complex response. By
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further optimizing and developing the direct reprogramming organoid model, we provide a
system in which the direct effects of transcription factor signaling can be investigated. This will
allow for identification of the factors involved in the process in mouse and better inform our
study of human adaptation through comparing the factors involved between species. Through
doing so, we may identify factors inactive in humans that, if activated, could promote adaptation.
When the cocktail of factors required for mouse regional reprogramming is determined, the
direct reprogramming model will provide a valuable model of regional reprogramming in a dish
for further study and can be utilized to test activity of signals in patient tissue to predict patient
response to resection.

4.9 Conclusions
Here, we have set up a system for using direct reprogramming of intestinal organoids to
test the effects of specific transcription factors on regional reprogramming. Using this system,
we analyzed the contribution of Gata4 to regional reprogramming in vitro using scRNA-seq. Our
analysis of the Gata4 overexpression system indicates that Gata4 alone is not sufficient to induce
regional reprogramming in vitro. Regardless, the continued study of the direct reprogramming
system indicates a role for Gata4 in cell differentiation and dedifferentiation in the organoid
system. It is possible that Gata4 plays a role in regional reprogramming, but is unlikely to act
alone. The direct reprogramming model can be further used to investigate additional
transcription factors for roles in regional reprogramming as well as the effects of combinations of
transcription factors. Further delineation of the combination of transcription factors at play can
result in creation of a new model of regional reprogramming in vitro.
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4.10 Materials and Methods
4.10.1 Cell Culture
HUVEC cells were obtained from Lonza (CC-2519) and maintained according to
manufacturer’s instructions at 37oC, 5% CO2 in an incubator with EGM-Plus Endothelial Cell
Growth Media (Lonza CC-5035).

4.10.2 Organoid Maintenance
I-CreERT2 regional mouse organoids were derived and provided by the Digestive
Diseases Research Core Center (DDRCC) Precision Animal Models and Organoids Core
(PAMOC) at Washington University in St. Louis Medical School. The organoids were
maintained as previously described in the StemCell Technologies Technical Bulletin with
modifications.187 Briefly, organoids were plated in 48-well cell culture plates (VWR 10062-898)
in 20 µL droplets consisting of 100% Growth-Factor Reduced, Phenol Red-free Matrigel
(Corning 356231). Droplets were polymerized for 10 minutes at 37oC, 5% CO2 in an incubator
before 250 µL of Mouse IntestiCult Organoid Growth Media (StemCell Technologies
#06005)was added. Organoids were maintained at 37oC, 5% CO2 in an incubator. Organoids
were passaged as described in the StemCell Technologies Technical Bulletin.187 Briefly,
Matrigel domes were broken down using Gentle Cell Dissociation Reagent (StemCell
Technologies #07174) and gentle rocking at room temperature for 10 minutes. Cells were
washed and centrifuged 2x before replating in 20 µL droplets consisting of 100% Growth-Factor
Reduced, Phenol Red-free Matrigel (Corning 356231) in 250 µL of IntestiCult Organoid Growth
Media (StemCell Technologies #06005).
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4.10.3 Cloning of Genes
Genes of interest for HIIP reprogramming (CDX2, GATA6, HNF4A, and FOXA3) were
obtained as a gift from the Atsushi Suzuki Lab and were in the pGCDNsam-IRES-eGFP
backbone (Miura & Suzuki, 2017). Regional reprogramming genes of interest (Gata4 (gift from
Wenjun Kong, Samantha Morris Lab), Klf4 (gift from Barak Cohen, Addgene plasmid #66656),
and Creb3l3 (gift from Dong-Yan Jin, Addgene plasmid #99509)) were cloned into backbone
pMSCV-loxp-dsRed-loxp-eGFP-Puro-WPRE (gift from Hans Clevers, Addgene plasmid
#32702) using restriction enzyme HpaI (New England BioLabs R0105S). The intervening
fusion-protein sequence between the gene insertion site and the eGFP sequence was replaced
with a t2a sequence to avoid complications of gene fusion on folding.

4.10.4 Retrovirus Production
Retrovirus for both HIIPs and regional reprogramming experiments was produced in
293T-17 cells (ATCC CRL-11268) and packaged with pCL-Ampho (HIIPs) (Novus Biologicals
NBP2-29541) or pCL-Eco (regional reprogramming) (Novus Biologicals NBP2-29540) using XtremeGENE 9 DNA Transfection Reagent (Sigma Aldrich XTG9-RO). Retrovirus for HIIP
reprogramming was collected 48 and 72 hours after transfection, filtered through a 0.45 µm filter
and concentrated using 50% PEG solution before application to cells. Retrovirus for regional
reprogramming was collected 72 hours after transfection, filtered through a 0.45 µm filter and
concentrated by centrifugation at 4500xg for 16-24 hours at 4oC before application to cells.
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4.10.5 HIIP Transduction
HIIPs were transduced with retrovirus (production methodology in Subsection 4.10.4)
using an adaptation of the methods described in Miura & Suzuki, 2017.80 Briefly, HUVEC cells
were grown to 20-30% confluence in a 6-well plate. Every 12 hours for a total of 8 transductions,
the endothelial growth medium was replaced with 1.86 mL media, 25 µL of each virus was
added, and 4 µL of 500x protamine sulfate was added. 12 hours after the final (8th) transduction,
cells were trypsinized (TrypLE Express (Gibco 12605036)) and resuspended at a concentration
of 1x105 cells/25 µL of Matrigel (Corning 543234) and plated as a 25 µL droplet in the wells of
a 48-well culture plate. Matrigel was allowed to polymerize for 10 minutes at 37oC, 5% CO2 in
an incubator before medium was added and cells cultured for 20-21 days before passaging or
analysis at 37oC, 5% CO2 in an incubator. For days 0-12, media consisted of a 4:1 ratio of
endothelial media:WCENR media. For days 12-16, media consisted of a 2:3 ratio of endothelial
media:WCENR media. For the final days 16-21, media consisted of 100% WCENR.
WCENR media consists of: Advanced DMEM/F-12 (Gibco 12634010), 1x B27 (Gibco
17504044), 1x N-2 (Gibco 17502048), 1 mM N-acetylcysteine (Sigma-Aldrich A9165), 2mM
GlutaMax

100x

(Gibco

35050061),

10

mM

HEPES

1M

(Gibco

15630106),

1x

penicillin/streptomycin, 10 µM Y-27632 (Sigma Aldrich Y0503), 0.5 µM A8301 (Tocris 2939),
10 µM SB202190 (Sigma Aldrich S7067), 10 mM Nicotinamide (Sigma Aldrich), 10 nM
[Leu15]-Gastrin1 (Sigma Aldrich G9145), 2.5 µM prostaglandin E2 (Sigma Aldric P5640), 50
ng/mL human recombinant EGF (Sigma Aldrich E9644), 100 ng/mL human recombinant
Noggin (PeproTech 250-38), 1 mg/mL human recombinant R-spondin1 (Miltenyi Biotec 130114-824), 100 ng/mL human recombinant Wnt3a (R&D Systems 5036-WN), and 3 µM
CHIR99021 (Cayman Chemicals 13122).
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4.10.6 Regional Reprogramming Transduction and Induction
Villin-CreERT2 ileal organoids were transduced with retrovirus (production methodology
in Subsection 4.10.4) using an adaptation of the methods described in Koo et al., 2012; Koo,
Sasselli, & Clevers, 2013; and Andersson-Rolf et al., 2014.43,224,225 Briefly, 2 days prior to
transduction, organoids were passaged and cultured in 20 µL droplets of Growth-Factor
Reduced, Phenol Red-free Matrigel (Corning 356231) in 250 µL IntestiCult Organoid Growth
Medium (StemCell Technologies #06005) supplemented with 5 µM CHIR99021 (Cayman
Chemicals 13122) and 10 mM Nicotinamide (Sigma Aldrich) to expand stem cells. On the day of
transduction, organoids were transferred from the plate and mechanically disrupted by pipetting
up and down 30-50 times using a P-200 pipette tip. Cells were centrifuged 5 minutes at 900xg at
4oC. The pellet was resuspended in 500 µL TrypLE Express (Gibco 12605036) and incubated at
37oC for 5 minutes until small cell fragments formed. 500 µL of IntestiCult (StemCell
Technologies #06005) was added and the cells centrifuged 5 minutes at 900xg at 4oC. To infect,
the prepared organoid cells were combined with the retroviral suspension (concentrated
retrovirus in IntestiCult (StemCell Technologies #06005) with 5 µM CHIR99021 (Cayman
Chemicals 13122), 10 mM Nicotinamide (Sigma Aldrich), 10 µM Y-27632 (Sigma Aldrich
Y0503), and 10 mg/mL protamine sulfate) in wells of a 48-well culture plate. The cells and virus
were mixed well using a P-1000 pipette tip then the plate sealed with Parafilm (Sigma Aldrich
P7793) before centrifugation for 60 minutes at 600xg at 32oC (“spinoculation”). After
centrifugation, the Parafilm was discarded and the plate incubated for 6 hours at 37oC, 5% CO2
in an incubator. After 6 hours, the cells were collected and centrifuged for 5 minutes at 900xg at
4oC. The infection medium was then aspirated, and the pellet left on ice for 5 minutes. Cells were
resuspended in 100 µL of Growth-Factor Reduced, Phenol Red-free Matrigel (Corning 356231)
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and plated in 25 µL droplets in the wells of a 48-well plate. The droplets were allowed to
polymerize for 10 minutes at 37oC, 5% CO2 in an incubator before addition of 250 µL of
infection medium (IntestiCult (StemCell Technologies #06005) with 5 µM CHIR99021 (Cayman
Chemicals 13122), 10 mM Nicotinamide (Sigma Aldrich), and 10 µM Y-27632 (Sigma Aldrich
Y0503). After 2-3 days of culture, medium was changed to pure IntestiCult, and we introduced
10 µL/mL puromycin (Sigma-Aldrich P8833) to select for successfully transduced organoids and
continued to passage and culture transduced organoids normally with puromycin selection until
use.
To induce overexpression of genes of interest, organoids were passaged and replated in
growth media + 10 µL/mL puromycin (excluding puromycin in non-transduced controls) for 10x
experiment. 1 µL of vehicle was added to proximal control wells and 1 µM Tamoxifen ((Z)-4hydroxy Tamoxifen) (Cayman Chemical 14854) was added to empty control and experimental
wells. After 48 hours of treatment, cells were monitored for appearance of eGFP as the dsRed is
cut out through recombination out and the gene overexpression induced. Media was refreshed as
needed. After 5 days, cells and controls were collected for scRNA-seq. Growth media consists
of: 21.75 µL basal media, 0.5 mL B27 (Gibco 17504044), 250 µL N-2 (Gibco 17502048), 65 µL
500 mM N-acetylcysteine (Sigma-Aldrich A9165), 12.5 µL 100 µg/mL EGF, 25 µL 100 µg/mL
stock mouse Noggin (PeproTech 250-38), 25 µL 100 µg/mL stock R-spondin 1 (R&D Systems
7150-RS0010/CF). Basal media consists of 48.5 mL Advanced DMEM:F12 (Gibco 12634010),
0.5 mL GlutaMax 100x (Gibco 35050061), 0.5 mL HEPES 1M (Gibco 15630106), 0.5 mL
penicillin/streptomycin.
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4.10.7 Quantitative PCR
HIIPs and organoids for qPCR were collected and prepared as follows. Each Matrigel
dome was scraped and dissociated by pipetting before pipetting into 15 mL tubes. Samples were
centrifuged at 500xg for 3 minutes. Media was carefully aspirated, and RNA was collected using
the RNeasy Mini Kit (QIAGEN 74104). cDNA was synthesized from equal amounts RNA using
the Maxima First Strand cDNA Synthesis Kit (Thermo Scientific K1641). cDNA was amplified
using TaqMan Gene Expression Master Mix (Applied Biosystems 4369016) and the primer
probes on the StepOnePlus Real-Time PCR System (Applied Biosystems 4376600) using
StepOne

Software

v2.3.

Primer

probes

were:

(Hs00156145_m1),

LGR5

(Hs02758991_g1),

Creb3l3

(Mm00520279_m1),

Apoa1

(Mm00437569_m1),

(Mm00516104_m1),

(Hs00969422_m1),

SOX9

VIL1
Gata4
Apoc3

(Hs00165814_m1),

(Hs01031724_m1),

KLF5
GAPDH

(Mm00484689_m1),
(Mm00445670_m1),

Klf4
Fabp1

(Mm00444340_m1), Fabp6 (Mm00434315_m1), Hprt (Mm03024075_m1), and Rbp2
(Mm00436300_m1) all from Applied Biosystems.

4.10.8 Organoid Collection for scRNA-seq
Controls and experimental organoids for scRNA-seq were collected and prepared as
follows. Each control or experimental Matrigel dome was scraped and dissociated by pipetting
before pipetting into 15 mL tubes. Samples were centrifuged at 500xg for 3 minutes. Media was
carefully aspirated and 3 mL TrypLE Express (Gibco 12605036) was added. Organoids were
agitated through pipetting up and down 20-30x with a p200 pipette and placed in a 37oC bath.
Every 5 minutes, cells were agitated via pipetting 20-30x and checked for breakdown to single
cells. When cells achieved single-cell state, 5 mL of DMEM:F12 (Gibco) was added, and the
cells were filtered through a 40 µm FlowMi strainer (Bel-Art H136800040). Cells were counted
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and viability checked using Trypan Blue exclusion (viability > 90% required). Final samples
were centrifuged at 500xg for 3 minutes at 4oC.

4.10.9 scRNA-seq Library Preparation
For single-cell library preparation on the 10x Genomics Chromium platform, we used the
3’CellPlex Kit Set A (PN-1000261), Chromium Next GEM Single Cell 3’ Kit v3.1 (PN1000268), 3’ Feature Barcode Kit (PN-1000262), Chromium Next GEM Chip G Single Cell Kit
(PN-1000120), and Dual Index Kit NN, Set A (PN-1000243), according to the manufacturer’s
instructions in the Chromium Next GEM Single Cell 3’ v3.1 Cell Surface Protein User Guide
(Rev. B). Resulting cDNA libraries were quantified on an Agilent Tapestation and sequenced on
an Illumina NextSeq500.

4.10.10 scRNA-seq Analysis
The Cell Ranger 6.0 pipeline was used to align reads to the mm10 genome build,
demultiplex at a confidence level of 0.75, and generate a digital gene expression (DGE) matrix:
(https://support.10xgenomics.com/single-cell-gene-expression/software/downloads/latest).

For

initial filtering of these DGE matrices, we first excluded cells with a low number (<200) of
unique detected genes. We then excluded cells for which the total number of unique molecules
(UMIs) (after log10 transformation) was not within 3 standard deviations of the mean. This was
followed by the exclusion of outlying cells with an unusually high or low number of UMIs/genes
given their number of reads by fitting a Loess curve (span = 0.5, degree = 2) to the number of
UMIs/genes with number of reads as predictor (after log10 transformation), removing cells with a
residual more than 3 standard deviations the mean. Finally, we excluded cells in which the
proportion of the UMI count attributable to mitochondrial genes was >15%. After filtering and
normalization of the DGE, the R package Seurat (Version 4) was used to cluster and analyze the
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single-cell transcriptomes.102 Highly variable genes were identified and used as input for
dimensionality followed by clustering and visualization via UMAP.103 CellOracle was used for
Gene Regulatory Network analysis and overexpression simulations.101 R package Capybara was
used for cell type identification and multi-id cell type identification.100

4.10.11 Imaging
Bright field images were taken on a Nikon Eclipse Ts2 with Nikon DS-Fi2 camera

4.10.12 Statistical Analysis
Statistical comparison of the qPCR datasets was performed using an unpaired
Student’s t test. Graphs with error bars represent fold change ± SD. P < 0.05 was considered
significant. Figure 4.2 statistics are based on the mean delta CT values (n = 2 technical
replicates) between controls and HIIPs (LGR5 is a separate experiment). Figure 4.5 statistics are
based on the mean delta CT values (n = 3 technical replicates) between groups. Figure 4.6
statistics are based on the mean delta CT values (n = 3 technical replicates) between Gata4 and
proximal control treatments, only this comparison is included for space constraints.
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Chapter 5: Conclusions and Future
Directions
5.1 Conclusions
In conclusion, this dissertation utilized scRNA-seq alongside computational and
experimental analysis to contribute to the field of work surrounding the study of Short Bowel
Syndrome and molecular-level adaptation after small bowel resection. The findings of this work,
both preliminary and published, greatly advance the available information regarding cellular
changes after adaptation and provide future researchers with two modeling tools for use in
continued study and discovery in SBS. These findings additionally lead the author to pose many
new questions and research directions for continued advancement of the field and this research.
In this work we addressed three major questions, the first of which concerned the
molecular changes associated with structural adaptation after SBR on a single cell level. To
approach this question, we utilized scRNA-seq to dissect cellular identities after resection on an
established in vivo model of SBR. We identified the novel occurrence of a proximalization of a
population of enterocytes of the remnant distal intestine which we deemed “regional
reprograming”. This regional reprogramming process consists of the upregulation of a variety of
nutrient and lipid transporters and markers typically associated with the proximal bowel. Our
scRNA-seq findings regarding changes in transporters such as Fabp1 in these cells were well
supported by previous literature reports of bulk gene expression changes after resection and we
performed additional validations of these findings using in situ detection methods.183 Based on
these results, we hypothesized that regional reprogramming is a functional compensatory effect
of adaptation. While structural adaptation compensates directly for loss of intestinal surface area,
regional reprogramming compensates for the loss of expression of critical nutrient and lipid
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transporters in order to maintain regional functionality of the bowel in nutrient absorption. The
elucidation of the regional reprogramming process accompanying structural adaptation answers
our initial question through defining distinct molecular changes in cell populations associated
with the adaptation process. The discovery of regional reprogramming and the accompanying
changes in gene expression provide researchers in the field with novel markers and pathways of
mouse adaptation to study for potential applications in human SBR treatments to encourage
adaptation.
Our interest in regional reprogramming and the molecular side of adaptation did not end
with determining molecular effects of structural adaptation, but also included diving into the
scRNA-seq data to answer our second question of how we could apply scRNA-seq datasets to
determine potential upstream drivers of adaptation and regional reprogramming. While structural
adaptation is well described, the actual pathways inducing adaptive changes (structural
adaptation and regional reprogramming) are ill-defined. The determination of upstream drivers
can identify specific triggers of successful adaptation which could be used to encourage
adaptation in humans. We applied in silico interactome analysis to our SBR dataset and
determined that Retinoic Acid metabolism and signaling was a likely driver of adaptation based
on our downstream gene activation. This finding was well supported by literature reports of the
effects of exogenous RA on structural adaptation.183
Our analysis in Chapter 2 indicated an upregulation of transcription factors Creb3l3 and
Klf4 after adaptation, sparking interest in upstream transcription factor drivers of regional
reprogramming that could be used in vitro to help model regional reprogramming. In subsequent
studies into modeling of regional reprogramming in vitro, we again turned to in silico analysis to
assist in picking out transcription factors likely to play a role in the process. We utilized
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CellOracle

to

identify

potential

upstream

transcription

factors

regulating

regional

reprogramming, pursuing Klf4 and Creb3l3.101 Using the scRNA-seq findings that there was
increased proximal enterocyte identity after SBR in our Chapter 2 dataset, we identified Gata4 as
a potential driver of regional reprogramming from the literature. Through these methods, we
combined in silico analysis of scRNA-seq data with our previous findings to identify potential
upstream drivers of regional reprogramming for further study, addressing our second question
and providing the field with novel likely candidates for induction of regional reprogramming in
mice.
Our in silico findings regarding RA signaling and upstream transcription factors led our
final drive to generate models of regional reprogramming in vitro for use in future study of
regional reprogramming. In doing so, we approached our final question of how we could model
adaptive responses using organoids, cellular reprogramming, and scRNA-seq analysis. In
following up on the findings indicating a role for RA in regional reprogramming, we
hypothesized that disruption of an endogenous Vitamin A/RA gradient induced regional
reprogramming of the distal bowel though exposure to higher levels of Vitamin A/RA.183 We
used this hypothesis to build our chimeric organoid model in which proximal and distal intestinal
organoids are combined to create a unique signaling environment between proximal and distal
tissue capable of reprogramming distal enterocytes through exposure to signaling factor
gradients.
We again utilized scRNA-seq to analyze the outcomes of this modeling system. In doing
so, we found preliminarily that the exposure of distal intestinal organoid tissue to a proximal
signaling environment through chimerization activates more proximal identities in distal cells
(detected by assignment of computational proximalization scores and cellular identities via
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Capybara).100 In doing so, we uniquely combined scRNA-seq analysis and cellular
reprogramming of organoids to generate a preliminary in vitro model of regional reprogramming
that can greatly increase the ability of labs to study regional reprogramming because of the
departure from an in vivo system.
We proposed utility for this model through using further computational analysis
(CellPhoneDB) on the scRNA-seq data.107 This analysis indicates a role for GC-C signaling
during chimerization-related regional reprogramming. This pathway has not previously been
associated with regional reprogramming and provides a future target for study and treatment and
highlights the utility of the chimeric model for discovery of novel pathways activated in regional
reprogramming.
We even further developed our modeling capabilities through applying our findings on
upstream transcription factor activation through use of direct reprogramming on distal organoids.
In doing so, we studied the effects of transcription factor overexpression in order to better
delineate effects of different transcription factors during the regional reprogramming process. In
utilizing Gata4 for direct reprogramming, we found that Gata4 alone was insufficient to induce
proximalization, but our findings led us to hypothesize that combinations of transcription factors
will produce the intended effect. Again, Capybara and proximalization scores were used to
identify proximalization or regional reprogramming in this system, highlighting how scRNA-seq
datasets can be used for high-level analysis of in vitro organoid and reprogramming systems.
Overall, our findings advance the field and promote future, more well informed studies of
the response of the bowel after resection. In Chapter 2, we identified a process inducing
molecular changes in adaptation–regional reprogramming–and mined our scRNA-seq dataset to
identify potential upstream drivers of regional reprogramming. These findings will assist in the
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further expansion of knowledge regarding successful adaptation in mice and can better inform us
of mouse triggers that could be employed to induce adaptation in human systems. In addition, the
scRNA-seq dataset we built of SBR is available online and can be mined by other labs for new
information. In Chapter 3, we introduced a preliminary model for in vitro regional
reprogramming and downstream discovery of pathways activated in regional reprogramming, the
chimera. This model can greatly contribute to the prediction of human response to resection
through using patient organoids for chimerization and measuring their endogenous response and
ability to proximalize. Ultimately this can better target treatments for specific patients. It also
provides a system to discover pathways affected by regional reprogramming for future study,
providing valuable targets for future treatment of SBS. Finally, in Chapter 4, we coupled direct
reprogramming with scRNA-seq analysis to provide a system capable of providing insight into
the effects of transcription factor signaling on regional reprogramming. This system will prove
valuable for testing which transcription factors are playing a role in successful mouse adaptation
and also can inform clinicians of the effects and potential utility of those transcription factors on
inducing regional reprogramming in humans through use of patient-derived organoids in the
direct reprogramming.
While our study provided us with new findings, models, and methods for investigating
and addressing SBS, it also piques interest in many follow-up studies and experiments. Some
questions we believe should be addressed in future studies include: How can we further mature
organoids in vitro? How can we improve the power of our scRNA-seq experiments? Is RA
signaling upstream of the chimeric changes? Can we use functional testing to validate regional
reprogramming in organoids and chimeras? What is the role of GC-C signaling in regional
reprogramming? Is proximalization accompanied by reciprocal distalization of remnant proximal
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tissue? What are the effects of Creb3l3 and Klf4 on distal organoids? And finally, how can we
use direct reprogramming to test combinations of transcription factors for induction of regional
reprogramming? In our final section, Section 5.2, we will propose experiments and
methodologies to approach these questions in the future.

5.2 Future Directions
The results and conclusions presented in this dissertation lay the groundwork for many
additional studies to follow up on and expand on the findings regarding regional reprogramming
and SBR. In this final section, we briefly outline future experimental approaches for pursuit of
these questions as are justified by our findings.
How can we further mature organoids in vitro? In Chapters 3 and 4 we utilized
organoid systems for modeling regional reprogramming in vitro, however, as discussed, we
struggled with formulating a media to promote differentiation of stem cells in the organoids. This
resulted in a high incidence of stem cells in all cultures. While expansion of stem cells is
necessary to culture organoids effectively, encouraging differentiation for endpoint experiments
is justified as it will better inform researchers about changes to end-point cellular composition in
the organoid models we present by enlarging the population of fully differentiated cells.
To approach this issue, we propose testing and formulation of multiple media conditions
to modulate the Wnt, Notch, and BMP pathways, as these are reported to control stem cell
renewal and differentiation in organoids. We suggest modulating the culture concentrations of Rspondin 1, Noggin, and Wnt3a to promote differentiation of cells.194 In particular, the
concentrations of R-spondin 1 and Noggin should be titrated down to promote differentiation but
still be present to promote stem cell proliferation for organoid growth. In order to determine the
optimized culture conditions, qPCR should be performed as before to check for increase in
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mature markers such as Alpi and decrease in stem markers such as Lgr5 while organoid growth
characteristics are monitored to maintain some cellular expansion. Once a promising formulation
(or several) is identified, the resulting organoids should be analyzed for differentiated cell
identities via scRNA-seq and for imaging to gain a full, consistent view of the population. This
experiment is critical to future use of the organoid models as it will allow for the organoids to
better recapitulate the cell distribution of the intestine and will optimize the models to best mimic
the in vivo environment for in vitro testing for further use in the field.
How can we improve the power of our scRNA-seq experiments? A shortcoming of the
experiments performed in Chapters 3 and 4 was underpowered analysis of scRNA-seq data due
to small sample sizes being of high enough quality to analyze. The causes of this were due to
failure to detect mT/mG cells and failure to demultiplex combined experiments. To improve the
power of the findings, future work should make two major changes: 1) chimeras should switch
from mT/mG organoids to UBC-GFP ad 2) cell multiplexing should be carefully titrated to
increase demultiplexing output.
Chapter 3 mentioned the use of mT/mG organoids expressing tdTomato to detect
organoid origins within a chimera. Unexpectedly, scRNA-seq analysis detected only low
numbers of cells identifiable by tdTomato expression. Research into the topic suggests this is a
common problem among users and may be due to the 3-D structure of tdTomato mRNA being
difficult to sequence. This results in what we call “drop out” or the failure of scRNA-seq to
detect expression of a gene even though it is expressed in the cell, often due to low levels of
expression. Ultimately, this resulted in our analysis having very few distally-derived chimera
cells to test and also meant that the remaining proximally-derived chimera cells could not be
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reciprocally tested for identity changes due to the likelihood of presence of “dropped out” distal
cells in their population.
Moving forward, the chimeric system must be optimized to avoid this detection issue.
Distal organoids should be newly derived from a GFP expressing mouse, such as the UBC-GFP
mouse, as GFP is well-detected by scRNA-seq. The chimeric experiments should be replicated
using these GFP organoids instead of mT/mG in order to increase detected populations of
distally derived organoids and allow for reciprocal proximal analyses.
In Chapter 3, R1, and Chapter 4, cell multiplexing methods were used to ameliorate
potential batch effects in the datasets.226 However, the multiplexing methods require more
optimization to enhance cell capture. The 10x Genomics CellPlex kit was utilized but a majority
of cells failed to be identified by their oligo-tag as the background detection was too high.
According to 10x Genomics representatives, future experiments can lower this background level
to allow for higher cell capture and identification by increasing wash steps after tagging of the
cells. Optimization must be carried out to test the effects of additional washes on background
detection and cell viability/quality such that the two can be balanced and enhance the datasets.
By using GFP in the chimera and amending the multiplexing, future studies will increase sample
sizes and the confidence of the analysis such that the results can be better interpreted and applied
to the field and the chimeric model can be used and studied with greater confidence.
Is RA signaling upstream of the chimeric changes? In Chapter 2, we identified RA
signaling as a likely upstream trigger of regional reprogramming. The actual presence of RA
signaling in the upstream cascades merits further investigation so that it can be determined the
role it truly plays. This question arises as RA signaling is reportedly related to many of our
investigations. RA is a putative activator of Creb3l3, Klf4, Gata4, and Cdx2—known to regulate
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Gucy2c expression.147,227,228 Because of this potential role of RA signaling upstream of the three
transcription factors of interest from direct reprogramming and the GC-C pathway activated by
chimerization, we ask what role RA signaling plays in regional reprogramming during
chimerization.
To address this question, we suggest utilizing RA inhibitors (inhibitors of RARs and
RXRs) and administration of exogenous RA (all-trans Retinoic Acid and/or 9-cis Retinoic Acid)
in organoid cultures during chimerization. After the growth period, we propose to follow with
scRNA-seq to analyze changes in proximalization compared to traditional chimera models as
well as look into expression of regional reprogramming related genes. If RA promotes regional
reprogramming, we’d expect administration of exogenous RA to chimeras to enhance
proximalization and gene expression while administration of inhibitors would lower
proximalization and gene expression. By performing this follow-up, the lab can better determine
how much of a role RA signaling is actually playing during the process. If RA is truly a highlevel upstream activator of regional reprogramming as we propose, it could be used for future
therapeutic advances for SBS, and the chimeric system could be used to titrate treatment.
Can we use functional testing to validate regional reprogramming in organoids and
chimeras? The conclusions of this dissertation regarding the proximal identity of resulting
organoids from chimerization or direct reprogramming relied on in silico modeling and analysis.
We recommend additional validations be performed on these models to validate that the altered
gene expression in the organoids relates to altered functions such as proximal nutrient transporter
activity. Such validation will assist in determining how well chimerization or other
reprogramming methods truly mimic regional reprogramming in a dish and their utility as
models.
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To investigate the functionality of the adaptive gene expression changes noted in
chimeras, we propose use of a labeling and transport approach. We suggest that the lab labels
various nutrients absorbed in the proximal intestine and monitors for increased transport in the
organoid system. One method to do this would be to focus on FABP1 and FABP2, proximally
expressed fatty acid binding proteins shown to increase after resection.183 These studies could
employ radiolabeled long chain fatty acids or BODIPY FL C16, a fluorescent fatty acid, to test
for functionally increased transport of fatty acids after chimerization.229 In doing so, the lab will
validate and strengthen the chimeric model for use in the field, increasing its applicability to
treatment-related studies as a functional model.
What is the role of GC-C signaling in regional reprogramming? The findings in
Chapter 3 encourage future study the GC-C pathway for involvement in SBR and SBS—a
previously unstudied and novel SBR-related pathway. As the Gucy2c discovery was first made in
the preliminary chimera model using in silico analysis, the place to start looking at Gucy2c
involvement in adaptation is to ask whether it is involved in vivo, then to investigate direct
effects. First, we recommend using the available Gucy2c knockout mouse model for 50% SBR
surgery as described and utilized in Chapter 2. Subsequently, scRNA-seq should be carried out
on the tissue after the adaptation period and compared to SBR in normal mouse to investigate for
regional reprogramming-related changes. If GC-C signaling increases play a role in the regional
reprogramming response, we would expect that loss of Gucy2c would have a detrimental effect
on detectable adaptation and regional reprogramming in the system. Investigation and validation
of Gucy2c signaling and its potential role in regional reprogramming will advance knowledge of
signals leading to regional reprogramming and gives way to potentially using modulations of
such signaling pathways to enhance adaptive responses in humans.
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Is proximalization accompanied by reciprocal distalization of remnant proximal tissue?
The CellPhoneDB investigation in Chapter 3 raised an interesting question due to the
observation that proximally derived chimeric tissue showed higher levels of GUCA2A and
GUCA2B expression compared to proximal controls.107 As previously mentioned, analysis of the
proximal portion of the chimera is confounded by the inclusion of dropped-out distal cells in the
population, but these increased levels of GUCA2A and GUCA2B in proximal cells begs the
question: does proximal intestine distalize via regional reprogramming in response to resection?
It seems likely, as the hypothesis that gradients change due to disrupted intestinal length would
affect proximal intestinal gradients as well.
To look into this possibility, we suggest to, in essence, repeat the work of Chapter 2, but
focus on the proximal intestine. After the traditional SBR and adaptation period, tissue proximal
to the anastomosis should be collected and analyzed for changes between sham and SBR mice. If
the proximal tissue is distalizing, we would expect to see an upregulation in expression of distalrelated transport genes in the cell populations, like Fabp6. This study would help generate a
more well-rounded picture of the adaptive response in the intestine as a whole instead of
focusing only on the distal intestine and could better inform how clinicians target future
treatments and even re-design regional bowel resections such that the remnant regions are more
likely to adapt.
What are the effects of Creb3l3 and Klf4 on distal organoids? Based on our findings in
Chapters 2 and 4, we remain inquisitive about the roles that Creb3l3 and Klf4 play in the regional
reprogramming process. We suggest that the lab continue use of the regional reprogramming
organoid model to delineate effects of these transcription factors in vitro. However, we suggest
that prior to these investigations, new organoid lines capable of being induced with minimal
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leakage are derived.208 To do so, the lab should source several organoid lines from different
litters of mice expressing Cre-recombinase in intestinal cells (e.g.: Villin-CreERT2, ROSA26CreERT2). The levels of Cre-recombinase in each line could be determined using Western
Blotting to identify a less-highly expressed but still active Cre-recombinase line for use. Deriving
new organoid lines will strengthen the direct reprogramming system for use as a temporal system
of reprogramming. Combination of this system with Creb3l3 and Klf4 will provide us with
greater knowledge of the roles of these upregulated transcription factors in regional
reprogramming, extending the knowledge from Chapter 2.
How can we use direct reprogramming to test combinations of transcription factors for
induction of regional reprogramming? Finally, our work implies that combinations of signals
and factors are necessary to induce regional reprogramming. We seek to answer the major
question: what combination of transcription factors induces regional reprogramming in vitro?
Testing combinations of transcription factors used to rely on a classical “pool and pull” approach
in which groups of factors were pooled and expressed and then removed one by one to determine
effects.70 The process was lengthy and prone to errors.
To overcome shortcomings of this process, we suggest future study utilize new
technology from the lab, CellTags, to greatly enhance this approach. We suggest using the
CellTag as a barcoded gene expression vector that can be used to detect what transcripts are
expressed in a cell. For this experiment, the researchers should clone transcription factors of
interest into individually barcoded CellTags, such that each transcription factor has a unique
barcode. The CellTags can then be pooled and utilized for direct reprogramming of organoids at
an MOI which encourages different combinations and amounts of viral particles infect each cell.
Following reprogramming, the organoids should be collected and analyzed for regional
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reprogramming-related changes via scRNA-seq. When cells are identified with promising
changes, the barcodes present in that cell can be used to determine which transcription factors are
expressed and involved in the identity changes. Further testing of these factors will lead to the
optimal combination of factors for induction of regional reprogramming.79 This experiment in
particular provides much to the field of SBS research, it will not only greatly advance our
knowledge of the upstream factors involved in regional reprogramming and their downstream
effects for targeted treatments to promote adaptation in humans, but also will provide a complete
in vitro model for investigation of regional reprogramming and modulation of the process.
In summation, the data and conclusions provided by this dissertation provide not only
important findings for the field of study around SBS and bowel resection, but also provide the
groundwork, models, and ideas for extensive future studies on regional reprogramming and
adaptation. Continued research based on the provided future directions will greatly increase
familiarity with what factors and pathways are driving regional reprogramming and adaptation,
how we can optimize our modeling of this process, and ultimately will directly impact human
health through promoting better, personalized testing and treatment of SBS.
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